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1. INTRODUCTION 
The goal of this investigator was to examine the effects of allelic 
variation of a regulatory gene on the expression of a plant biosynthetic. 
pathway. The anthocyanin pathway was chosen because of its long history of 
scientific study, its biological and economic importance, and its potential for 
modeling quantitative traits. 
Maize was chosen as the ideal organism for studying regulatory gene 
action in the anthocyanin pathway. Over 90 years of research on the genetic 
control of seed pigmentation means that the pathway in maize is well 
described. Most major steps in the pathway have been identified with a gene 
locus. Both the structural and regulatory genes have varied and plentiful 
mutants and some are now being described at the molecular level. For many 
of the encoded enzyme products, biochemical assays are available. 
Specifically, this study was designed to investigate the effects of the CI 
regulatory locus on the expression of the anthocyanin pathway during maize 
aleurone tissue development. It was also designed to identify a series of 
flavonol glycoside and anthocyanin derivatives related to quercetin when 
these compounds are expressed in the selected tissues. To meet these two 
objectives, the tasks were subdivided into the following categories: 
1) selection of tissues examined for anthocyanin pathway expression, 
2) identification of anthocyanin pathway products present in the selected 
tissues, 3) examination of the effects of selected CI locus alleles and tissue 
maturities on the expression of identified anthocyanin pathway products, 
and 4) integration of the experimental results with the information currently 
available in the literature. 
2 
The selection of which tissues to examine is actually a selection of 
experimental treatments. As defined in this study's goals, the two types of 
treatments are: 1) CI locus allelic variability and 2) kernel tissue maturity. 
There are a range of options available for each. The CI locus variability can 
be divided into several classes of alleles, while kernel maturity can extend 
from pollination to complete dry down of a fully developed kernel. 
To select the CI locus treatments, a large set of alleles were screened. 
These alleles represented the naturally occurring variability at this locus and 
included C-I dominant color inhibitors, C dominant color producers, and c 
colorless recessives. The c alleles were further subdivided into those that 
contained transposable elements (receptor elements) and those created 
through other mutational events. 
This initial set of CI locus alleles was evaluated in their original genetic 
background to establish their relative dominance. A representative subset 
was then selected. This subset includes members of the C-I, C, c-transpos-
able element, and c classes of alleles. 
These alleles were transferred via a crossing program into a common 
genetic background. In this way the selected CI locus allele is the sole source 
of variation in the genotype treatment. The presence of other anthocyanin 
pathway loci variations in the original stocks should not contribute to the 
variation in treatment genotype. 
To select the maturity treatments, several evenly spaced kernel 
maturities measured in days after pollination (DAP) plus the fully mature 
dry kernel were evaluated. Then a smaller set representing the kernel 
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maturation process was selected. These selections make up the tissue 
maturity treatment. 
A second task was the identification of anthocyanin pathway products 
for examination in this study. This focused on the latter half of the pathway 
and included both enzyme activities and flavonoid products. Of particular 
interest was the utilization of quercetin and the production of its derivatives. 
Of the anthocyanin pathway enzymes identified in maize, 
UDPglucose:flavonoid 3-0-glucosyltransferase (UFGT) is the only one 
identified which utilizes quercetin. UFGT is also the only glucoside 
transferase identified in maize. Hence, the study of treatment (Ci locus and 
maturity) effects on quercetin utilization included an examination of UFGT. 
In maize there is evidence to suggest the presence of other glucoside 
transferases (Dooner, 1979; Ceska and Styles, 1984). No positive identification 
has been made. In other species, UDPglucose:flavonoid 7-0-
glycosyltransferase has been identified (Sutter et. ah, 1972; Sutter and 
Griesbach, 1973). This is a quercetin utilizing enzyme. Therefore, crude 
enzyme extracts were screened for quercetin utilization not associated with 
UFGT. In this way, evidence was gathered which supports the hypothesis 
that an enzyme such as UDPglucose:flavonoid 7-0-glycosyltransferase exists 
in maize. 
The other anthocyanin pathway products which were screened for are 
flavonoids. These included quercetin glycoside derivatives, substituted 
cinnamic acids, and acylated anthocyanins. The selection of the individual 
compounds for this screening depended on previous reports of occurrences in 
maize and the availability of standards for identification purposes. 
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The third task was to examine the effects of the selected CI locus alleles 
and tissue maturities on anthocyanin expression in aleurone tissue. It 
utilized the tissue treatments (Ci locus genotypes and tissue maturities) and 
assayed for anthocyanin pathway products identified in the previous two 
tasks. Replicated samples for each treatment were utilized to develop a 
profile of anthocyanin pathway expression in maize aluerone. 
Finally, these results are analyzed and related to the information 
currently available on the anthocyanin pathway in maize. Information is 
presented on the identification of anthocyanin pathway products not 
previously isolated in maize aleurone. The influence of kernel maturation on 
the accumulation of many of the assayed anthocyanin pathway products is 
described for the first time. This study also expands the description of the 
selected Cl locus alleles by comparing their effects on pathway expression. 
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2. LITERATURE REVIEW 
In 1835, L. C. Marquait first used the word "anthocyanin" to describe 
the blue pigments found in flowers. Later this definition was expanded to 
include many, if not most, water-soluble blue, purple, magenta, red, and 
orange pigments found in flowers, fruits, leaves, stems, and roots of higher 
plants. Since the mid-1800's, detailed chemical, genetic and biological 
studies have defined the structure, biosynthesis, genetic control, and 
biological activity of anthocyanins and 14 other related classes of flavonoids. 
Today, over 3000 flavonoid compounds have been reported in higher 
plants (Harborne, 1986). These represent 15 classes of compounds, 
including; anthocyanins, flavones, flavonols, flavone and flavonol glycosides, 
chalcones, aurones, dihydrochalcones, proanthocyanidins, flavonones, 
dihydroflavonols, C-glycosylflavonoids, bioflavonoids, isoflavonoids, and 
neoflavanoids (Harborne et al., 1975). For a brief description of each along 
with a structural diagram see Appendix I. 
2.1. Flavonoids Express a Variety of Biological Functions 
Flower, fruit, and plant colors have probably attracted humans since 
prehistoric times. As indicators of food ripeness and quality they have played 
a role in our survival. Anthocyanins are the principle pigments for orange to 
blue plant tissue coloration. Hence, their continued importance to the 
agricultural and food industries. For recent reviews on the contributions of 
anthocyanins to food and beverage coloration see reviews edited by P. 
Markakis (1982) and by V. Cody and coworkers (1988). 
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In the last several decades, the impact that flavonoids have on 
agriculture has become increasingly apparent. Individual flavonols, flavone 
and flavonol glycosides, aglycones, and anthocyanins affect insect feeding 
behavior. Cotton is an example of the diversity of plant-insect interactions. 
Quercetin (a flavonol), quercetin-7-glucoside, and -3'-glucoside (flavonol 
glycosides) are stimulants for the boll weevil feeding on cotton buds (Hedin et 
al., 1968). In contrast, the cotton bollworm experiences growth inhibition 
with the consumption of flavonol glycosides and aglycones (Chan et al., 1978). 
The anthocyanin, cyanidin-3-glucoside, is a feeding inhibitor. Its target 
insect is the tobacco budworm (Hedin et al., 1983) which also feeds on cotton. 
With the increased societal pressure to phase out toxic pesticides, the 
understanding of and ability to utilize flavonoid effects on insects will have 
increasing economic value. 
Flavonoids also mediate interactions between plants and bacteria. Root 
exudates of legumes such as alfalfa contain flavones and/or flavanones 
which act as inducer molecules for nod gene expression in Rhizobium 
bacteria (Peters et al., 1986; Redmond et al., 1986; Zaat et al., 1987). The nodD 
gene of individual Rhizobium species exhibits a host plant specificity. This 
selectivity is the result of the nodD gene product's ability to interact with 
individual flavonoids (Spaink et al., 1987). With an increased understanding 
of the role flavonoids play in root nodulation, this nitrogen fixing symbiotic 
relationship may undergo engineering for improved agricultural utilization. 
A relatively new area of study is the pharmacological activity of 
flavonoids. Proceedings from two meetings (Cody et al., 1985; and Cody et al., 
1987) contain papers on numerous pharmacological properties of flavonoids. 
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These include: both anti-allergic and sensitizing, anti-inflammatory, anti­
tumor, and antiviral activities. With continued study, the vast variety of 
biological properties associated with flavonoids promises to expand. 
2.2. Flavonoid Biosynthesis and the Anthocyanin Pathway 
The anthocyanin pathway begins with the first commitment step to 
flavonoid biosynthesis, condensation of three malonyl-CoA with coumaroyl-
CoA to form chalcone. Figure 2.1 illustrates the steps from carbohydrates to 
the formation of chalcone. The end products are glycosylated 
anthocyanidins, i.e., anthocyanins. The steps from chalcone to anthocyanins 
including branches to other flavonoids are illustrated in Figure 2.2 
Individual reaction steps are discussed and illustrated in the following 
sections. (For more in-depth reviews see Ebel and Hahlbrock, 1982; Heller 
and Forkmann, 1988.) The number with each enzyme is the Enzyme 
Commission classification number. 
2.2.1. Formation of chalcone bv chalcone svnthase 
Chalcone synthase (EC 2,3.1.74) catalyzes the condensation of malonyl-
CoA and the CoA ester of a substituted cinnamic acid to form chalcone 
(Figure 2.1). The best cinnamic acid derived substrate for this reaction is 
4-coumaroyl-CoA which is produced in the Shikimate pathway. No cofactor 
is required by chalcone synthase (CHS) to catalyze this reaction. 
Using crude extracts from UV-irradiated parsley cells {Petroselinum 
hortense) K. Hahlbrock and co-workers were the first to demonstrate in vitro 
chalcone synthesis (Kreuzaler and Hahlbrock, 1972; Heller and Hahlbrock, 
1980; Light and Hahlbrock, 1980). In several species, (Matthiola, 
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Carbohydrates 
Acetyl-CoA 
3 Malonyl-CoA 
Chalcone 
Synthase 
Shikimate 
I 
Arogenate 
i 
Phenylalanine 
Cinnamate 
1 
4-Coumarate 
I 
4-Coumaroyl-CoA 
CHALCONE 
4,2',4',6'-tetrahydroxychalcone 
.R 
R O 
Figure 2.1. Schematic of the pathways leading to the chalcone synthase 
catalyzed condensation of three malonyl-CoA and 
4-couniaroyl-CoA to form chalcone. When R indicates 
hydroxyl groups (-0H) substituted on the chalcone rings the 
chalcone is 4,2',4',6'-tetrahydroxychalcone (modified after 
Heller and Forkmann, 1988) 
Figure 2.1 
f 
CHALCONE 
(4,2',4',6'-tetrahydroxychalcone) 
R O 
chalcone 
isomerase 
(2S)-PLAVAN0NE 
(Naringenin) 
R 0 
I 
facing page 
ISOFLAVONE 
(Genistein) 
R.^^0. 
/ R 
PLAVONE 
(Apigenin) 
R 0 
Figure 2.2. Schematic of the steps leading to anthocyanin synthesis from 
chalcone (Figure 2.1) with branch points to other flavonoids. 
Each flavonoid class is indicated in capital letters. The 
skeleton of each is drawn to illustrate the structural changes 
which occur during synthesis. When the R groups are 
hydroxyls (-0H) the compound name is given in ( ). 
Enzymes are indicated where known. Additional details of 
anthocyanin biosynthesis are given in Section 2.2. 
Individual reaction steps are illustrated when discussed 
(modified after Heller and Forkmann, 1988) 
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Antirrhinum, and Zea mays) the genetic control of chalcone synthase is 
known. This knowledge of UV-light induced chalcone synthase expression 
in Petroselinum hortense and the availability of genetic mutants lead to the 
molecular analysis of chalcone synthase cDNA and genomic clones in 
Petroselinum hortense (Reimold et al., 1983), Antirrhinum majus (Bonas et 
al., 1984; Sommer and Saedler, 1986), Petunia hybrida (Keif et al., 1985), and 
Zea mays (Wienand et al., 1986). 
2.2.2. Formation of flavanone bv chalcone isomerase 
Flavanones such as naringenin are formed from chalcone by 
isomerization (Figure 2.3). This reaction is catalyzed by chalcone isomerase, 
(EC 5.5.1.6) which is also called chalcone flavanone isomerase (CHI). The 
reaction is stereospecific for the formation of (2S)-flavanones (Kuhn et al., 
1978). No cofactors are required. 
isomerase 
chalcone 
R 0 
CHALCONE 
R O 
(2S)-FLAVAN0NE 
Figure 2.3. Isomerization of chalcone to flavanone is catalyzed by 
chalcone isomerase. When the R groups are hydroxyls (-0H) 
the chalcone is 4,2',4',6'-tetrahydroxychalcone and the 
flavanone is naringenin. See Figure 2.2 for integration of 
this reaction into the anthocyanin pathway 
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Substrate specificity defines two types of chalcone isomerases. Those 
that isomerize both 2',4'-dihydroxychalcones and 2',4',6'-trihydroxychalcones 
(Dixon et al,y 1982; Chmiel et al., 1983) and those that only isomerize 2',4',6'-
trihydroxychalcones (Kuhn et al., 1978; Chmiel et al., 1983). In the absence of 
chalcone isomerase 2',4',6'-trihydroxychalcones can spontaneously 
isomerize under physiological conditions. This produces a racemic product. 
Elevated levels of chalcone isomerase may repress this spontaneous reaction 
(Mol et al., 1985). 
Molecular analysis of chalcone isomerase was first reported for CHI 
from Phaseolus vulgaris (Mehdy and Lamb, 1987). In Petunia hybrida the 
chalcone synthase and chalcone isomerase genes were found to be 
coordinately regulated (van Tunen et al., 1988). As with chalcone synthase, 
chalcone isomerase is UV-light induced. 
2.2.3. Formation of dihvdroflavonol bv flavanone-3-hvdroxvlase 
The hydroxylation of (2S)-flavanones at the 3 position produces 
dihydroflavonols (Figure 2.4). This reaction is catalyzed by flavanone 3-
hydroxylase (EC 1.14.11.9). First described in Matthiola flower extracts 
(Forkmann et al., 1980) this enzyme is a 2-oxoglutarate-dependent 
dioxygenase. It also requires the cofactors, Fe^+ and ascorbate. 
2.2.4. Formation of flavonol bv flavonol synthase 
The formation of flavonol from dihydroflavonol is catalyzed by a soluble 
2-oxoglutarate-dependent dioxygenase (Britsch et al., 1981). Flavonol 
synthase most likely catalyzes this reaction via a 2-hydroxy intermediate that 
then undergoes spontaneous elimination of water (Figure 2.5). M. Hauteville 
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R^O 0 
3-hydroxylase ySt 
R 0 R O 
(2S)-FLAVAN0NE DIHYDROFLAVONOL 
Figure 2.4. Hydroxylation of a flavanone in the 3 position by flavanone-3-
hydroxylase produces the corresponding dihydroflavonol. 
When the R groups are hydroxyls (-0H) the flavanone is 
naringenin and the dihydroflavonol is dihydrokaempferol 
R 
R 
flavonol 
'OH 
OH 
synthase 
^^^OH 
R 0 
DIHYDROFLAVONOL 2-HYDROXY-
DIHYDROFLAVONOL 
HgO R 
R 
OH 
R 0 
FLAVONOL 
Figure 2.5. The most likely mechanism for flavonol synthase. 
Conversion of dihydroflavonol to flavonol is via a 2-hydroxy 
intermediate. The 2-hydroxydihydroflavonol then undergoes 
spontaneous dehydration to form flavonol. When the R 
groups are hydroxyls (-0H) the dihydroflavonol is 
dihydrokaempferol, the 2-hydroxydihydroflavonol is 
2-hydroxydihydrokaempferol, and the flavonol is kaempferol 
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and coworkers (1979) have shown that 2-hydroxy-dihydrokaempferol and 2-
hydroxydihydroquercetin (two proposed intermediates) undergo spontaneous 
elimination of water. 
2.2.5. Formation of flavan-3.4-diol bv dihvdroflavonol 4-reductase 
Evidence for a NADPH-dependent dihydroflavonol 4-reductase was first 
obtained from Pseudotsuga menziesii cell suspension cultures (Stafford and 
Lester, 1982). This enzyme catalyzes the conversion of (2R,3R)-
dihydroquercetin to its flavon-3,4-cis-diol derivative, (2R,3S,4S)-leucocyanidin 
(Figure 2.6). NADPH is the only necessary cofactor. 
Dihydroflavonol 4-reductase has been studied in numerous plant 
species. In Zea maySy transposon tagging was used to clone the al locus 
(O'Reilly et al., 1985). With this cDNA, the in vitro expression of NADPH-
dependent reduction of (+)-dihydroquercetin to the flavon-3,4-cis-diol was 
observed (Reddy et al, 1987). 
it u 
DIHYDROFLAVONOL 
Figure 2.6. Dihydroflai 
dihydroflavonol 
4-reductase 
NADPH NADP " UH 
FLAVAN-3,4-ds-DIOL 
vonol undergoes NADPH-dependent reduction to 
form flavan-3,4-c/s-diol. Dihydroflavonol 4-reductase 
catalyzes this reaction. When the R groups are hydroxyls 
(-0H) the dihydroflavonol is dihydrokaempferol, and the 
flavan-3,4-cis-diol is leucopelargonidin 
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2.2.6. Formation of anthocvanidin-3-O-glvcosides from flavan-3.4-diol: The 
first stable products of anthocvanin biosynthesis 
Feeding studies of Matthiola anthocyanin mutants have established that 
flavan-3,4-diols (leucoanthocyanins) are the precursors to anthocyanins 
(Heller et al., 1985). Heller and Forkmann (1988) proposed a sequence of steps 
leading from flavan-3,4-diols to anthocyanidin-3-O-glycosides, the first stable 
products of anthocyanin biosynthesis (Figure 2.7). 
This is a series of reactions including a hydroxylatlon at the 2 position, 
two dehydration steps and a glycosylation at position-3. Glucose is the most 
common sugar. Figure 2.7 illustrates several possible sequences for these 
reactions. 
The only detectable intermediates in this conversion from flavan-3,4-diol 
to anthocyanidin-3-O-glucoside are the pseudobases (Heller and Forkmann, 
1988). Because flavan-3,4-diols (leucoanthocyanidins) are unstable, it is 
assumed that the other intermediates are also unstable. This instability 
along with the natural rarity of free anthocyanidins make the exact ordering 
of the four reactions steps from flavan-3,4-diol to anthocyanidin-3-0-
glucosides difficult. 
UDPglucose:flavonoid 3-0-glucosyltransferase (UFGT; EC 2.4.1.9) is the 
only enzyme known to glycosylate flavan-3,4-diols to form anthocyanins. 
UFGT is responsible for the transfer of glucose from UDPglucose to the 3-0-
position of both flavan-3,4-diols and flavonols (Larson and Lonergan, 1972). 
This results in anthocyanidin 3-0-glucosides and flavonol 3-0-glucosides. 
The enzymes responsible for the attachment of other sugars to the 3 position 
have not been identified. 
FLAVAN-3,4-DI0L 
(Leucopelargonidin) 
R % ,.a". dehydration R 3JJ-
R OH 
2 position 
hydroxylation 
dehydration 
3 position M 
giycosylation*^ ' 
R % 
O-Glu 
2 position 
hydroxylation 
2 position 
hydroxylation 
PSEUDOBASE 
3 position 
glycosylation 
R m 
PSEUDOBASE 
O-Glu 
R % 
? 
dehydration 
ANTHOCYANIDIN 
(Pelargonidin) 
2 dehydrations ^ 
R m 
R 
dehydration 
ANTHOCYANIDIN-3-O-GLYCOSIDE 
(Pelargonidin 3-glucoside) 
3 position 
glycosylation 
"7^  
UDPG UDP 
0-Glu 
R m 
Figure 2.7. Several possible sequences for the reactions which convert flavan-3,4-diols to 
anthocyanidin-S-O-glycosides, The reactions include a hydroxylation at the 2 position, 2 
dehydrations and a 3 position glycosylation. UFGT has been shown in vitro to transfer a 
glucose from UDPG to the 3 position of anthocyanidins to form anthocyanidin-3-0-
glucosides in maize (Larson and Coe, 1968; Larson and Lonergan, 1972). Names in () 
indicate the compounds having hydroxyl groups at the sites marked with -R (modified 
from Heller and Forkmann, 1988) 
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2.2.7. Modification of flavonoid classes 
Individual flavonoid classes produced in the biosynthetic pathway can 
undergo several types of structural modification. These include: 
hydroxylation (particularly at the 3' and 5' B-ring positions), glycosylation of 
hydroxyl groups, acylation of the attached sugar moieties, and methylation of 
hydroxyl groups. Other modifications such as C-glycosylation and 
sulphation are restricted to only a few flavonoid classes and will not be 
covered here (see W. Heller and G. Forkmann's 1988 review). 
2.2.7.1. B-ring hvdroxvlation of flavanones. dihvdroflavonols. flavones. 
and flavonols The B-ring substitution patterns observed for many 
flavonoids could result from synthesis using different substituted cinnamic 
acids. The alternative hypothesis is that B-ring modifications follow the 
synthesis of the C15 skeleton. This second hypothesis is supported by the 
substrate specificity of chalcone synthase isolated from Matthiola incana and 
Antirrhinum majus (Spribille and Porkmann, 1981, 1982). Additional 
support comes from two enzymes which are known to catalyze the 
hydroxylation of the B-ring of flavonoids, flavonoid 3'-hydroxylase and 
flavonoid 3',5'-hydroxylase (Fritsch and Grisebach, 1975; Stotz and 
Forkmann, 1982). Both require the cofactor NADPH, molecular oxygen, and 
use 4'-hydroxylated substrates. In addition, the flavonoid 3',5'-hydroxylase 
will use 3',4'-hydroxylated substrates. Figure 2.8 illustrates the reactions 
catalyzed by flavonoid 3'-hydroxylase and flavonoid 3',5'-hydroxylase. 
2.2.7.2. Glvcosvlation of flavanones. dihvdroflavonols. flavones. and 
flavonols Dihydroflavonol and flavonol 3-0-glucosides are formed by 
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Figure 2.8. B-ring hydroxylation of flavonoids by flavonoid 3'-
hydroxylase and flavonoid 3',5'-hydroxylase. Both require 
NADPH as a cofactor and molecular oxygen 
Figure 2.9. Glycosylation of flavanones, dihydroflavonols, flavones, and 
flavonols may occur at the 7 position. UDP-
glucoserflavone/flavonol 7-0-glucosyltransferase is the only 
characterized flavonoid 7-0-glycosyltransferase (Heller and 
Forkmann, 1988). It will not accept flavonol 3-0-glycosides 
as substrates. Only the dihydroflavonols and flavonols can 
be glycosylated at the 3 position. UFGT, the same enzyme 
which produces anthocyanidin 3-0-glucosides, catalyzes the 
3-0-glycosylation of flavonols and dihydroflavonols 
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UDPglucose:flavonoid 3-0-glucosyltransferase (UFGT). This is the same 
enzyme that catalyzes the formation of anthocyanidin-3-O-glucosides (Larson 
and Lonergan, 1972). UFGT is classified as a flavonol 3-0-
glycosyltransferase. 
A glucosyltransferase has also been identified which is specific for the 
7-0 position of flavonoids (Sutter et ah, 1972; Sutter and Griesbach, 1973). 
UDP-glucose:flavone/flavonol 7-0-glucosyltransferase uses UDP-glucose or 
TDP-glucose as the glucosyl donors. A variety of flavones, flavonols, and 
fiavonones can act as acceptors, but flavonol 3-0-glycosides can not. This 
enzyme is classified as a fiavonoid 7-0-glycosyltransferase. 
Hence, the formation of flavonol 3,7-diglucosides must start with the 
formation of the flavonol-7-O-glucoside. This conclusion is supported by the 
UFGT isolated from parsley suspension cultures (Sutter and Griesbach, 
1973). Quercetin 7-0-glucoside is a substrate for UFGT catalyzed 3-0-
glycosylation. 
Figure 2.9 illustrates the possible reactions catalyzed by these two 
glucosyltransferases. The detection of such flavonol (-3-0 and -7-0 glucoside) 
derivatives will be reported in Section 4.3.2. 
2.2.7.3. Further glvcosvlation of anthocvanins Anthocyanidin-3-0-
glucosides may undergo further glycosylation. Anthocyanidin 3-0-glucoside 
glycosyltransferase links a sugar such as rhamnose or xylose to the glucose 
moiety of the anthocyanidin 3-0-glucoside (Kamsteeg et oZ., 1980a; Teusch, 
1986) forming an anthocyanidin 3-bioside. Anthocyanidin 3,5-diglucosides 
can also act as substrates forming anthocyanidin 3-biosido-5-0-glucosides. 
Anthocyanidin 3,5-di-O-glucosides are formed when the 5 position hydroxyl 
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group of anthocyanidin 3-0-glycosides are glucosylated. This reaction is 
catalyzed by anthocyanidin 3-0-glycoside 5-0-glucosyltransferase. The 
genetic control of this enzyme activity was first described in Silene dioica 
(Kamsteeg et al., 1980b). Anthocyanidin 3-biosido-5-0-glucosides can also be 
formed by the glucosylation of anthocyanidin 3-biosides (Kamsteeg et al., 
1978). 
2.2.7.4. Aromatic acvlation of anthocvanins Acyltransferases have 
been identified in Silene (Kamsteeg et al., 1980c) and Matthiola (Teusch et al., 
1986). In Silene anthocyanidin 3-0-biosides and 3-0-biosido-5-0-glucoside are 
acylated with 4-coumaric or cafFeic acid. In Matthiola the anthocyanidin 3-0-
glucosides and 3~0-xylosylglucosides are acylated. These anthocyanidin 3-0-
glycoside acyltransferase catalyzed reactions involve the transfer of either the 
4-coumaroyl or caffeoyl moiety from the respective CoA esters to the 3-0-
sugar. Detection of this type of anthocyanin derivative will be reported in the 
results Section 4.4. 
2.2.7.5. Methvlation of anthocvanins In their 1982 review, J. Ebel and 
K. Hahlbrock described many enzymes catalyzing the transfer of a methyl 
group (CHg) from S-adenosylmethionine to hydroxy 1 groups of flavonoid 
substrates. Anthocyanidin 3-0-(4-coumaroyl)-rutinosido-5-0-glucosides are 
the only effective substrates for B-ring methylation in Petunia hybrida 
(Jonsson et al., 1982). As with the B-ring hydroxylases, both anthocyanin 3'-
0- and 3',5'-0-methyltransferases are possible (Heller and Forkmann, 1988). 
Methylation may also occur on the A-ring (Ebel and Hahlbrock, 1982). 
In maize a S-adenosylmethionine-flavonoid 3'-0-methyltransferase of 
unknown genetic control has been described (Larson, 1989). It methylates 
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flavonone, flavone, and flavonols prior to glycosylation. Flavanones are in a 
direct line to anthocyanin synthesis. This suggests that in maize 
methylation occurs at an earlier step in the synthesis of anthocyanin than the 
step reported in petunias (Jonsson et al., 1982). 
2.3. The Anthocyanin Pathway in Zea mays 
The genetic study of genes controlling the anthocyanin pathway in 
maize follows the developmental course of genetics as a science. East and 
Hayes (1911) reviewed the contributions of maize to the rediscovery of 
Mendel's work by DeVries and Correns. Among other traits, Correns (1901) 
reported on both red pericarp and purple aleurone. Today the anthocyanin 
genes are utilized frequently as genetic markers because of their easy 
identification and lack of detrimental effects on the plant. They are studied to 
understand pathway and structural gene regulation, gene structure and 
function, and as a tool to understanding other genetic phenomenon such as 
transposable elements. 
The anthocyanin pathway as currently understood in maize is outlined 
in Figure 2.10. This figure is modified from Figure 2.2 to indicate the 
enzymes and genes known and their site of action. The structural and 
regulatory genes will be discussed in more detail in Sections 2.3.1. and 2.3.2. 
For other reviews see Coe et al., 1988, Jayaram and Peterson, 1990, and 
Booner et aL, 1991. 
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I + 
3 Malonyl-CoA + 4-Couinaryl-CoA 
C2 I Chalcone Synthase 
CHALCONE 
Chalcone Isomerase il 
FLAVANONE 
22? I Flavanone 3-hydroxylase 
DIHYDROFLAVONOL ^^^onol^ FLAVONOL 
(synthase . Dihydroflavonol BzI UFGT 4-Reductase 1 
FLAVAN-3,4-DIOL 
A2 
FLAVONOL 
3-GLUCOSIDE 
I 
3-HYDROXYANTHOCYANIDIN 
Bzl I UFGT 1 
ANTHOCYANIDIN 
3-O-GLUCOSIDE 
ACYLATED 
ANTHOCYANINS 
Figure 2.10. The steps leading to anthocyanin synthesis in Zea mays. 
Classes of compounds are in capital letters. The enzymes 
and genes associated with each reaction are indicated 
where known. The Pr locus product, NADPH: flavonoid: 
3'-hydroxylase modifies dihydroflavonols. This reaction is 
not necessary for anthocyanin synthesis and is not marked 
on the flow chart (modified after Styles and Ceska, 1989) 
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2.3.1. Structural genes and their expression in aleurone tissue 
Almost all tissues in corn are potential sites of anthocyanin pathway 
expression. The 1988 review by Coe and co-workers summarizes the tissue 
specific expression of numerous genotypes. The following sections will 
concentrate on those genes affecting anthocyanin expression in the aleurone. 
References to investigations of anthocyanin expression in other tissues will 
be included as needed. 
2.3.1.1. Chalcone synthase is the C2 gene product The genetic control of 
chalcone synthase (CHS) in maize was established in 1983. H. K. Dooner 
showed that mutants of the C2 locus are the only anthocyanin mutations to 
exclusively affect CHS expression (Dooner, 1983a). Using extracts from 
immature endosperms, Dooner demonstrated that cl,c2, clf, r, and vpl 
endosperms were chalcone synthase deficient. When the same endosperms 
were tested for UFGT activity (Bz locus), recessive alleles of cl, r, and vpl 
(Dooner and Nelson, 1979) and clf (Dooner, 1983a) all severely reduced UFGT 
levels. 
U. Wienand and co-workers (Wienand et al., 1986) cloned the C2 locus in 
maize using the En(Spm) transposable element as a gene tag. Sequence 
comparisons indicate that maize CHS is similar to the CHS enzymes 
previously described in dicots. It has approximately the same molecular 
weight as the Petroselinum hortense CHS. 
A second chalcone synthase gene in maize is white pollen, Whp (Coe et 
al., 1981; Franken et al., 1991). Whp shows a 94% homology with the coding 
regions of C2. In homozygous recessive c2 in aleurone tissue, Whp can 
complement C2 function leading to anthocyanin expression (Coe, 1985; 
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Franken et al., 1991). Such complementation is not possible in the presence 
of In. Thus, differential regulatory gene action regulates the tissue 
specificity of the C2 and Whp duplicate loci. The in locus regulation of Whp 
expression appears to be at the translational level. 
2.3.1.2. Dihvdroflavonol 4-reductase is the A J gene product Cloning of 
the A1 locus via En(Spm) and Mul transposon tagging (O'Reilly et al., 1985) 
preceded the discovery of the A2 gene product. Consisting of 4 exons, the A1 
gene codes for an amino acid sequence homologous with the NADPH-
dependent reductase of the pallida gene in Antirrhinum majus (Schwartz-
Sommer et al., 1987). 
By testing this prediction, the gene product was shown to be the 
enzyme dihydroflavonol 4-reductase (Reddy et al., 1987). Also called 
dihydroquercetin reductase or flavonoid:4-reductase, this enzyme catalyzes 
the reduction of dihydroflavonols and flavanones to the corresponding flavan-
3,4-diols and flavan-4-ols (Styles and Ceska, 1989). Genetic evidence suggest 
that the expression of Ai is cell autonomous (Coe et ah, 1988). 
2.3.1.3. NADPHrflavonoid 3'-0-hvdroxvlase is the Pr gene product In 
1955, E. H. Coe first associated Pr function with the control of 
3'-hydroxylation of anthocyanins. This was based on the presence of 
pelargonidin glycosides in red (pr) kernels and cyanidin glycosides (3'-0H 
derivatives of pelargonidin) in purple (Pr) kernels. 
A flavonoid 3'-hydroxylase was first characterized in maize seedlings 
(Larson and Bussard, 1986). This microsomal enzyme can use a variety of 
substrates. Those tested included kaempherol (a flavonol), naringenin (a 
flavanone), and apigenin (a flavone). These are hydroxylated to form 
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quercetin, eriodictyol, and luteolin respectively. This flavonoid 
3'-hydroxylase is NADPH and oxygen dependent. The effects of cytochrome c, 
carbon monoxide, and light suggests that this enzyme can be classified as a 
CytP-450 monooxygenase. The results from seedling and aleurone gene 
dosagezenzyme ratios and gene dosage:pigment-type ratios have established 
Pr as the enzyme encoding NADPHrflavonoid 3'-0-hydroxylase (Larson, 
Bussard and Coe, 1986). 
2.3.1.4. A dioxvgenase is the putative A2 gene product Early work to 
assign A2 its place in the anthocyanin pathway took two directions. Inter-
tissue complementation tests placed the A2 gene action after A1 and before 
Bzl and Bz2 (Reddy and Coe, 1962). Screening of mutant genotypes for the 
accumulation of anthocyanin pathway intermediates, detected both 
leucocyanidin and leucopelargonidin in homozygous a2 kernel tissue (Reddy, 
1964). Both of these compounds are flavan-3,4-diols. They are also known as 
leucoanthocyanins (See Appendix I). 
The placement of A2 action implies the catalytic function of the A2 
product. Conversion of flavon-3,4-diols to 3-hydroxyanthocyanins requires 
the ^mns-elimination of water and the oxidation of carbon number 2. Heller 
and Forkmann (1988) have proposed a multistep mechanism for this 
conversion (see Section 2.7). One or more of these steps is presumably 
catalyzed by the A2 product. 
With the cloning of the A2 gene (Menssen et al., 1990), a different 
approach was possible for identifying the A2 gene product. This product is 
expected to be a 43.5 KD protein. The 395 amino acid sequence is encoded by a 
single open reading frame. Comparison of this peptide sequence with other 
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known proteins identifies several homologies. A 100 amino acid section of the 
A2 carboxy-terminus has a 38% identity with the pTOMlS polypeptide of 
tomato. The entire A2 protein exhibits a 26% identity and 48% similarity with 
this ACC-oxidase (A. Menssen, H. Saedler, and A, Gierl, personal 
communication and MGCNL 65:50-51). 
The flavanone-3-hydroxylase encoded by the Inc gene in Antirrhinum 
majus also exhibits homology to the A2 protein. First described in Matthiola 
flower extracts (Forkmann et al, 1980), this enzyme is a 2-oxoglutarate-
dependent dioxygenase. Ascorbate and Fe++ are the other required 
cofactors. Confirmation that these structural similarities predict the 
functionality of the A2 product await isolation or in vitro synthesis of the 
enzyme. 
2.3.1.5. UFGT is the Bzl erene product The first in vitro studies of 
flavonol 3-0-glucoside formation used extracts from maize pollen (Larson 
and Coe, 1968). The enzyme which catalyzes this reaction is 
UDPglucose:flavonoid 3-0-glucosyltransferase (UFGT). UDPglucose is the 
sugar donor and the 3-position hydroxyl group of either flavonols or 
anthocyanidins is the acceptor (Larson and Lonergan, 1972). 
UFGT is expressed throughout the maize plant. Initially characterized 
in pollen (Larson, 1971), UFGT expression has been described in seedling, 
mature seed, leaf, and sheath tissue (Larson and Lonergan, 1973). 
Numerous studies have examined UFGT expression throughout kernel 
development. 
The determination that UFGT expression is linearly related to Bzl 
dosage established Bzl as the structural gene for UFGT (Larson and Coe, 
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1977). In the appropriate genetic background (i.e., one that allows UFGT 
expression), expression of the dominant Bzl alleles results in the 
accumulation of red or purple pigments. When the Bzl locus is homozygous 
recessive, accumulated pigments produce a bronze coloration (Rhoades, 
1952). 
Five genes have been identified which affect Bzl (UFGT) expression in 
maize aleurone tissue. These include CI, R, Vpl (Dooner and Nelson, 1977a; 
1979), C//* (Dooner, 1983a), and in (Klein and Nelson, 1983). When dominant 
Bzl y Cl, R, Vpl, Clf, and In alleles are all present, UFGT activity increases 
with increasing endosperm development. If any of the 
Bzl, CI, R, or Vpl loci are homozygous recessive the UFGT expression 
remains at low, uninduced levels throughout development. When the 
intensifier locus is homozygous recessive, the UFGT specific activity in 
UFGT competent tissue is increased 1.5 to 2-fold (Klein and Nelson, 1983). 
The mechanism for the in enhanced UFGT expression is unknown. 
Recent work on the effects of in on Whp expression in aleurone tissue 
indicates that in is a post-transcriptional regulator of Whp (Franken et al., 
1991). This regulation appears to be tissue specific. Elucidation of the in 
regulatory role for the Bzl locus awaits further study. 
2.3.1.6. The Bz2 gene product is still unknown Based on inter-tissue 
complementation (Reddy and Coe, 1962) the Bz2 gene product is known to act 
late in the anthocyanin pathway. Placement after the action of Bzl (UFGT) 
implies that it is an anthocyanin modifying enzyme. No substrate 
accumulation in bz2 / bz2 tissue has been identified. Nash and co-workers 
(1990) have speculated that the Bz2 product may be an acyZ-transferase. With 
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the cloning of the Bz2 locus (Theres et al., 1987; McLaughlin and Walbot, 
1987), identification of the enzyme by working from the gene sequence may 
now be possible. 
2.3.2. Re^latorv ^enea affecting anthocvanin expression in aleurone 
The CI, Clf, in, R, and Vpl loci are the known regulatory genes 
controlling anthocyanin pathway expression in maize aleurone. Together 
CI, R, and Vpl have been shown to induce high levels of 
UDPglucoseiflavonoid glucosyltransferase (UFGT, Bz product) at about the 
fourth week of kernel development (Dooner and Nelson, 1977a; 1979). 
Homozygous clf has only been tested in mature endosperms where it reduces 
UFGT expression (Dooner, 1983a). When either cl, clf, r, or vpl is 
homozygous recessive, chalcone synthase (CHS, C2 product) is deficient. 
Kernels homozygous for in express increased levels of UFGT (Klein and 
Nelson, 1983). Accumulation of anthocyanin pathway intermediates is also 
increased in homozygous in aleurone (Reddy and Peterson, 1978). 
The properties of the Vpl, Cl, R and in loci will be discussed further in 
Sections 2.3.2.1. to 2.3.2.4. 
2.3.2.1. The Vpl locus regulates general flavonoid biosvnthesis 
Phenotypically, the action of the Vpl regulatory locus is confined to early 
embryo and aleurone development. This gene is pleiotropic, affecting the 
phenotype of two traits (Robertson, 1955). In homozygous recessive vpl 
kernels, the aleurone tissue is colorless, lacking anthocyanin pigment 
production. In these same kernels, embryos carrying some alleles fail to 
enter dormancy. They are viviparous. Mutable alleles exhibit well defined 
32 
colored sectors in the aleurone tissue suggesting cell-autonomous expression 
of Vpl (McCartye^ aL, 1989). 
The vpl mutation affects the expression of a number of enzymes 
including several in the anthocyanin pathway and in basic metabolism, i.e., 
non-anthocyanin specific. These include: UDPglucose:flavonoid 3-0-
glucosyltransferase (UFGT, Bzl), chalcone synthase (CHS, C2), 
phenylalanine ammonia lyase (PAL), glucose-6-phosphate dehydrogenase 
(G6PDH), alcohol dehydrogenase (ADH, Adhl), and catalase (Catl and Cat2) 
(Dooner, 1983a; b; 1985; Dooner and Nelson, 1979). 
Following the cloning of the up-muml allele (McCarty et aL, 1989), the 
Vpl transcript was localized to the seed embryo and endosperm tissue. Low 
levels of Vpl transcript in total endosperm tissue suggest localization of Vpl 
expression to a subset of the endosperm cells, i.e., aleurone cells. In vpl 
mutant seed tissue, CI mRNA transcripts are not detectable. This has led to 
the speculation that Vpl may control CI tissue specificity, while other 
developmental signals may control the timing of CI induction (McCarty et 
al, 1989). 
2.3.2.2. The Cl locus regulates via a putative DNA binding protein 
product The CI locus has several types of mutant phenotypes. The C-I 
alleles are dominant over the C, c-p, and c alleles (Coe, 1962; Chen and Coe, 
1977). The C-I alleles inhibit anthocyanin accumulation. This inhibition is 
dosage dependent with C-I I C-I  I  C-I  producing colorless aleurone,  C/C/C 
producing colored aleurone, and the C-I I C-I (C and C-IICIC heterozygotes 
producing intermediate pale shades. The degree of C-I color suppression 
depends on the C-I allele present (Peterson and Leleji, 1974). 
The C alleles induce color formation in otherwise genetically competent 
aleurone and scutellum tissue and are dominant to c-p and c. The c-p type of 
allele produces colorless mature kernels. Upon exposure to light and seed 
germination c-p induces pigment formation (Kirby and Styles, 1970; Chen 
and Coe, 1977). The c alleles (sometimes referred to as c-n) are colorless and 
completely recessive. 
Based on the observations that the CI locus affects UFGT and chalcone 
synthase expression by the Bzl and C2 genes (see Section 2.3.2.), the CI locus 
was assigned a regulatory role in anthocyanin expression. With the cloning 
of the CI locus an examination of this role became possible (Paz-Ares et a/., 
1986; Cone et al., 1986). Northern analysis of mRNA from different C and C-I 
mutants showed that the CI locus affects expression of the A1 and Bzl loci at 
the transcriptional level (Cone et al., 1986). A potential CI binding site in the 
Bzl promoter has recently been described (Roth et al., 1991). 
The putative protein product of the CI locus has two domains (Paz-Ares 
et al., 1987). The amino terminus contains a basic domain with 40% 
homology to the myb family of proto-oncogenes. In the myb proteins this 
domain has the capacity to bind DNA. The carboxy terminus contains a short 
acidic domain. In yeast, transcription activator genes contain these same 
two domains suggesting that the CI regulatory role is at the level of 
transcription activation. 
A sequenced C-I allele contains mutations which prematurely 
terminate the putative protein product and alter its amino acid sequence 
(Paz-Ares et al., 1987). These changes delete the major acidic domain and 
reduce the acidity of a minor acidic domain. They do not affect the proposed 
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binding domain. These sequence changes and resulting phenotype are 
consistent with the hypothesized binding and transcription activating 
domain functions. 
2.3.2.3. The R locus mav regulate the fate of flavonones The R locus is 
a compound locus containing both plant and seed determinants which 
mutate independently and can be separated by crossing-over (Stadler, 1951; 
Stadler and NufFer, 1953; Stadler and Emmerling, 1956). This has resulted in 
a large number of alleles with different expression characteristics, including 
tissue specificity. 
Several R homologous loci (JR., B, Sn, and Lc) are known. Work with 
these loci has identified both structural and regulatory differences among the 
R family of genes. G. I. Patterson and co-workers (1991) demonstrated that 
the B-Peru allele of the B locus contains a single coding region, even though it 
has multiple tissue specificity similar to the R locus. Comparison of the light 
inducible R and Sn loci has identified differences in sensitivity to red light 
although blue and white light responses are similar (Mereghetti et al., 1991). 
The R locus regulatory function has been demonstrated in several ways. 
In aleurone tissue, R is necessary for the expression of both UFGT and 
chalcone synthase, the Bzl and C2 gene products (Dooner and Nelson, 1977a, 
1979; and Dooner, 1983a). In seedlings, light-induced expression of the 
anthocyanin pathway is regulated by the R locus (Taylor and Briggs, 1990). 
Both the A1 and Bz2 genes require a dominant R allele for light-mediated 
accumulation of mRNA transcripts. 
Examination of the flavonoid products of the anthocyanin pathway 
shows that a recessive r allele blocks the formation of 3-hydroxyflavonoids 
(Styles and Ceska, 1977, 1989). No structural gene has been identified for a 
flavanone 3-hydroxylase. H. K. Dooner and O. E. Nelson (1979) speculated 
that the R gene product functioned by one of two possible mechanisms. 
Either the R product acts as a regulator of a set of anthocyanin pathway 
structural genes, or it is an enzyme (flavanone 3-hydroxylase?) acting early 
in the pathway. The presence (or absence) of this enzyme then has a 
regulatory effect on other genes encoding pathway enzymes. 
The cloning of the R locus (Dellaporta et al. y 1988) has shown that the R, 
B,Sn, and Lc loci share sequence homology. Further investigation of the Lc 
locus, has predicted the amino acid sequence of a protein product (Ludwig et 
al., 1989). This protein has sequence homology with the myc family of DNA 
binding proteins and contains an acidic domain like transcriptional 
activators. A potential R protein binding site has recently been described in 
the Bzl promoter (Roth et al., 1991). It is homologous to the myc consensus 
binding sequence. Such structural evidence supports the hypothesis that R is 
a regulatory gene. The exact role R plays in flavonone 3-hydroxylase 
expression awaits further investigation. 
2.3.2.4. The in locus regulates through a post-transcription mechanism 
In the dominant state the In {intensifier) locus has no identified effect on 
expression of the anthocyanin pathway. When homozygous recessive, in/in, 
the effects include a general increase in pigment accumulation (Fraser, 1924; 
Reddy and Peterson, 1978). 
In c2lc2 in I in WhplWhp aleurone tissue, in expression leads to the 
complementation of C2 function by Whp (Coe, 1985). The result is pale 
coloration of the aleurone. The recent cloning of the Whp locus has allowed a 
doser examination of in function (Franken et al., 1991). In the aleurone, in 
was found to regulate Whp expression at the post-transcriptional level. 
P. Franken and coworkers propose two models to explain intensifier 
gene action on Whp. In the first model In is the functional allele. Here In 
would either encode a translational factor which would suppress Whp 
expression or it would encode an activator for an inhibitor affecting Whp. In 
the second model, the In locus is a parallel situation to the CI locus. That is, 
In is the non-functional allele, but retains enough function to be dominant. 
In this model, if the In locus encodes a translational factor, then the In 
product would competitively bind Whp preventing translational activation by 
the in product. If the In locus acted on a Whp translational factor locus, only 
in /in genotypes would initiate the cascade to Whp expression. A complete 
analysis of the in regulatory functions will probably require the cloning of 
this locus and isolation of additional mutants. 
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3. MATERIALS AND METHODS 
3.1. Genetic Stocks 
3.1.1. Selection of diverse alleles of the CI locus 
In an effort to examine the effects of variation in a regulatory locus on 
expression of a plant pathway, 12 alleles of the CI locus (Table 3.1) were 
selected for this anthocyanin pathway gene. These diverse alleles were 
classified into four groups based on their effects on pigment expression in the 
maize aleurone. The C-J alleles (dominant inhibitors) produce a colorless 
kernel when homozygous and suppress pigment expression by the C alleles. 
The C alleles produce colored kernels both when homozygous and in 
combination with the recessive colorless alleles. These recessive colorless 
alleles can be further subdivided into mutable and stable classes. The 
selected mutable {c-ruq) alleles were created by the insertions of the 
transposable element ruq into a C allele (Caldwell and Peterson, 1989). These 
c-ruq alleles express a spotted phenotype in the presence of an independently 
segregating Uq or Ac transposable element (Caldwell and Peterson, 
submitted). This spotted phenotype is dominant over the stable recessive c 
class of alleles. In the absence of a Uq element, the c-ruq alleles are 
phenotypically indistinguishable from the stable recessive c. Except during 
stock development, c-ruq lines will be maintained without Uq to insure a 
colorless phenotype. 
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Table 3.1. Twelve selected alleles of the CI locus are listed along with 
their source, type of allele and homozygous phenotype. Row 
number refers to numbers in Figure 4.1 
Allele Source Allele Type Phenotype 
1. C-I(Cornell) dominant color 
inhibitor 
colorless 
2. C-I(K55) Inbred K55 dominant color 
inhibitor 
colorless 
3. C-I (A69) Inbred A69 dominant color 
inhibitor 
colorless 
4. C-S B. McClintock^ dominant color 
producer 
colored 
5. C-(hiloss) Hi Loss B line^ dominant color 
producer 
colored 
6. C-(Cshbz) C sh bz wx line dominant color 
producer 
colored 
7. C-(lineC) color converted W22 dominant color 
producer 
colored 
8. c-ruq67^ c-m816667 mutable (+ Uq), 
colorless (no Uq) 
spotted, 
colorless 
9. c-ruq66^ c-m816666 mutable (+ Uq), 
colorless (no Uq) 
spotted, 
colorless 
10. c-ruq65^ c-m816665 mutable (+ Uq), 
colorless (no Uq) 
spotted, 
colorless 
11. c-ruq31 c-m804531 mutable (+ Uq), 
colorless (no Uq) 
spotted, 
colorless 
12. c c sk Bz wx line recessive colorless colorless 
®Via K. Cone. 
(^From M. M. Rhoades. 
(^Recent evidence supports hypothesis that these are reisolates of the 
same mutation (Pisabarro et al., 1991). 
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3.1.2. Comparison of the CI dosage effects and dominance of the 12 selected 
âlMêS 
The ability of alleles of the CI locus to produce a large dosage effect in 3n 
aleurone tissue (Coe, 1962) has been used to distinguish C-I alleles (Peterson 
and Leleji, 1974). To fiirther describe the alleles selected in Section 3.1.1., the 
12 were intermated to establish their relative dominance and ability to 
express dosage (see Figure 3.1 for list of Crosses 1 to 4). This evaluation of the 
relative potency of these alleles was made using the lines from which these 12 
alleles will be isolated (see Section 3.1.3 ). No attempt was made here to 
control the allelic variation present at other loci. 
To assay the dominance of the selected alleles, those alleles with a 
colorless phenotype (C-I, c-ruq, and c) were crossed both as a male (Cross 1) 
Cross 1 
Female 
colored 
Male 
colored „ colorless A colorless — >  
Embryo 
colorless 
colored 
Endosperm 
colorless 
colored 
colored 
Cross 2 colorless colorless 
colored 
colored 
colorless 
colored 
colorless 
colorless 
colored 
Cross 3 colored 
colored 
colored 
colored 
colored 
colored 
colored 
Cross 4 
Figure 3.1. 
colorless 
colorless self 
colorless 
^ colorless 
colorless 
colorless 
colorless 
Summary of the crosses used to compare the phenotypes, 
relative dominance, and dosage effects of alleles of the CI 
locus. Genotypes are listed using "colorless" to represent any 
of the C-I, c-ruq, ore alleles. "Colored" refers to the C alleles 
and as a female (Cross 2) with those alleles expressing a colored phenotype 
(C). This allows a comparison of the phenotypic effects when the colorless 
allele is present in one dose (from male parent) versus in two doses (from the 
female parent). Selfing the colored (Cross 3) and colorless (Cross 4) parents 
allows the comparison of the two heterozygotes (from Crosses 1 and 2) with 
the homozygous parental types carrying three doses of their respective 
alleles. See Section 4.1 for the results of these crosses. 
3.1.3. Conversion of the selected alleles of the CI locus to a common genetic 
background 
The selected alleles of the CI locus were obtained from lines known to 
differ for several quantitative plant traits including: drought tolerance, plant 
color, and plant height. Therefore, these lines may be expected to carry 
diverse alleles affecting the anthocyanin pathway. To reduce the effects of 
this diversity, the selected alleles were converted to a single genetic 
background. This conversion was designed to eliminate variations in 
enzyme expression of UDPglucose: flavonoid 3-0-glucosyltransferase due to 
allelic differences for the Bzl locus. This conversion will also reduce, if not 
c o m p l e t e l y  e l i m i n a t e ,  t h e  e f f e c t s  o f  a l l  o t h e r  l o c i  e x c e p t  C I .  
The line chosen to serve as the common Bzl genetic background was 
selected based on several criteria. First, the line must carry alleles for color 
production at all the known anthocyanin loci required for aleurone 
pigmentation (Al, A2, Bzl, Bz2, C2, and R required, CI and Pr optional). 
Second, the Bzl allele must be identifiable. That is, the Bzl allele from the 
line contributing the common background must be distinguishable from the 
Bzl alleles present in the lines carrying the selected C-I, C, c-ruq, and c 
alleles. This may be accomplished with a closely linked recessive (non-
anthocyanin) marker such as shl (3.0 map units from CI ). 
The c sh Bz wx line was selected as the common Bzl background for 
several reasons. First, this line carried one of the selected alleles of the CI 
locus; therefore, its use eliminated the need for conversion of one allele. 
Second, the Bz allele in the c sh Bz wx line was flanked by two endosperm 
markers, shrunken (shl) and waxy (wx). Figure 3.2. shows the linkage 
relationship of the CI, Shl, Bzl, and Wx loci. Because the CI and Bzl loci are 
linked, the shl and wx alleles proved particularly useful in identifying the 
crossover progeny necessary to develop the desired lines. 
__ ^tt~ (-0 — 
CI Shl Bzl Wxl 
Figure 3.2. A simplified drawing of the chromosome 9 linkage map 
shows the relationship between the CI, Shl, Bzl and Wxl 
loci. 0 indicates the centromere location. CI, Shl, Bzl and 
Wxl are at positions 26, 29, 31, and 56 respectively on the 
short arm. The centromere is between positions 62 and 64 
For the following discussion on line development the Bz allele from the c 
sh Bz wx line will be marked with an asterisk {Bz*). This will distinguish it 
from the Bz alleles originally linked to the selected C-J, C, and c-ruq alleles. 
This asterisk will be dropped after line development is complete (Section 
3.1.3.5). Figure 3.3 outlines the crosses used to convert the C-I (Part A), C 
(Part B) and c-ruq (Part C) alleles to a common Bzl allele, Bz*. Conversion of 
all three classes of CI locus alleles required three growing seasons. 
Figure 3.3. Crosses used to convert the selected C-I (Part A), C (Part 
B), and c-ruq (Part C) alleles to a common Bzl background. 
The tester c sh Bz* wx was used as the common Bzl source 
in Season 1. Season 2 resulted in the isolation of crossover 
progeny combining the selected alleles for the CI and Bzl 
loci. In Season 3 the crossover progenies were selfed to 
form the desired line. Tissue samples were collected and 
genotypes confirmed in Season 4 
43 
Part A. C-/ alleles 
C-IShBzWx Season 1 
Season 2 
C-IShBzWx X 
c sh Bz* wx 
c sh Bz* wx 
colorless colorless 
round shrunken 
non-waxy waxy 
All colorless 
round non-waxy 
I 
f 
C-IShBzWx 
c sh Bz* wx 
colorless 
round 
non-waxy 
X 
C — bz'm4 Wbc 
C — bz-m4 Wx 
bronze 
shrunken 
non-waxy 
CROSSOVER 
C-I Sh Bz Wx 
Season 3 
sh Bz* wx 
I 
colorless 
shrunken 
non-waxy 
C-I sh Bz* wx 
7 — bz-in4 Wx 
f t 
self 
1 C-I sh Bz* wx 
4 C-IshBz*wx 
colorless 
shrunken 
•waxy 
DESIRED LINE 
I 
Season 4 self 
I 
1 C-IshBz* wx , 1 C 
"2 C 
] 
bz-m4 Wx 
— bz-m4 Wx 
colorless 
shrunken 
non-waxy 
4 C — bz-m4 Wx 
colored 
shrunken 
non-waxy 
TISSUE COLLECTION 
all colorless confirms genotype 
(mature portion of ear) 
Figure 3.3. Crosses used to convert the selected C-I (Part A), C (Part 
B), and c-ruq (Part C) alleles to a common Bzl background. 
The tester c sh Bz* wx was used as the common Bzl source 
in Season 1. Season 2 resulted in the isolation of crossover 
progeny combining the selected alleles for the CI and Bzl 
loci. In Season 3 the crossover progenies were selfed to 
form the desired line. Tissue samples were collected and 
genotypes confirmed in Season 4 
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Part B. C alleles 
Season 1 CShBzWx 
CShBzWx 
colored 
round 
non-waxy 
X 
c sh Bz* wx 
c sh Bz* wx 
colorless 
shrunken 
wasy 
All colored round non-waxy 
I 
f 
Season 2 CShBzWx 
c sh Bz* wx 
colored 
round 
non-waxy 
c sh bz wx 
c sh Bz wx 
colorless 
shrunken 
waxy 
CROSSOVER 
C Sh Bz Wx 
Season 3 colored 
shrunken 
waxy 
f 
sh Bz* wx 
I 
C sh Bz* wx 
c sh Bz (or bz) wx 
—t— 
self 
_1 C sh Bz* wx , 1 Csh Bz* 
4 C sh Bz* wx 
colored 
shrunken 
waxy 
DESIRED LINE 
I 
wx 
2 c shBz (or bz) wx 
colored 
shrunken 
•wscxy 
1 csh Bz (or bz) wx 
4 c sh Bz (or bz) wx 
colorless 
shrunken 
waxy 
' (indistinguishable) | 
Season 4 self TISSUE self 
I COLLECTION | 
all colored segregating colorless 
CONFIRMS genotype ELIMINATES genotype 
TISSUE 
COLLECTION 
Figure 8.3. Crosses used to convert the selected C-/ (Part A), C (Part 
B), and c-ruq (Part C) alleles to a common Bzl background. 
The tester c sh Bz* wx was used as the common Bzl source 
in Season 1. Season 2 resulted in the isolation of crossover 
progeny combining the selected alleles for the CI and Bzl 
loci. In Season 3 the crossover progenies were selfed to 
form the desired line. Tissue samples were collected and 
genotypes confirmed in Season 4 
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Season 1 —2-
Part C. c-ruq alleles 
Uq c-ruq Sh Bz Wx 
+ c-ruq Sh Bz Wx 
spotted 
round 
non-waxy 
X -
+ cshBz*wx 
+ cshBz*wx 
colorless 
shrunken 
waxy 
f 
All spotted or colorless 
round non-waxy 
I 
Season 2 Uq c-ruq Sh Bz Wx „ 
— —————— X 
+ c sh Bz* wx 
spotted 
round 
non-waxy 
+ c sh Bz* wx 
+ cshBz*wx 
colorless 
shrunken 
waxy 
CROSSOVER 
c-ruq Sh Bz Wx 
DC 
Season 3 spotted 
shrunken 
waxy 
self 
9 spotted 
— shrunken 
waxy 
1 + c-ruq sh Bz* wx 
16 + c-ruq sh Bz* wx 
DESIRED LINE 
sh Bz* wx 
t 
Uq c-ruq sh Bz* wx 
+ c sh Bz* wx 
i 
BLl c-ruQ (or o)shBz*wx ELIMINATED : 
Uq c-ruq sh Bz* wx 
2 + c-ruq sh Bz* wx . 4 Uq/ + c sh Bz* wx 
16 + c sh Bz* wx ' 16 Uq! + csh Bz* wx 
(3 are indistinguishable) 
Season 4 self TISSUE 
COLLECTION 
X Uq c sh wx Uq c sh wx 
self 
X 
. TISSUE 
COLLECTION 
Uq c sh wx 
Uq c sh wx 
self 
X 
TISSUE 
COLLECTION 
Uq c sh wx 
Uq c sh wx 
All spotted 
CONFIRMS genotype 
Half spotted All colorless 
ELIMINATES genotype ELIMINATES genotype 
In the first season (Summer 1986) the selected C-I ,  C and c-ruq alleles 
(linked to Sh Bz) were crossed with the c sh Bz* wx line. The resulting 
heterozygotes were then screened in the second season (Fall 1986) for progeny 
resulting from crossovers between the CI and Shi loci. These crossover 
progeny were then selfed in the third season (Spring 1987) to recover either 
C-I sh Bz* wx (Figure 3.3. Part A), C sh Bz* wx (Part B) or c-ruq sh Bz* wx 
(Part C) in the homozygous condition. Final genotype confirmation and 
tissue collection were accomplished in the fourth season (Summer 1987). 
3.1.3.1. Selection of testers for use in the second season The second 
season crosses used three different testers (C - bz-m4 Wx in Figure 3.3. Part 
A; c sh (bzfBz) wx in Part B; and c sh Bz* wx in Part C) to screen for 
crossovers. This reduces the background uniformity between the fiinal lines, 
but allows development of all stocks to be completed after the third season. 
The decision to use these testers was based on several considerations. 
3.1.3.2. Conversion of the C-I alleles First, aC sh tester was required 
to distinguish the C-I sh Bz* wx crossover chromosome product (desired 
progeny) from the c sh Bz* wx parental chromosome (See Figure 3.3, Part A). 
This tester could be a recovered C sh Bz* wx line (final product in Figure 3.3, 
Part B), which would add three seasons to the C-I sh Bz* wx stock 
development. Alternatively, the tester could he aC sh bz line such as C • bz-
m4 Wx which is unrelated to the c sh Bz* wx tester. An added advantage to 
using the C - bz-m4 Wx tester is the dominant Wx allele which this line 
carries. In season 3, plants carrying the desired crossover were selfed. The 
progeny from these plants segregated 3/4 colorless to 1/4 colored. Only a third 
of the colorless were homozygous for C-I sh Bz* wx (desired). The remaining 
two-thirds of the colorless were heterozygous C-I sh Bz* wxIC-sh bz Wx. By 
selecting only those colorless that were waxy (wxlwx) only the desired 
homozygous C-I progeny were saved. The heterozygous C-I/C, which were 
also non-waxy (Wx/wx), were eliminated. In season 4 this new line was 
planted and selfed for tissue collection and reconfirmation of its genotype. 
3.1.3.3. Conversion of the C alleles Both the C and c-ruq alleles 
required a colorless shrunken line to identify the desired C sh Bz* wx and 
c-ruq sh Bz* wx crossover progeny. The c sh Bz* wx line used in the first 
season was the choice for keeping background variation to a minimum in the 
second season. Unfortunately, in the second season (Fall 1986), only a few 
small  ears  were produced from the C Sh Bz Wx/c sh Bz* wx x  c  sh Bz* wxIc 
sh Bz* wx crosses and no crossover progeny were recovered. Therefore, to 
recover C sh Bz* wx homozygous progeny in time for planting in the 1987 
nursery, crossover progeny from the cross C ShBz WxIc sh Bz* wx x c sh bz 
wx!c sh Bz wx (Figure 3.3, Part B, season 2) was used. When these crossover 
progeny were selfed in season 3, ears segregating 3/4 colored to 1/4 colorless 
were produced. Among the colored, a third were C sh Bz* wx homozygotes 
(desired) ,  and were not  dis t inguishable  f rom the C sh Bz* wxIc sh Bz wx 
heterozygotes. Therefore, to insure the availability of the desired C 
homozygote, excess seed was planted in season 4 (Summer 1987). Selfed ears 
from the C/C and C/c plants were used both for tissue samples and genotype 
confirmation. Those ears segregating for colorless (from C/c plants) and 
their tissue samples were then eliminated. While the tissues collected from 
C/C plants were used in the biochemical experiments. 
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3.1.3.4. Conversion of the c-rua alleles For the c-ruq alleles, the second 
season cross with the c sh Bz* wx tester produced crossover progenies 
(Figure 3.3, Part C). These were identified as spotted shrunken kernels; and 
hence, carried Uq. The crossover progenies which lacked Uq were not 
distinguishable from the homozygous c sh Bz* wx progenies and were, 
therefore, lost. When these spotted crossover progenies were selfed in season 
3 the ears segregated 9/16 spotted to 7/16 colorless. Only 1/7 of the colorless 
are the desired c-ruq sh Bz* wx no Uq homozygotes. The remaining colorless 
carry c sh Bz* wx. To insure the availability of the homozygous c-ruq sh Bz* 
wx in the summer of 1987 (season 4) an excess of colorless was planted; 
sampled and tested (see Section 3.2.1.). 
3.1.3.5. Availabilitv of the C-I sh Bz* wx. C sh Bz* wx. c-ruq sh Bz* wx 
and c sh Bz* wx lines The conversion of the selected C-I, C, c-ruq and c 
lines to a common Bz* background (c sh Bz wx) was restricted to three 
seasons. These were summer 1986 at the Iowa State University Bruner farm, 
fall 1986 in the Iowa State University's Agronomy department greenhouse, 
and spring 1987 in the same greenhouse. This time restriction was made to 
allow all genotypes to be grown in the summer of 1987 (season 4) at the 
Bruner farm for the collection of tissue samples. Of the 12 CI alleles (Table 
3.1) initially started in this conversion program, only 3 completed the 
conversion in time for the 1987 summer nursery. These lines were C-I(A69) 
sh Bz wx,  C-( l ineC) sh Bz wx and c-ruq66 sh Bz wx.  A fourth l ine c  sh Bz wx 
was available without conversion. The other lines failed to meet the three 
season deadline due to unsuccessful crosses or failure to recover the desired 
crossover. 
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3.2. Collection of Kernel Samples for Biochemical Analysis 
3.2.1. Plant Cultivation 
The four newly developed lines carrying the selected C-I(A69), C-(lineC), 
c-ruq66, and c alleles and a common Bzl allele (from c sh Bz wx, see Section 
3.1.3) were planted in the spring of 1987. These lines were planted in rows 
which were 12 feet (3.6 meters) long and spaced 40 inches (1 meter) apart. 
Plants were direct seeded at a density of 14 plants per row. 
For two of the lines (see Figure 3.3, Parts B and C) not all of the seed 
collected to form the lines were the desired genotype. To insure a sufficient 
number of plants of the correct genotype for this experiment, extra seeds 
were planted. The number of extra plants was determined using a table 
developed by Sedcole (Sedcole, 1977). This table gives the total number of 
plants needed to recover "x" number of plants of a given genotype when the 
frequency of that genotype in the population (line) is known. The number of 
plants needed was based on a .95 probability of recovering the desired number 
of plants. 
At anthesis each plant was self pollinated and marked with the 
pollination date. For the c-ruq66 sh Bz wx line, additional crosses were made 
to confirm the genotype of each plant (See Figure 3.3, Part C). 
3.2.2. Tissue harvest 
Kernel tissue for each of the genotypes was harvested at 3 day intervals 
starting at 15 days after pollination (DAP) and ending at 52 DAP. These 
samples were collected by peeling back the husks and removing the upper 
third to half of the ear. The remaining section of the ear was covered and 
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allowed to mature. The collected section of ear was quickly frozen in liquid 
nitrogen, sealed in a plastic bag with a harvest tag, and transported on dry 
ice to a freezer where it was stored at -15°C. The number of ear sections 
collected per maturity-genotype combination was based on ear availability, 
frequency of the desired genotype, and a 95% probability of obtaining 2 to 3 
samples of the desired genotype (Sedcole, 1977). 
The remaining segment of each ear was allowed to mature on the plant. 
These ears, along with the test-crosses, were later harvested, dried and 
examined to confirm each plant's genotype. Those tissue samples collected 
from plants with the desired genotypes were then used in the following 
biochemical studies. 
3.3. Analysis of UDPglucose:flavonoid 3-0-glucosyltransferase Activity 
The conversion of quercetin to isoquercitrin (quercetin-3-glucoside) is 
used as a measure of UDPglucose;flavonoid 3-0-glucosyltransferase (UFGT) 
activity in crude enzyme extracts. The enzyme extraction, assay, and 
isoquericitrin detection methods follow the general procedure of Gerats et al., 
1983. 
3.3.1. Preparation of UFGT enzvme extracts 
Crude enzyme extracts were prepared from frozen kernel samples. 
These kernels are from ears sampled at selected days after pollination (DAP), 
frozen in the field with liquid nitrogen, transported on dry ice, and stored in a 
-15°C freezer. The procedure for preparing the extracts is modified from 
Gerats et al. 1983 and is listed below. The extraction buffer used in step 3 is a 
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35 mM Tris-HCl solution of pH 8.2 with 25 mM mercaptoethanol. Final 
volume of each extract is approximately 300 to 500 |il. 
Steps: 
1. While frozen, remove pericarp and embryo from three kernels 
(rechill as needed with liquid nitrogen). 
2. Grind in chilled mortar and pestle, 1-2 minutes (depends on 
maturity). 
3. Add 0.5 to 1.0 ml extraction buffer (see preceding paragraph), 
(volume depends on kernel fluid content/maturity). 
4. Grind to smooth paste, 1-2 minutes. 
5. Add 0.1 ml Dowex 1-2X. 
6. Grind 1 minute. 
7. Centrifuge 10,000 rpm, 5 minutes, 3-10 °C (Sorvall RC-5B). 
8. Decant and measure volume of supernatant. 
9. Transfer 50 |J.l aliquots to 1.5 ml Eppendorf tubes. 
10. Freeze in liquid nitrogen. 
3.3.2. Assavinp for UFGT activitv 
UDPglucose:flavonoid 3-0-glucosyltransferase (UFGT) is responsible for 
the glucosylation of quercetin to form isoquercitrin (quercetin-3-glucoside). 
UDPglucose (abbreviated UDPG) is the glucosyl donor. This procedure for 
assaying UFGT activity in the maize kernel aleurone tissue uses a crude 
enzyme extract. Addition of the UDPG solution initiates the UFGT mediated 
reaction. The tris-buffer is a 40 mM Tris-HCl solution at pH 9. 
The reaction mixture consists of: 
50 to 100 |j1 extract (generally 50 pi) 
50 to 100 |nl extraction buffer (100 |il less extract vol.) 
20 nl quercetin, 5 x 10-4 M in methanol 
30 jxl water 
46 10.1 Tris buffer (see preceding paragraph) 
_4 ^ il UDPG, 0.05 M in Tris buffer 
200 III FINAL VOLUME 
The blank consists of: 
50 to 100 |il extract (same as reaction mixture) 
50 to 100 |il extraction buffer (100 ill less extract vol.) 
20 |xl quercetin, 5 x 10-4 M in methanol 
30 |il water 
50 111 Tris buffer 
200 ^il FINAL VOLUME 
Steps: 
1. Shake mixture briefly. 
2. Incubate at 37-38 °C, 5-10 minutes (generally 5 min.), 
3. Stop reaction with 800 p,I chloroform:methanol (2:1). 
4. Mix. 
5. Centrifuge 2 minutes, 13,000 rpm (table top). 
6. Isoquercitrin and quercetin are contained in upper phase. 
The modified blank used to calculate initial quercetin content of the 
reaction mixture is the same as the blank but with an incubation time of 
55 
3.3.3. High pressure liquid chromatographic detection of auercetin and 
isoQuercitrin 
High pressure liquid chromatography (HPLC) is the method chosen for 
detecting and quantifying the conversion of quercetin to isoquercitrin. 
Following the addition of the methanol-chloroform stop solution to the UFGT 
reaction mixture (Section 3.3.2) isoquercitrin and quercetin are recovered in 
the aqueous-methanol upper phase. This aqueous-methanol solution is 
ready for analysis by reverse phase HPLC using a Lichrosorb 10RP18 (25 x 0.5 
cm) column. The HPLC system includes a Waters Lambda Max 481 LC 
spectrophotometer and Model 510 pumps and is driven by Waters Expert 
version 5.1 or 6.2 software. 
All eluents are filtered through a 0.2 |im nylon filter when prepared. 
Prior to each use of the HPLC, air bubbles are removed from the system. This 
procedure consists of first displacing the air from the eluens using a stream 
of helium bubbled at 100 ml/min through the solutions for 20 minutes. Next 
the pumps are primed at a combined flow rate of 11.0 ml/min (5.5 
ml/min/pump), while by-passing the column (see Appendix II, pump 
program QPRIME). Following the introduction of the column to the system 
at a zero flow rate, the analytical conditions are established as 25% methanol, 
75% 10:65 acetic acid:water at 3 ml/min (see Appendix II, pump program 
QUERBEG). The system is allowed to equilibrate for approximately one hour 
before beginning sample injections. 
Samples are analyzed using an isocratic gradient of 25% methanol, 10% 
glacial acetic acid, and 65% water. Injections consist of 50 to 100 |il (usually 
100 |il) of the aqueous-methanol phase created from the enzyme assay 
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mixture (Section 3.3.2). Isoquercitrin with a retention time of 4.21 minutes 
and quercetin with a retention time of 6.14 minutes were detected at 254 nm. 
The quercetin stock also contains a minor component with a retention time of 
6.71 minutes. Data collection extended 20 minutes from the time of injection 
(Appendix II, pump program QUER45). Waters software, Expert Version 5.1 
or 6.2, controlled both data acquisition and processing. 
3.3.4. Identification and quantitation of isoauercitrin 
Positive identification of isoquercitrin in the UFGT enzyme reaction 
mixture was accomplished using standard isoquercitrin solutions. A 5 x 10"* 
M solution of isoquercitrin in methanol was used as the 100% concentration 
to make a serial dilution series of 100, 75, 50, 25,12.5, and 6.25 percent 
solutions in methanol. The 5 x 10"^ M solution has the same concentration as 
the quercetin solution added to the enzyme assay mixture. 
These solutions were used to identify and quantify the reaction product 
from the UFGT assays. The serial dilutions were added to a modified 
reaction mixture (see following) and treated identically to the unknowns 
except for the incubation time. Results from these samples were used to 
establish both the isoquercitrin retention time and a standard curve for 
converting absorbance units to p-g isoquercitrin. 
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The isoquercitrin standard curve mixture consists of: 
100 |il extract buffer 
20 |Lil isoquercitrin 
30 |il water 
46 |il Tris buffer 
4 |il UDPG in Tris buffer 
200 ^il FINAL VOLUME 
Steps: 
1. No incubation. 
2. Add 800 |j.l chloroform: MeOH (2:1), 
3. Mix. 
4. Centrifuge 2 minutes, 13,000 rpm (table top). 
5. Isoquercitrin in upper phase. 
3.4. High Pressure Liquid Chromatographic Detection and 
Quantitation of Naturally Occurring Flavonoids 
The Bzl converted lines are screened to determine their patterns of 
flavonol and anthocyanin expression. These flavonoids are extracted from 
both the immature and mature ears sampled for UFGT activity. 
Identification of the flavonoid compounds in each extract is by comparison of 
HPLC retention times with those of known compounds contained in standard 
extracts. These standards are from the petunia varieties Blue Magic (for 
flavonols) and USDA-83 (for anthocyanins). 
The HPLC system consists of a Lichrosorb 10RP18 (25 x 0.5 cm) reverse 
phase column, Waters Lambda Max 481 LC spectrophotometer, Model 510 
pumps and Waters Expert version 6.2 or 6.22 software. The procedures are a 
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modification of those used for geranium cultivar identification (Asen and 
Griesbach, 1983; R. Griesbach, personal communication). 
3.4.1. Extraction of flavonols 
Flavonols are extracted from frozen kernel samples, mature (dry) seeds, 
and freeze-dried petals of Blue Magic petunia (provided by Dr. R. Griesbach, 
USDA, Beltsville, MD). Extraction follows the procedure of Dr. R. Griesbach 
(personal communication). 
Steps: 
1. While frozen, remove pericarp and embryo from one kernel. 
2. Crush in mortar and pestle (paste or fine meal depending on 
maturity). 
3. Add 0.5 ml water (HPLC grade). 
4. Grind until smooth paste. 
5. Transfer to centrifuge tube. 
6. Rinse mortar and pestle 2 times with 0.5 ml water (HPLC 
grade) and pool liquid 
7. Centrifuge 10,000 rpm, 5 min, 3-10°C (Sorvall RC-5B). 
8. Freeze supernatant. 
9. Freeze dry using speed vac (Lid covered to keep sample in 
dark). 
For the Blue Magic standard this procedure is modified by extracting one 
freeze-dried petunia flower petal. The resulting extract (step 7) is hot pink in 
color and is divided into 4 to 5 aliquots (depending on color intensity) before 
freezing and drying. 
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All samples are redissolved in 50-200 |xl methanol (HPLC grade) prior to 
HPLC analysis. The resulting solutions were centrifuged 2 minutes at 13,000 
rpm before injection to remove any undissolved solids. 
3.4.2. Preparation of HPLC system for flavonol analvsis 
All eluens are filtered through a 0.2 |im nylon filter when prepared. 
Prior to each use of the HPLC, air bubbles are removed from the lines. This 
procedure consists of first sparging an aqueous solution of 1% triethylamine 
(pH 3.0 with phosphoric acid) for 20 minutes with 100 ml/min helium. The 
acetonitrile is not sparged because of the lack of appropriate ventilation. 
Next, the two pumps are primed at a combined flow rate of 11.0 ml/min (5.5 
ml/min/pump), while by-passing the column (see Appendix II, pump 
program QPRIME). Following reintroduction of the column to the system at 
a zero flow rate, the analytical conditions are established as 1% triethylamine 
solution at 1 ml/min (see Appendix II, pump program FLABEG). The 
column is then equilibrated for approximately one hour before using. 
3.4.3. HPLC resolution and quantitation of flavonol s 
High pressure liquid chromatographic separation of flavonols is 
accomplished using a linear gradient of two eluens. The aqueous eluen 
consists of 1% triethylamine adjusted to pH 3.0 with phosphoric acid. The 
second eluen is HPLC grade acetonitrile. This gradient consists of two parts, 
a 20 minute linear gradient from 0 to 20% acetonitrile (100 to 80%, 1% 
triethylamine) followed by 20 minutes isocratic gradient of 20% acetonitrile. 
See Appendix II, for a complete listing of the pump program, FLAV. 
Flavonols are detected at 340 nm. 
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To identify individual flavonol compounds an extract of Blue Magic is 
injected into the column and separated using the FLAV pump program. The 
resulting plot is then compared with a plot (Figure 3.4.) prepared by Dr. R. 
Griesbach which accompanied the freeze-dried tissue. Retention times and 
peak names from the control are entered into the Waters Expert calibration 
function and used for data processing of subsequent unknown samples. A 
control is run each day and the calibration table adjusted to reflect variations 
in retention times. 
3.4.4. Extraction of anthocvanins 
Anthocyanins are extracted from frozen kernel samples, mature (dry) 
seeds, and freeze-dried petals of USDA-83, petunia (provided by Dr. R. 
Griesbach, USDA, Beltsville, MD). Extraction follows the procedure of Dr. R. 
Griesbach (personal communication) which is a slightly modified version of 
the procedure in Section 3.4.1. 
Steps: 
1. While frozen, remove pericarp and embryo from one kernel. 
2. Crush in mortar and pestle (paste or fine meal depending on 
maturity). 
3. Add 0.5 ml 1% HCl in water (HPLC grade). 
4. Grind until smooth paste. 
5. Transfer to centrifuge tube. 
6. Rinse mortar and pestle 2 times with 1% HCl in water (HPLC 
grade) and pool liquid. 
7. Centrifuge 10,000 rpm, 5 min, 3-10°C (Sorvall RC-5B). 
8. Freeze supernant. 
Flavonol Glycosides 
Petunia: Blue Magic 
Column: Cig 
Gradient: 0 to 20% acetonitrUe (linear) 
in 20 minutes 
20% for 15 minutes 
Buffer 1% triethylamine, pH 3.0 
with phosphoric acid 
Flow: 1 ml/min 
Monitor: 340 nm 
to CO 
0.0 
m 
0.5 1.0 1.5 
A X10 minutes 
Figure 3.4. Reproduction of HPLC plot furnished by Dr. R. Griesbach (USDA, Beltsville, MD) with a 
freeze dried sample of Blue Magic petunia blossoms. The flavonol profile of Blue Magic 
is plotted as volts versus retention time in 10^ minutes. Separation conditions listed on 
the plot and are similar to those listed in Section 3.4.3. Eight flavonols are identified. 
These are: 
retention 
time fmin) flavonol 
percent 
volts 
20.26 cafFeic acid-glucoside 4 
21.36 quercetin-3-sophoroside-7-glucoside 9 
22.57 quercetin-3-(caffeoylsophoroside)-7-glucoside n.a. 
24.13 quercetin-3,7-diglucoside 9 
26.80 p-coumaric acid n.a. 
27.93 quercetin-3-sophoroside 60 
29.15 quercetin-7-glucoside 11 
29.84 quercetin-3-glucoside n.a. 
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9. Freeze dry using Speedvac (Lid covered to keep samples in 
dark). 
For the USDA-83 standard this procedure was altered by extracting 
pieces of freeze-dried petunia petal. Amount estimated to equal one petal. 
The resulting extract (step 7) is peach colored and is divided into 4-5 aliquots 
(depending on color intensity) before freezing and drying. 
All samples are redissolved in 1% HCl in methanol (HPLC grade) prior 
to HPLC analysis. The resulting solutions are centrifuged 2 minutes at 
13,000 rpm before each injection. 
Note that the first extraction solvents tried were 1% acetic acid in water 
for the initial extraction and 1% acetic acid in methanol for redissolving the 
pigments following freeze-drying. When using the 1% acetic acid in 
methanol, the resulting solutions rapidly faded from bright red to pale 
yellow. Under these conditions, the USDA-83 plots did not reproduce the peak 
profile accompanying the freeze-dried tissue. With the change to 1% HCl in 
water and 1% HCl in methanol, the solution colors are more stable and the 
USDA-83 plots reproduce the standard peak profile. 
3.4.5. Preparation of HPLC svstem for anthocvanin analysis 
Initial procedures used to prepare the HPLC for sample analysis are the 
same as those outlined in Section 3.4.2. The only change is the composition of 
the aqueous solvent. The eluens used are acetonitrile and a solution of 15% 
acetic acid, 1.5% phosphoric acid, in water. 
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3.4.6. HPLC resolution and quantitation of anthocvanins 
High pressure liquid chromatography separation of anthocyanins is 
accomplished using a linear gradient of two eluens. The aqueous eluen 
consists of 15% acetic acid plus 1.5% phosphoric acid in water. The second 
eluen is HPLC grade acetonitrile. The initial linear gradient used, is from 0 
to 20% acetonitrile (100 to 80% 15:1.5:83.5 acetic acid:phosphoric acid:water) 
in 50 minutes. See Appendix II, pump program AN. Early results (not 
reported) exhibited interference of polyphenols with anthocyanin detection. 
The actual gradient used to analyze the anthocyanin content of maize 
kernels is a two part gradient. The first 10 minutes are an isocratic gradient 
of 1% acetonitrile and 99% 15:1.5:83.5 acetic acid:phosphoric acid:water to 
elute the polyphenols. The last 50 minutes of data collection are a linear 
gradient from 1 to 20% acetonitrile (Appendix II, pump program ANTWO). 
Anthocyanins are detected at 540 nm. 
To identify individual anthocyanin compounds, an extract of USDA-83 is 
injected into the column and separated using the ANTWO pump program. 
The resulting plot is then compared with a plot (Figure 3.5) prepared by Dr. 
R. Griesbach which accompanied the freeze-dried tissue. Retention times 
and peak names from the current control sample are entered into the Waters 
Expert calibration function and used for data processing of subsequent 
unknown samples. The calibration table is adjusted each day to reflect 
variations in retention times. 
Anthocyanins (Anthocyanidin Glycosides) 
ID tf) 
m 
2.5 
2.0 
1.5 
II) 
"5 
1.0 
Petunia: 
Column: 
Gradient: 
Buffer. 
Flow: 
Monitor: 
0.5 
USDA-83 
Ci8 
0 to 20% acetonitrile (linear) 
in 50 minutes 
15% acetic add and 
1.5% phosphoric add 
1 ml/min 
540 nm 
cn 
1.0 
—r-
2.0 
10 
3.0 
minutes 
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Figure 3.5. Reproduction of HPLC plot furnished by Dr. R. Griesbach (USDA, Beltsville, MD) with a 
freeze dried sample of USDA-83 petunia blossoms. The anthocyanin (anthocyanidin 
glucoside) profile of USDA-83 is plotted as lO ^ volts versus retention time in 10^ 
minutes. Separation conditions listed on the plot are the initial conditions listed in 
Section 3.4.6. Six anthocyanins are identified. These are: 
retention 
time fmin) anthocvanin 
percent 
volts 
13.36 cyanidin-3-(p-coumarylrutinoside)-5-glucoside 1 
34.74 petunidin-3-(caffeylrutinoside)-5-glucoside 1 
39.19 peonidin-3-(caffeylrutinoside)-5-glucoside 15 
40.43 malvidin-3-(cafFeylrutinoside)-5-glucoside 11 
43.55 peonidin-3-(p-coumarylrutinoside)-5-glucoside 71 
48.03 malvidin-3-(p-coumarylrutinoside)-5-glucoside <1 
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3.5. Statistical Methods for Data Analysis 
The treatment design includes two types of treatments (genotype and 
kernel maturity) tested in all combinations. This two factor factorial design, 
results in 20 replicated treatment combinations. Statistic analysis of the data 
is by analysis of variance (ANOVA) of treatment means (Steel and Torrie, 
1980). 
A representative ANOVA table generated from the total 340 nm 
absorbance of the flavonol extracts is illustrated in Table 3.2. Unweighted ear 
means are used and 4 out of 40 ears are missing from the design. 
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Table 3.2. Analysis of variance (ANOVA) table for the total 340 nm 
absorbance of the flavonol extracts (see Section 4.3.1.). Line 1 
examines variations in the data when the genotype is the only 
treatment compared. Line 5 examines the data as if the only 
treatments are maturity. Line 9 examines variations in the data 
when all 20 treatments (4 genotype, 5 maturity) are considered. 
Additional contrasts (Lines 2-4, 6-8,10-12) are listed. The mean 
square among ears within the plot was used as the experimental 
error term. The ears sum of squares (Line 13) is the sum of 
square error term divided by 1.67, the harmonic mean. n.s. 
indicates a "probability of a greater F" greater than 10%. In 
lines 2-4 and lines 10-12, the letters distinguish the genotype 
treatments. "L" is C-(lineC), "i" is C-I(A69), "s" is c, and "6" is 
c-ruq66 
Source of 
variability 
Degrees 
of 
freedom 
Type I 
sums of 
squares 
Mean 
square F value 
Probability 
of greater 
F 
1 Genotype 3 298343250 99447750 1.41 n.s. 
2 L vs si6 1 197771149 197771149 2.80 n.s. 
3 i vs s6 1 28545065 28545065 .40 n.s. 
4 s vs 6 1 72027034 72027034 1.02 n.s. 
5 Maturity 4 950799977 237699994 3.37 .050 
6 Linear 1 4209914 4209914 .06 n.s. 
7 Quadradic 1 48279491 48279491 .68 n.s. 
8 Residual 2 898310572 449155286 6.37 .025 
9 Genotype by 
Maturity 
12 767739367 63978280 .91 n.s. 
10 L vs si6 * 
Linear 
1 14196 14196 .009 n.s. 
11 i vs s6 * 
Linear 
1 35527573 35527573 .50 n.s. 
12 s vs 6 * 
Linear 
1 93180032 93180032 1.32 n.s. 
13 Ears 16 1128459200 70528700 
4. RESULTS 
4.1. Selected Cl Locus Alleles Express Different Dosage 
Effects and Dominance 
Twelve alleles of the CI regulatory locus (Table 3.1.) were initially 
evaluated before selecting the genotype treatments used to study the effects of 
the CI locus on anthocyanin pathway expression in maize aleurone. This 
initial evaluation included a determination of the phenotypes, relative 
dominance, and dosage effects of the 12 alleles. This was accomplished 
using a complete diallel crossing design. 
The crosses used to control the endosperm dosage for the comparison of 
the 12 alleles of the CI locus were discussed in Section 3.1.2. and Figure 3.1. 
All lines carried dominant alleles at the other gene loci necessary for 
pigment synthesis. But, no attempt was made to control the allelic variation 
at these loci. 
Progeny kernel phenotypes for each of the crosses are shown in the 
photograph in Figure 4.1. (Part A). The endosperm genotype of each kernel 
is listed in Figure 4.1. (Part B). The kernels homozygous (three doses) for 
each of the colored alleles [4 = C-S, 5 = C-(hiloss), 6 = C-(Cshbz), and 7 = 
C-(lineC)] are repeated in the upper most row over the left and right boxes. 
These represent the female parents of kernels located in the left box, the male 
parents of kernels in the right box, and the progeny of Cross 3 (Figure 3.1.). 
In the far left column are kernels homozygous (three doses) for each of the 
colorless alleles [1 = C-I(Cornell), 2 = C-I (K55), 3 = C-I (A69), 8 = c-ruq67, 9 = 
c-ruq66, 10 = c-ruq65, 11 = c-ruq31, and 12 = c]. These were used as the male 
PART A. 
Figure 4.1. The endosperm phenotypes observed when the selected colorless 
and colored alleles of the CI locus are intermated (see Figure 
3.1. for summary of crosses). Kernels labeled* 4, 5, 6, and 7 in 
the top row represent homozygous C-S, C-(hiloss), C-(Cshbzj and 
C-(lineC) genotypes respectively. Kernels in the far left column 
labeled* 1-3, and 8-12 represent homozygous C-I(Cornell), C-
I(K55), C-I(A69), c-ruq67, c-ruq66, c-ruq65, c-ruq31 and c 
genotypes respectively. Kernels in the boxes represent the 
heterozygous progeny from Cross 1 (right box) and Cross 2 (left 
box). 
A) Sample kernels. B) Corresponding endosperm genotypes 
*Numbers correspond to rows in Table 3.1. 
PARTE. 
CzS. c-rhiioss) n-rcahbz) ç.(Um C), 
as C-(hiloss) C-(Cshbz) C-dine C) 
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4 5 6 7 
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C-Œiloss) 
C-(hiloss) 
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parent to produce the kernels in the left box, as the female parent of those 
kernels in the right box, and are the progeny of Cross 4 (Figure 3.1). 
When examining the parental CI phenotypes, colored verses colorless 
refers to the presence or absence of anthocyanin pigmentation in the 
aleurone. Kernel coloration for these lines are also affected by other genes 
controlling either the starch (opaque or translucent) or ^-carotene (white or 
yellow) content of the endosperm. These genes do not affect anthocyanin 
pigmentation and therefore, will not be considered further. For the colored 
genotypes, coloration of the homozygous kernels is affected by modifier genes 
of the anthocyanin pathway. C-S (no. 4) and C-(hiloss) (no. 5) are 
homozygous dominant for both Pr and Bz; therefore, the kernels are purple. 
The C-(Cshbz) kernel (no. 6) is homozygous recessive for bz; therefore, the 
kernels are bronze. The red coloration of the C-(lineC) genotype (no. 7) is due 
to the recessive pr allele being homozygous. Since the bz and pr alleles affect 
the type of pigment present, relative dominance of the alleles of the CI locus 
will be based on the presence or absences of pigment and not on the type 
(color). 
Differences among both the dominant color inhibitors (C-/ alleles) and 
the dominant color producing (C) alleles are revealed by Crosses 1 and 2 
(Figure 3.1). When C-S is present in two doses (progeny of Cross 1), the C-S 
allele is only partially suppressed by the C-I alleles (Figure 4.1 Part A 
Coordinates:Left 1, 2, 3; Top 4). As seen in Figure 4.1, a single dose of the 
C-I(Cornell), and C-I(K55) alleles partially suppress the C-S expression 
resulting in dark pale kernels (Left 1,2; Top 4). C-I(A69) allows almost full 
expression of the C-S phenotype (Left 3; Top 4). 
When one dose of C-S is present (Cross 2) only C-I (Cornell) and C-I 
(K55) are able to completely suppress C-S expression (Right 1,2; Top 4). C-I 
(A69) allows limited pigment formation by one dose of C-S (Right 3; Top 4). 
Hence, the conclusion that C-S is partially dominant to the C-I class of 
alleles. This agrees with the description by Karen Cone and co-workers 
(1986) which is based on the C-S interaction with one C-I allele. 
The C-I alleles are indistinguishable when examining progeny 
containing two doses of C-I and a single dose of C-(hiloss), C-(Cshbz), or 
C-dineC) (Cross 2; Right 1,2,3; Top 5,6, 7). When looking at the progeny of 
Cross 1 which contain only one dose of C-I, allelic differences do emerge. C-I 
(A69) is not able to suppress any of the C alleles tested (Left 3; Top 4-7). C-I 
(Cornell) allows a weak pigmentation with C-(line C) (Left 1; top 7). These 
observations allow the ordering of the C-I alleles based on their suppression 
ability with the strongest listed first; C-I (K55), C-I (Cornell), and C-I (A69). 
These observations also allow the ordering of the C-(hiloss), C-(lineC), and 
C-(Cshbz) in decreasing order of dominance after the C-I alleles and C-S. 
When the recessive alleles are mated with the dominant colored alleles, 
one dose of the c-ruq67, c-ruq66, c-ruq65, c-ruq31 or c allele does not generally 
affect the expression of the C alleles (Left 8-12; Top 4-7). The one exception 
may be the c allele in combination with C-(Cshbz) or C-(line). The progeny of 
these two crosses (Left 12; Top 6, 7) appear paler than the other crosses of this 
group. 
When the c-ruq67, c-ruq66, c-ruq65, c-ruq31 and c alleles are present in 
two doses, differences are detected depending on the C allele that is chal­
lenged. With either C-S or C-(hiloss) there is no visible effect on expression 
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(Right 8-12; Top 4,5). (Note that the c by C-hiloss progeny (Right 12; Top 5) is 
not available for this comparison.) The c-ruq67, c-ruq66, c-ruq65, c-ruq31 and 
c alleles do reduce the expression of the C-(Cshbz) and C-(lineC) alleles when 
present in two doses (Right 8-12; Top 6, 7). Some slight difference between the 
c-ruq31 allele (Right 11; Top 6, 7) and the c-ruq67, c-ruq66, c-ruq65 and c 
alleles may be apparent but it is not great enough to quantify visually. 
The dominance of these recessive alleles relative to each other can be 
visually determined by the interactions of the recessive c-ruq and c alleles 
with the C alleles along with the c-ruq and c interactions in the presence of 
Uq. The c-ruq31 allele is either slightly less dominant than the c-ruq67, 
c-ruq66, and c-ruq65 alleles or equally dominant (colored alleles appear to 
produce slightly more pigment when heterogygous c-ruqSl than when 
heterozygous with c-ruq67, c-ruq66, or c-ruq65). The c allele has the least 
dominance of any of the tested alleles. The c allele could also be described as 
the most recessive of the alleles. Figure 4.2 summarizes the relative 
C-I(K55) > C-KCornell) > C-I(A69) > C-S > C-hiloss 
> C-(lineC) > C (Cshbz) > c-ruq67 = c-ruq66 
= c-ruq65 > c-ruqSl > c 
Figure 4.2. Selected alleles of the CI locus ordered for relative dominance 
based on a comparison of the pigmentation expressed by progeny 
from a complete diallel of the colored and colorless alleles. The 
progeny phenotypes are shown in Figure 4.1. Parts A and B 
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dominance of alleles tested. Recent molecular studies of the c-ruq alleles 
support the phenotypic differences observed here which group the c-ruq67, 
c-ruq66, and c-ruq65 alleles together. Using specific primers for ruq66 and 
PGR amplification, A. G. Pisabarro and co-workers (1991) have shown that 
the c-ruq65, c-ruq66, and c-ruq67 alleles are very likely the same mutation. 
Hence, only the c-ruq66 allele will be considered further in this study. 
4.2. Analysis of UDPglucoserflavonoid 3-0-glucosyltransferase (UFGT) 
Activity in Selected Maize Kernel Genotypes and Maturities 
The Bzl encoded UDPglucose:flavonoid 3-0-glucosyltransferase (UFGT) 
catalyzes the glycosylation of quercetin to form isoquercitrin (Larson and Goe, 
1977). This reaction can be monitored by two methods: either detecting 
isoquercitrin accumulation or detecting quercetin consumption. 
The enzyme assay conditions used to detect UFGT activity were detailed 
in Section 3.3. The crude enzyme extracts were treated with Dowex l-2x resin 
to remove endogenous anthocyanidin compounds or precursors. Therefore, 
the isoquercitrin detected in the assays was a product of quercetin and hence 
UFGT catalysis. 
UFGT activity can also be measured as a function of quercetin 
disappearance. However, this assumes that UFGT is the only enzyme 
present which can use quercetin as a substrate. If the crude enzyme extracts 
contain other quercetin utilizing enzymes, then quercetin disappearance 
may reflect multiple reactions. Hence, isoquercitrin detection is the 
preferred method. 
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4.2.1. UFGT assay production of isoquercitrin 
4.2.1.1. Establishment of an isoquercitrin standard curve The Waters 
Expert version 5.1. and 6.2. software collects HPLC data as absorbance (254 
nm) and computes peak area. To quantify the conversion of quercetin to 
isoquercitrin by UFGT, peak area must be related to units of isoquercitrin 
(nanograms). This relationship is established by constructing a standard 
curve (see Section 3.3.4.). 
An isoquercitrin solution of 5 x IQ-^M was used to create a serial 
dilution series of 100, 75, 50, 25,12.5, and 6.25 percent. When used to create a 
standard curve, these solutions correspond to 4651, 3488, 2326, 1163, 581, and 
291 nanograms isoquercitrin. Each solution was assayed 5 to 8 times (Table 
4.1). 
Linear regression was used to fit a straight line to the data points in 
Table 4.1. This line (y = mx + b) is the standard curve (Figure 4.3) from 
which ng isoquercitrin will be calculated for each experimentally determined 
peak area. In this equation, y is the nanograms of isoquercitrin, m is the 
slope, X is the absorbance in peak area, and b is the y-intercept. Using linear 
regression, the best fit line for the standard curve has a slope of m = 3.606 x 
10-3 ng/peak area and a y-intercept of b = 86.425 ng. These values along with 
the experimentally determined isoquercitrin peak area are used to solve the 
equation for y (ng isoquercitrin) produced in each assay. 
4.2.1.2. Correction of assav raw data to a standard time and enzvme 
extract volume The UFGT enzyme activity contained in the aleurone of 
selected maize genotypes and maturities is reflected in the conversion of 
quercetin to isoquercitrin. Individual assays varied in the total crude enzyme 
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Table 4.1. Raw data used to establish an isoquercitrin standard curve 
(Figure 4.3.). Solutions containing from 291 to 4651 ng 
isoquercitrin were used to determine the relationship between the 
observed absorbance at 254 nm (recorded as peak area by Waters 
Software, Expert 5.1 or 6.2) and isoquercitrin concentration 
Entry 
ng 
isoquercitrin 
Absorbance 
in peak area Entry 
ng 
isoquercitrin 
Absorbance 
in peak area 
1 291 50832 21 2326 634080 
2 291 159714 22 2326 505330 
3 291 57040 23 2326 667672 
4 291 82039 24 2326 552881 
5 291 100471 25 2326 726002 
6 581 135415 26 3488 836764 
7 581 253080 27 3488 983542 
8 581 200427 28 3488 870596 
9 581 99171 29 3488 680784 
10 581 163925 30 3488 881948 
11 581 208515 31 3488 851521 
12 1163 260104 32 3488 937277 
13 1163 389232 33 4651 1305633 
14 1163 320158 34 4651 1369477 
15 1163 204006 35 4651 1403160 
16 1163 281011 36 4651 1324896 
17 1163 302157 37 4651 1096972 
18 1163 350532 38 4651 1424260 
19 2326 569261 39 4651 1030294 
20 2326 726239 40 4651 1244506 
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Figure 4.3. Isoquercitrin standard curve plotted as nanograms 
isoquercetin versus absorbance in peak area. Each 
concentration of isoquercitrin was sampled 5 to 8 times (for 
raw data see Table 4.1.). Linear regression was used to fit 
a straight line to the data points. The equation for this line 
is y = mx + b, where y is nanograms of isoquercetrin, m is 
the slope, x is absorbance in peak, area, and b is the y-
intercept. For this line, m = 3.606 x lO"^ ng/peak area and b 
= 86.425 ng 
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extract volume and incubation time. Therefore, the raw data (isoquercitrin 
peak area) can not be compared directly. 
The isoquercitrin peak area from each assay was first corrected for 
endogenous isoquercitrin present in the enzyme extract which was not 
removed bythe Dowex 1-2 resin. Waters Expert Version 5.1 or 6.2 software 
subtracted the isoquercitrin detected in the blank (assay without the UDP-
glucose substrate) from the isoquercitrin in the corresponding assays. The 
resulting peak area still must be converted to ng isoquercitrin and corrected 
for differences in incubation time and volumes. Appendix III lists the raw 
data, intermediate calculations, and final corrected values for each UFGT 
enzyme assay in eight tables. This data will be discussed in Section 4.2.1.3. 
Each assay is identified with kernel maturity (days after pollination or 
DAP), ear number, and sample name. The peak area is first corrected for 
variations in incubation time (Equation 1). The resulting value is x in the 
linear equation developed in Section 4.2.1.1. (Equation 2). Finally ng of 
isoquercitrin is corrected for the total enzyme extract volume (Equation 3). 
Equation 1 (peak area)(300 sec) incubation time, sec 
time 
=corrected 
peak area 
Equation 2 
Vtime 
corrected 
^peak area 
^ 
+ 86.425 ng = ng isoquercitrin 
p
Equations 
ng Ytotal |j,n 
isoquercitrin XextractJ _ ng isoquercitrin 
50 |il used in assay "produced in 300 sec. Ï 
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4.2.1.3. Initial survey of UFGT activities in four genotypes: C-I(A69) sh 
Bz wx. C-(lineC) sh Bz wx. c-rua66 sh Bz wx and c sh Bz wx In an initial 
screening of UFGT activities, all four genotypes developed in Section 3.1.3. 
were assayed. These genotypes are C-I(A69) sh Bz wx, C-(lineC) sh Bz wx, 
c-ruq66 sh Bz wx, and c sh Bz wx. Each genotype was assayed at 14 
maturities (15, 18, 21, ... 51 DAP and Mature). Only one extract from a 
single ear per genotype/maturity combination was used. 
For the colorless C-I(A69) sh Bz wx genotype, only one of the extracts for 
the DAP tissue (1 out of 26 assays, 1 out of 13 extracts) produced isoquercitrin 
(Figure 4.4). This resulted in a mean for two assays of 661 ng 
isoquercitrin/300 seconds corrected for volume for the 45 DAP tissue. A 
similar peak in isoquercitrin production was observed for 45 DAP c sh Bz wx 
tissue (Figure 4.7). Both of these peaks in isoquercetin production correspond 
to a larger peak observed with the C-(lineC) sh Bz wx genotype (Figure 4.5). 
No other extracts of the C-I(A69) sh Bz wx genotype produced detectable levels 
of isoquercitrin. 
The colored C-(lineC) sh Bz wx genotype exhibits two peaks in 
isoquercitrin production (Figure 4.5). The presence of two peaks is somewhat 
surprising. From cell division and tissue growth alone, one would expect an 
increasing amount of extractable UFGT activity and hence isoquercitrin 
production with increasing maturity. The first peak of 8298 ng isoquercitrin 
produced in 300 seconds occurs at 33 DAP. Accentuating this peak is the 
apparent immaturity of the 39 DAP sample. (These kernels appear 
physiologically younger than either the 33 and 36 DAP kernels). The second 
peak in isoquercitrin production is at 45 DAP and is 14,081 ng 
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15 18 21 24 27 30 33 36 39 42 45 48 51 M 
Kernel Maturity in DAP 
UFGT activities initially observed for the C-I(A69) sh Bz wx 
genotype. Values are corrected for incubation time and 
extract volume (see Section 4.2.1.2. and Appendix HI, 
Table A.3.I.). Assays were replicated two times for each 
enzyme extract. One extract was used for each kernel 
maturity. Units are days after pollination or DAP. || and 
II represents individual assay results. 0 represents the 
mean of two values for a given DAP 
82 
16 
CO 
s 14 
X 
y 12 
en 
O 
1 
10 
•| 8 
•g 
1 6 
o 
a 4 
bo A 
2 
0 
15 18 21 24 27 30 33 36 39 42 45 48 51 M 
Kernel Maturity in DAP 
Figure 4.5. UFGT activities initially observed for the C-(lineC) sh Bz wx 
genotype. Values are corrected for incubation time and 
extract volume (see Section 4.2.1.2. and Appendix III, 
Table A.3.2.). Assays were replicated two times for each 
enzyme extract. One extract was used for each kernel 
maturity. Units are days after pollination or DAP. || and 
represents individual assay results. |represents the 
mean of two values for a given DAP 
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Figure 4.6. 
Kernel Maturity in DAP 
UFGT activities initially observed for the c-ruq66 sh Bz wx 
genotype. Values are corrected for incubation time and 
extract volume (see Section 4.2.1.2. and Appendix HI, 
Table A.3.3.). Assays were replicated two times for each 
enzyme extract. One extract was used for each kernel 
maturity. Units are days after pollination or DAP. 0 and 
; represents individual assay results. 0 represents the 
mean of two values for a given DAP 
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Figure 4.7. UFGT activities initially observed for the c sh Bz wx 
genotype. Values are corrected for incubation time and 
extract volume (see Section 4.2.1.2. and Appendix III, 
Table A.3.4.). Assays were replicated two times for each 
enzyme extract. One extract was used for each kernel 
maturity. Units are days after pollination or DAP. |and 
represents individual assay results. |represents the 
mean of two values for a given DAP 
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isoquercitrin/SOO seconds. On reaching physiological maturity (black layer 
formed by 51 DAP) and seed dry down, extractable UFGT activity decreases. 
Sample availability for the colorless c-ruq66 sh Bz wx genotype is 
limited. Isoquercitrin production levels peak early in kernel development, at 
or near 27 DAP (Figures 4.6). This peak in UFGT activity of 2301 ng 
isoquercitrin/300 seconds is much smaller than either peak observed with 
C-(lineC) sh Bz wx. In contrast with the other colorless genotypes, the 
c-ruq66 sh Bz wx genotype has low levels of UFGT activity present throughout 
kernel development. 
The c sh Bz wx (colorless) genotype expresses the same isoquercitrin 
production profile (Figure 4.7) as C-1(A69) sh Bz wx (Figure 4.4). The peak 
extractable UFGT activity from c sh Bz wx is at or near 45 DAP. (48 and 51 
DAP samples are not available.) The 45 DAP tissue produces an average of 
548 ng isoquercitrin/300 seconds. This is slightly less than the activity 
extracted from 45 DAP C'I(A69) sh Bz wx tissue. No other c sh Bz wx 
extracts representing the available DAP samples produced detectable 
quantities of isoquercitrin. 
The mean isoquercitrin production results from C-I(A69) sh Bz wx 
(Figure 4.4), C-(lineC) sh Bz wx (Figure 4.5), c-ruq66 sh Bz wx (Figure 4.6) 
and c sh Bz wx (Figure 4.7) are combined in Figure 4.8 for comparison. 
4.2.1.4.' UFGT activitv assavs replicated for five maturities To 
establish the repeatability of the UFGT activities observed in Section 4.2.1.3., 
assays were replicated for five tissue maturities. This reduction in the 
number of maturities sampled is due to two factors. First, the only tissue 
maturities available for all four genotypes are 18, 27, 36, 45 DAP and Mature 
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Figure 4.8. Summary of the mean UFGT activities initially observed 
for C-I(A69) sh Bz wx, C-(lineC) sh Bz wx, c-ruq66 sh Bz 
wx, and c sh Bz wx. UFGT activity is measured as ng 
isoquercitrin produced under standard assay conditions. 
Individual results for each genotype are presented 
separately in Figures 4.4 to 4.7. Each mean value 
represents two assay replications of one enzyme extract. 
Values are corrected for incubation time and extract 
volume. Genotypes are coded as follows: = C-I(A69) sh 
Bz wx, 0 = C-(lineC) sh Bz wx, • = c-ruq66 sh Bz wx, 0 = c 
sh Bz wx 
(see Figure 4.6). Secondly, the number of assays necessary to replicate 
results for all genotype/maturity combinations was quite large and initial 
results (Section 4.2.1.3.) indicated that wider sampling intervals would be 
adequate. 
Replications consisted of two ears per genotype/maturity. Each ear was 
sampled twice to produce two enzyme extracts. Each extract was then 
assayed two times. This makes a total of eight assays per maturity/genotype. 
For the colorless C-I(A69) sh Bz wx genotype, many of the assays 
detected a low level of isoquercitrin production (Figure 4.9). Mean assay 
values are 382, 187, 650, 457, and 569 ng isoquercitrin/300 seconds (corrected 
for volume) for the 18, 27, 36, 45 DAP and Mature tissue respectively. The 
assay values are listed in Appendix III, Table A.3.5. and ranged from 0 to 
1660 ng isoquercitrin/300 seconds (corrected for volume). This indicates a 
basal isoquercitrin production capacity in C-I(A69) sh Bz wx throughout 
kernel development. This is consistent with the low "uninduced" levels of 
XJFGT observed in vp, c, and r tissue (Dooner and Nelson, 1979). 
For the colored C-(lineC) sh Bz wx genotype, the initial UFGT activity 
survey gave a jagged plot of observed isoquercitrin production (Figure 4.5). 
This was in part associated with a discrepancy between the visually 
determined maturity and recorded age (see Section 4.2.1.3.). Selection of the 
18, 27, 36, 45 DAP and mature tissues for replicated assays eliminated the 
ears in question. The resulting isoquercitrin production in ng/300 minutes 
(corrected for volume) is listed in Appendix III, Table A.3.6. and plotted in 
Figure 4.10. The mean isoquercitrin produced increases with maturity. 
Following a crest at 45 DAP, accumulation by Mature tissue extracts drops 
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Figure 4.9. Isoquercitrin produced when assaying for UFGT activity in 
C-I(A69) sh Bz wx kernel tissue. Values are corrected for 
incubation time and extract volume (see Section 4.2.1.2 and 
Appendix III, Table A3.5.). Assays were replicated two 
times for each enzyme extract. Two extracts were made 
from each ear and two ears were sampled per maturity. 
This is a total of eight assays per maturity. Boxes 
represent individual assay results. The boxes connected by 
a line represent the mean of all values for each maturity 
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Figure 4.10. 
Kernel Maturity in DAP 
Isoquercitrin produced when assaying for UFGT activity in 
C-(lineC) sh Bz wx kernel tissue. Values are corrected for 
incubation time and extract volume (see Section 4.2.1.2 and 
Appendix III, Table A.3.6.). Assays were replicated two 
times for each enzyme extract. Two extracts were made 
from each ear and two ears were sampled per maturity. 
This is a total of eight assays per maturity. The exception 
is the 27 DAP maturity where only one ear is available. In 
this case four assays were conducted. Boxes represent 
individual assay results. The boxes connected by a line 
represent the mean of all values for each maturity 
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slightly suggesting that the tissue drying process may effect UFGT stability. 
Mean assay values are 0, 1396, 5548,8359, and 7222 ng isoquercitrin/300 
minutes for the 18, 27, 36, 45 DAP and Mature ears respectively. 
The colorless c-ruq66 sh Bz wx genotype exhibits a low level of 
extractable UFGT activity throughout kernel development (Figure 4.11). The 
peak in UFGT activity occurs early in development at 27 DAP with a mean 
isoquercitrin production of 1169 ng/300 min. The isoquercitrin production 
means for 18, 27, 36, 45 DAP and Mature samples are 754,1169, 243,591, and 
461 ng/300 min respectively. 
Replication (Figure 4.12) alters the isoquercitrin production pattern 
observed initially for the c sh Bz wx assays (Section 4.2.1.3, Figure 4.7). 
Isoquercitrin production is only detectable during the latter stages of kernel 
development and then only at low levels. Mean assay values are 0, 0, 0, 137, 
and 481 ng isoquercitrin/300 minutes for 18, 27, 36, 45 DAP and Mature 
kernels respectively. This compares with the other two colorless genotypes, 
C-ICA69) sh Bz wx and c-ruq66 sh Bz wx, which have the potential for a 
nearly steady low level production of isoquercitrin throughout development. 
The mean isoquercitrin production (UFGT activity) results from 
C-I(A69) sh Bz wx (Figure 4.9), C-(lineC) sh Bz wx (Figure 4.10), c-ruq66 sh 
Bz wx (Figure 4.11), and c sh Bz wx (Figure 4.12) are combined in Figure 4.13 
for comparison. 
4.2.2. UFGT assav consumption of quercetin 
The disappearance of quercetin from the UFGT reaction mixture was 
monitored along with the production of isoquercitrin. Quercetin 
consumption is not the primary means for determining UFGT activity; 
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Figure 4.11. Isoquercitrin produced when assaying for UFGT activity in 
c-ruq66 sh Bz wx kernel tissue. Values are corrected for 
incubation time and extract volume (see Section 4.2.1.2 and 
Appendix III, Table A.3.7.). Assays were replicated two 
times for each enzyme extract. Two extracts were made 
from each ear and two ears were sampled per maturity. 
This is a total of eight assays per maturity. The exceptions 
are the 18, 36, and 45 day maturities where only one ear 
was available for each. In these cases four assays were 
conducted. Boxes represent individual assay results. The 
boxes connected by a line represent the mean of all values 
for each maturity 
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Figure 4.12. Isoquercitrin produced when assaying for UFGT activity in 
c sh Bz tux kernel tissue. Values are corrected for 
incubation time and extract volume (see Section 4.2.1.2 and 
Appendix III, Table A.3.8.). Assays were replicated two 
times for each enzyme extract. Two extracts were made 
from each ear and two ears were sampled per maturity. 
This is a total of eight assays per maturity. Boxes 
represent individual assay results. The boxes connected by 
a line represent the mean of all values for each maturity 
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18 27 36 45 M 
Kernel Maturity in DAP 
Summary of the mean UFGT activities observed for 
replicated assays of the C-I(A69) sh Bz wx, C-(lineC) sh Bz 
wx, c-ruq66 sh Bz wx, and c sh Bz wx genotypes. UFGT 
activity is measured as ng isoquercitrin produced under 
standard assay conditions. Individual results for each 
genotype are presented separately in Figures 4.9 to 4.12. 
Each mean value represents two assays per enzyme 
extract. Two extracts were made from each ear and two 
ears were sampled per maturity. This is a total of eight 
assays for maturity/genotype. The exceptions are the 27 
day maturity for C-(lineC) sh Bz wx and the 18, 36, and 45 
day maturities for c-ruq66 sh Bz wx. In these cases only 
one ear was available for each maturity/genotype and 
hence, mean values were calculated using four assay 
values. Genotypes are symbolized as follows: ^ = C-I(A69) 
sh Bz wx, g = C-(lineC) sh Bz wx, m = c-ruq66 sh Bz wx, g 
= c sh Bz wx 
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therefore, the HPLC determined quercetin peak area will not be converted to 
ng quercetin. 
4.2.2.1. Correction of assay raw data to a standard time and enzvme 
extract volume Due to the composition of the assay and blank reaction 
mixtures, the quercetin detected in each assay cannot be corrected for any 
quercetin introduced with the enzyme extract. Here results from individual 
assays and blanks are converted to quercetin consumed before correcting for 
the total crude enzyme extract volume and incubation time. Appendix IV 
lists the raw data, intermediate calculations and final corrected values in 
four tables. These data will be discussed in Section 4.2.2.2. 
Each assay and blank is identified with kernel maturity (days after 
pollination or DAP), ear number, and sample name. The quercetin peak 
area is presented in different units from the isoquercitrin peak areas 
(Sections 4.2.1.3. and 4.2.1.4, Appendix III). The Waters Expert program 
versions 5.1 and 6.2 experienced some difficulty integrating the quercetin 
peak areas due to the relative sizes of the quercetin, and the UDP/UDPglucose 
peaks. This problem was overcome for the isoquercitrin peaks by subtracting 
each blank data file from the corresponding assay data files. Because this 
manipulation was not informative for the quercetin peak, each area was 
hand calculated (Equation 4). The resulting quercetin peak area was then 
converted to peak area consumed using the mean initial peak area from a 
series of modified blanks (zero incubation time) and Equation 5. Corrections 
for incubation time (Equation 6) and enzyme extract volume (Equation 7) 
variations were then calculated. 
Equation 4 
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|(peak base width)(peak height) = quercetin peak area 
^ 69 mean initial^ ^observed ^ , 
Equation 6 [peak area J " [peak area J = P«ak area consumed 
Equation 6 
&rd](300sec) incubation time, sec = «me-corrected peak area 
Equation? 
^time-correctedYtotal \iV 
[peak area j extract ^ 
50 |il used in reaction = quercetin consumed in 300 sec. 
4.2.2.2. Quercetin consumption bv four genotypes: C-I(A69) sh Bz wx, 
C-(lineC) sh Bz wx. c-ruo66 sh Bz wx and c sh Bz wx The disappearance of 
quercetin was examined for the enzyme extracts assayed in Section 4.2.1.4. 
These extracts are from five tissue maturities, 18, 27, 36, and 45 DAP, and 
Mature. Data are plotted as quercetin consumed in the UFGT assay, 
quercetin consumed in the blank, and the difference (Figures 4.14 to 4.17). 
Only the mean values for each maturity are used. 
The quercetin consumed in the UFGT assay does not distinguish 
between the conversion to isoquercitrin by UFGT and utilization by other 
enzymes present in the crude extract. In the absence of UDPglucose, the 
blank detects the disappearance of quercetin not associated with UFGT 
mediated conversion to isoquercitrin. Subtracting the blank from the assay 
isolates the quercetin disappearance associated with UFGT activity. 
For the C-I(A69) sh Bz wx genotype. Figure 4.14 plots the quercetin 
consumption. For both the assays and the blanks, quercetin consumption is 
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Figure 4.14. Quercetin consumed when assaying for UFGT activity in 
C-I(A69) sh Bz wx kernel tissue. Values are corrected for 
incubation time and extract volume (see Section 4.2.2.1, 
and Appendix IV, Table A4.1.). j/ mean quercetin 
consumption values observed for UFGT assays. 
Represents the mean of eight assays per maturity (two 
assays per enzyme extract, two extracts per ear, and two 
ears per maturity). mean quercetin consumption 
observed for UFGT blanks. Represents the mean of four 
blanks per maturity (one blank per enzyme extract). M is 
the difference between the mean quercetin consumption in 
assay (|) and blank reactions ( ). This is the quercetin 
consumption which is attributed to UFGT activity 
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"Assay Assay-Blank 
M-
18 27 36 45 M 
DAP C-(lineC) 
Quercetin consumed when assaying for UFGT activity in 
C-(lineC) sh Bz wx kernel tissue. Values are corrected for 
incubation time and extract volume (see Section 4.2.2.1. 
and Appendix IV, Table A.4.2.). || mean quercetin 
consumption values observed for UFGT assays. 
Represents the mean of eight assays per maturity (two 
assays per enzyme extract, two extracts per ear, and two 
ears per maturity). mean quercetin consumption 
observed for UFGT blanks. Represents the mean of four 
blanks per maturity (one blank per enzyme extract). 0 is 
the difference between the mean quercetin consumption in 
assay (|) and blank reactions ( ). This is the quercetin 
consumption which is attributed to UFGT activity. Note 
only one ear was available for the 27 DAP maturity 
98 
ai 
§ 
CO 
M 
'S 
3000 
2500 
2000 
1  ë  O o 1500 
o 6 
1t§ 
Oh 
1 
1000 
500 
0 
'Assay Assay-Blank 
-500 
18 27 36 45 M 
DAP c-ruq66 
Figure 4.16. Quercetin consumed when assaying for UFGT activity in c-
ruq66 sh Bz wx kernel tissue. Values are corrected for 
incubation time and extract volume (see Section 4.2.2.1. 
and Appendix IV, Table A4.3.). |mean quercetin 
consumption values observed for UFGT assays. 
Represents the mean of four or eight assays per maturity 
(two assays per enzyme extract, two extracts per ear, and 
either one (18, 36, 45 DAP) or two ears (27 DAP, Mature) per 
maturity). mean quercetin consumption observed for 
UFGT blanks. The mean is calculated using one blank per 
enzyme extract. Represents the mean of two or four blanks 
per maturity (one blank per enzyme extract). 0 is the 
difference between the mean quercetin consumption in 
assay Jj) and blank reactions 1 ). This is the quercetin 
consumption which is attributed to UFGT activity 
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Figure 4.17. Quercetin consumed when assaying for UFGT activity in c 
sh Bz wx kernel tissue. Values are corrected for 
incubation time and extract volume (see Section 4.2.2.1. 
and Appendix IV, Table A.4.4.). |mean quercetin 
consumption values observed for UFGT assays. 
Represents the mean of eight assays per maturity (two 
assays per enzyme extract, two extracts per ear, and two 
ears per maturity). mean quercetin consumption 
observed for UFGT blanks. Represents the mean of four 
blanks per maturity (one blank per enzyme extract). 0 is 
the difference between the mean quercetin consumption in 
assay (|) and blank reactions ( J. This is the quercetin 
consumption which is attributed to UFGT activity 
100 
the highest at 27 DAP. This consumption then steadily declines with tissue 
maturity. The difference between the assays and blanks indicates no UFGT 
utilization of quercetin at 27 DAP. The highest utilization by UFGT is at 45 
DAP. Tliis low, fluxuating utilization of quercetin by UFGT agrees with the 
low isoquercitrin production observed (Figure 4.9). 
The C-(lineC) sh Bz wx genotype (Figure 4.15) exhibited the largest 
consumption of quercetin at 18 DAP. A second peak of consumption occurs at 
45 DAP when isoquercitrin production is greatest. The difference between 
quercetin disappearance under assay and blank conditions follows the 
isoquercitrin production curve very closely (Figure 4.10). 
Both the c-ruq66 sh Bz wx and c sh Bz wx genotypes (Figures 4.16 and 
4.17) exhibit quercetin consumption patterns similar to C-I(A69) sh Bz wx 
(Figure 4.14). UFGT utilization of quercetin, while always low, is greatest 
late in tissue development (45 DAP or mature tissue). 
All four genotypes exhibit high quercetin utilization in immature 
tissues (peak at 27 DAP). This indicates the presence of quercetin utilizing 
enzymes other than UFGT in crude extracts from these tissues. Only the 
C-(lineC) sh Bz wx genotype exhibits high quercetin consumption late in 
development. This quercetin utilization does correspond with UFGT 
production of isoquercitrin. 
4.3 Analysis of Flavonol Glycosides and Related Compounds 
in Selected Maize Kernel Genotypes and Maturities 
Results from the analysis of UDPglucose:flavonoid 3-0-glucosyl 
transferase (UFGT) suggested that moi'e than one enzyme capable of 
utilizing quercetin was present in some of the extracts (Figures 4.14 to 4.17). 
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In some tissues quercetin consumption was greater than isoquercetin 
production suggesting the possibility of other fates for quercetin. To examine 
the possible fates of quercetin, kernels from each of the 20 genotype/maturity 
combinations were screened for the presence of flavonol glycosides (see 
Sections 3.4.1. to 3.4.3.). 
Comparison of HPLC profiles from each extract with a standard profile 
identifies six quercetin derivatives, caffeic acid-glucoside, and p-coumaric 
acid. Each 340 nm absorbance peak area is corrected for the total volume of 
each extract and the extract volume assayed. The results from Equation 8 
can then be compared on a "per kernel" basis. 
„ „ / x^total extract volume^ total peak area of 
Equations (peak area)^ volume assayed j = extracted compound 
4.3.1. Total 340 nm absorbance of kernel extracts 
The total absorbance peak area at 340 nm for each flavonol extract was 
determined by summing the individual peak areas. These peaks represent 
the individual compounds composing the methanol extract for the detection 
of flavonols. Each peak was corrected for the total extract volume and the 
volume assayed by HPLC (see Section 4.3.). 
Total extractable absorbance at 340 nm is plotted in Figure 4.18 as mean 
values. Units are peak area x 106. A total of four genotypes and five 
maturities were tested. The C-(lineC) sh Bz wx genotype is the only genotype 
tested which produced a colored aleurone. This genotype maintains an 
absorbance value of between 8.8 x 10^ and 14.1 x 10^ until maturity (18, 27, 36, 
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Figure 4.18. Mean total 340 nm absorbance x 10^ versus maturity (PAP) 
for flavonol extracts from each of four genotypes: 1 C-(lineC) 
sh Bz wx, C-I(A69) sh Bz wx, g c-ruq66 sh Bz wx, and " 
c sh Bz wx. Each mean is calculated from a total of three to 
six extracts from one or two ears. Figure 4.19 lists the 
number of extracts and ears used for each genotype/maturity 
combination. Tables A5.1. to A.5.4. (Appendix V) lists total 
absorbance values contributing to each mean. These totals 
were derived by summing the area of all absorbance peaks 
observed in the HPLC profile of each extract (Equation 8, 
Section 4.3.). Maturity "M" is the fully mature dry kernel 
103 
and 45 DAP). Between 45 days after pollination and maturity the absorbance 
at 340 nm increases 3.5 to 5.5 fold to 48.8 x 10®. 
A similar trend was observed for the c sh Bz wx genotype (Figure 4.18). 
Here all observed values were lower than those for C-(lineC) sh Bz wx. This 
difference is greatest for the Mature kernels, where the absorbance is 25.0 x 
106 or approximately one-half that of the C-(lineC) sh Bz wx value. 
The accumulation of extractable 340 nm absorbing compounds exhibits 
a different pattern for the C-I(A69) sh Bz wx and c-ruq66 sh Bz wx genotypes. 
For C-I(A69) sh Bz wx the absorbance values gradually increase and then 
start to plateau with the 36 DAP samples. Total absorbance peak area does 
not exceed 13.3 x 106. 
The c-ruq66 sh Bz wx genotype exhibits the highest absorbance peak 
areas of any of the genotypes before 36 DAP. Following an initial high value 
of 25.7 X 10® at 27 DAP the observed total peak area decreases to 7.6 x 10® before 
recovering to 20.3 x 10^ at maturity. 
Figure 4.19 lists the number of extracts (kernels) and ears sampled for 
each mean "total extractable 340 nm absorbance" value plotted in Figure 4.18. 
See Appendix V, Table A.5.1. to A.5.4. for a listing of each sample value. 
4.3.2. Identification of six ouercetin-^lvcosides 
The available petunia standard, Blue Magic, identified six quercetin 
derivatives in the flavonol extracts. These derivatives are quercetin-3-
glucoside, quercetin-3,7-diglucoside, quercetin-7-glucoside, quercetin-3-
sophoroside, quercetin-3-sophoroside-7-glucoside, and quercetin-3-
(caffeoylsophoroside)-7-glucoside. See Sections 4.3.2.1 to 4.3.2.6 for figures 
illustrating the structure of each of these quercetin glycosides. 
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Genotype 
Maturity C-(lineC) C-I(A69) c-ruq66 c 
18 DAP 6227-lt®, 3 6133-6®, 3 6233-8®, 3 6424-5/-15t, 3 
6228-2t0,3 6138-8®, 2 6440-120,3 
27 DAP 6228-1®, 3 6134-1®, 3 6230-3®, 3 6422-5®, 3 
6137-13®, 3 6233-1®, 3 6424-14®, 3 
36 DAP 6225-40,3 6135-5®, 3 6234y-3®, 3 6423-5®, 3 
6225-7®, 3 6137-4®, 3 6424,-6®, 3 
45 DAP 6228-6t®, 3 6134-1®, 3 6230-1®, 3 6422-2®, 3 
6229-12®, 2 6136-6®, 3 6422-19®, 3 
Mature 62264®, 3 6132-3®, 3 6231-70, 3 6422-19®, 3 
6228-5®, 3 6136-10®, 3 6234y-3®, 3 6424-8®, 3 
Figure 4.19. The ears and number of kernels sampled for flavonol-
glucoside content. The genotypes are listed by column. Each 
genotype is the sh Bz wx converted line containing the 
designated CI locus allele. Maturities are listed by row. The 
box for each genotype (columnVmaturity (row) contains the 
1987 ear numbers followed by a comma and the number of 
kernels from each ear assayed. The means reported in this 
and the following subsections of Section 4.3. are derived from 
the analysis of these samples. Individual results are listed in 
Appendix V, Tables A-5.1. to A-5.8 
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The individual peak areas for each of these quercetin derivatives were 
summed following correction for the total extract volume and volume assayed 
by HPLC (Equation 8, Section 4.3.). Figure 4.20 plots the mean total 340 nm 
absorbance due to these quercetin derivatives. The units are in peak area x 
105. 
Total absorbance at 340 nm attributable to the six quercetin derivatives 
(Figure 4.20) follows the same trend observed for total 340 nm absorbance 
(Figure 4.18). For the C-(lineC) sh Bz wx genotype, absorbance due to the 
quercetin derivatives remains low (below 66 x 105) until maturity. The 
mature samples exhibit a mean absorbance of 372 x 10®, approximately 5.7 
times greater than that observed for the 45 DAP samples. 
For the c sh Bz wx genotype, the 340 nm absorbance attributable to 
quercetin derivatives (Figure 4.20) exhibits a variation on the upward trend 
observed for the total 340 nm absorbance (Figure 4.18). There is a small peak 
in absorbance peak area at 27 DAP. The Mature value of 125 x 10^ is 
approximately one-third the peak area observed for C-(lineC) sh Bz wx. 
The 340 nm absorbance associated with the quercetin derivatives 
remains low throughout development for C'I(A69) sh Bz wx. The slight 
increase in absorbance peak area occurs later for the quercetin derivatives 
(Figure 4.20) than for the total absorbance (Figure 4.18). 
Of all the genotypes c-ruq66 sh Bz wx exhibits the highest 340 nm 
absorbance values (156 x 10^) for the quercetin derivatives at 27 DAP. After a 
sharp decline to 44 x 10^ at 36 DAP the absorbance values climb to 86 x 10^ at 
maturity. This is approximately half of the 27 DAP value. 
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C-GineC) c-ruq66 
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Figure 4.20. Total mean absorbance at 340 nm attributable to six 
quercetin derivatives: quercetin-3-glucoside, quercetin-3,7-
diglucoside, quercetin-7-glucoside, quercetin-3-sophoroside, 
quercetin-3-sophoroside-7-glucoside, and quercetin-
3(cafreoylsophoroside)-7-glucoside. The jH C-(lineC) sh Bz 
IVX, C-I(A69) sh Bz wx, 0 c-ruq66 sh Bz wx, and • c s/i 
Bz wx genotypes are compared for five maturities; 18, 27, 36, 
45 DAP and Mature (M) kernels. Figure 4.19 summarizes 
the ear sources and number extracts contributing to each 
mean plotted. Individual values for the quercetin 
derivatives are listed in Appendix V by genotype 
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When the absorbance peak area attributable to the quercetin derivatives 
is converted to a percent of total 340 nm absorbance all four genotypes exhibit 
variations of a general theme (Figure 4.21). That is, the quercetin derivatives 
contribute over 50% of the 340 nm absorbance peak area both early and late in 
kernel development. During intermediate stages in development these 
contributions drop from between 24 iC-(lineC) sh Bz wx) and 63 iC-î(A69) sh 
Bz wx) percentage points. For the c-ruq66 sh Bz wx and c sh Bz wx genotypes 
the contribution of the quercetin derivatives crests at 45 DAP and experiences 
a second decline at maturity not observed for C-(lineC) sh Bz wx and C-I(A69) 
sh Bz wx. 
4.3.2.1. Quercetin-3-glucoside expression One of the simplest 
quercetin derivatives is quercetin-3-glucoside, also called isoquercitrin 
(Figure 4.22). This flavonol 3-0-glucoside is formed by a flavonol 3-0-
glycosyltransferase such as UDPglucose:flavonoid 3-0-glucosyltransferase 
(UFGT). The accumulation of quercetin-3-glucoside for each of the four 
genotypes examined is plotted in Figure 4.23. This accumulation is 
measured in units of absorbance peak area x 10'^ at 340 nm. These results are 
also in tabular form in Appendix V, Tables A.5.1. to A. 5.4. 
For the C-(lineC) sh Bz wx genotype, the absorbance at 340 nm remains 
low (from approximately 56 to 79 x 10^) for the 18, 27, and 36 DAP maturities. 
The absorbance increases, reaching a peak at 45 DAP which is more than 
five times this early level. By maturity (Mature), when the kernels are dry, 
the 340 nm absorbance due to quercetin 3-glucoside has dropped to 45% of the 
peak level. 
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Figure 4.21. Percent mean absorbance at 340 nm attributable to the six 
quercetin derivatives examined in Figure 4.20. Each mean 
total quercetin absorbance value (Figure 4.20) was divided by 
the mean total 340 nm absorbance (Figure 4.18) and 
multiplied by 100 to derive the percent. These percents 
represent the contribution of the quercetin derivatives to the 
340 nm absorbance of the extracts 
109 
OH 
HO 
OH 
0- Glucose 
OH O 
Figure 4.22. Structure of quercetin-3-glucoside which is also known by the 
name, isoquercitrin 
The C-I(A69) sh Bz wx genotype, shows a similar trend for quercetin-3-
glucoside accumulation. With an absorbance peak area of 33 x 10^ at 18 DAP, 
this colorless genotype starts the increase in accumulated quercetin-3-
glucoside in younger tissue than the C-(lineC) sh Bz wx genotype. 
Accumulation is the highest (550 x 10^) at 45 DAP before dropping to 152 x 10^ 
at maturity. 
The c-ruq66 sh Bz wx genotype (Figure 4.23) experiences an abrupt 
increase in quercetin-3-glucoside accumulation early in kernel development 
(from approximately 34 x 10^ to 628 x 10^ absorbance peak area in three days). 
The accumulation level then drops in the next three days to near 200 x 10^ 
where it remains to maturity (Mature). 
The c sh Bz wx genotypes differ from the other genotypes by exhibiting 
two peaks in quercetin-3-glucoside accumulation (36 DAP and Mature). At 
no time does the absorbance peak area exceed 238 x lO^. This is 63% of the 
C-(lineC) sh Bz wx maximum and only 43 to 50% of the C-I(A69) sh Bz wx and 
c-ruq66 sh Bz wx maximum values for quercetin-3-glucoside accumulation. 
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Figure 4.23. Quercetin-3-glucoside accumulation during kernel 
development for four genotypes: I C-(lineC) sh Bz wx, 
C-I(A69) sh Bz wx, #| c-ruq66 sh Bz wx, and m c sh Bz wx. 
Mean values in units of 340 nm absorbance peak area x 10^ 
are plotted for each of five maturities: 18, 27, 36,45 DAP 
and Mature (M) kernel tissue. Figure 4.19 summarizes 
the ear sources and number of extracts contributing to 
each mean value plotted. Individual values are listed in 
Appendix V by genotype 
When the quercetin-3-glucoside absorbance is measured as a percent of 
the total absorbance attributable to quercetin derivatives (Figure 4.24), a 
single trend emerges. The maximum quercetin-3-glucoside contribution to 
the total 340 nm absorbance is greater than 50% for all four genotypes at 
either the 36 or 45 DAP maturity. For the C-I(A69) sh Bz wx genotype this 
contribution reaches a high of 83.7% at 45 DAP. The earliest (18 DAP) and 
latest (Mature) maturities examined show a percent contribution of less than 
26.4% (six of the eight mean values are less than 14%). 
4.3.2.2. Quercetin-7-glucoside expression A second simple quercetin 
derivative detected in the flavonol glycoside screen is quercetin-7-glucoside 
(Figure 4.25). This compound results from the glucosylation of quercetin by a 
flavonoid 7-0-glycosyltransferase. It may then become a substrate for a 
flavonol 3-0-glycosyltransferase (possibly UFGT) for the formation of 
diglycosides (see Section 4.3.2.3.). 
The accumulation of quercetin-7-glucoside, as measured by 340 nm 
absorbance peak area x 10^, follows the same pattern for all four genotypes 
tested (Figure 4.26). There is an initial maxima in absorbance values at 27 
DAP. This varies from 64 x 10"^ for C-I(A69) sh Bz wx to 485 x 10*^ for c-ruq66 
sh Bz wx. Accumulated quercetin-7-glucoside then return to near 18 DAP 
levels before experiencing a second maxima in accumulated levels at 
maturity (M). 
Absorbance due to quercetin-7-glucoside as a percent of absorbance due 
to quercetin derivatives follows the same trend (Figure 4.27). That is, a 
maxima at 27 DAP and again at maturity (M). The exception is the C-(lineC) 
sh Bz wx genotype. This genotype does not return to the 18 DAP percent 
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Quercetin-3-glucoside absorbance as a percent of the 340 
nm absorbance attributable to six detected quercetin 
derivatives (Figure 4.20). Mean values are plotted for four 
genotypes (| C-(lineC) sh Bz wx, C-I(A69) sh Bz wx, @ 
c-ruq66 sh Bz m, and • c sh Bz wx) at each of five 
maturities (18, 27, 36, 46 DAP and Mature (M)) 
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Figure 4.25. Structure of quercetin-7-glucose 
contribution to absorbance before experiencing the second increase. The 
second peak in percent absorbance then occurs at 45 DAP, followed by a 
second decline. 
4.3.2.3. Quercetin-S.T-diglucoside expression Quercetin-3,7-
diglucoside (Figure 4.28) is derived from quei'cetin in a two step process. 
First, quercetin is converted to quercetin-7-glucoside by a flavonoid 7-0-
glucosyltransferase (see Section 4.3.2.2.). This then becomes a substrate for a 
flavonol 3-0-glucosyltransferase such as UFGT (see Section 4.3.2.1.). 
Figure 4.29 illustrates the mean absorbance peak area detected for 
quercetin-3,7-diglucoside at 340 nm. All four genotypes exhibit an increase in 
accumulated product late in development. The C-(lineC) sh Bz wx genotype 
exhibits an initial increase in quercetin-3,7-diglucoside accumulation which 
crests at 36 DAP. Following a decline to 18-27 DAP levels, Mature tissue 
expresses the highest level observed for any genotype/maturity combination 
tested. This Mature mean quercetin-3,7-diglucoside absorbance peak area is 
2.691 X 107. 
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Figure 4.26. Quercetin-7-glucoside accumulation during kernel 
development for four genotypes: |C-(lineC) sh Bz wx, 
C-I(A69) sh Bz wx, g| c-ruq66 sh Bz wx, and m c sh Bz wx. 
Mean values in units of 340 nm absorbance peak area x 10^ 
are plotted for each of five maturities: 18, 27, 36, 45 DAP 
and Mature (M) kernel tissue. Figure 4.19 summarizes 
the ear sources and number of extracts contributing to 
each mean value plotted. Individual values are listed in 
Appendix V 
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C'ruq66 C-(lineC) 
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Figure 4.27. Quercetin-7-glucoside absorbance as a percent of the 340 nm 
absorbance attributable to six quercetin derivatives CFigure 
4.20). Mean values are plotted for four genotypes (I C-(lineC) 
sh Bz wx, C-I(A69) sh Bz wx, B c-ruq66 sh Bz wx, and ^ c sh 
Bz wx) at each of five maturities (18, 27, 36, 45 DAP and Mature 
(M) kernel tissue) 
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Figure 4.28. The structure of quercetin-3,7-diglucoside. The current 
understanding of flavonol glycosylation (see Section 2.2.7.2) 
orders the addition of glucose to the 7-OH group before the 
addition of glucose to the 3-OH group (Sutter and Griesbach, 
1973) 
For the C-I(A69) sh Bz wx and c sh Bz wx genotypes a similar pattern of 
quercetin-3,7-diglucoside accumulation emerges (Figure 4.29). 
Accumulation is low in immature tissues of both genotypes. For c sh Bz wx 
the absorbance peak area at maturity is nearly one-fifth that observed for C-
(lineC) sh Bz wx. The Mature value observed for the C-1(A69) sh Bz wx 
genotype is one-eighteenth of the colored C-(lineC) sh Bz wx kernels. 
The c-ruq66 sh Bz wx genotype is different. It shows the accumulation 
of quercetin-3,7-diglucoside to be largest (almost 4 x 10®) in 18 DAP kernels. 
By 36 DAP the accumulated level falls to near the 18 DAP value for the other 
three genotypes. Finally there is a partial recovery in accumulated 
quercetin-3,7-diglucoside by Mature tissue. 
The absorbance due to quercetin-3,7-diglucoside is also calculated as a 
percent of the total absorbance attributable to quercetin derivatives and is 
plotted in Figure 4.30. For this quercetin derivative, plots of absorbance 
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M 18 27 36 45 
Maturity (DAP) 
Quercetin-3,7-diglucoside accumulation during kernel 
development. Five maturities (18, 27, 36, 45 DAP and 
Mature (M)) were sampled for each of four genotypes: | 
C-(lineC) sh Bz wx, 0 C-I(A69) sh Bz wx, c-ruq66 sh Bz 
wx, and m c sh Bz wx. Mean values are reported in units 
of 340 nm absorbance peak area x 10"^. Figure 4.19 
summarizes the ear sources and number of extracts 
contributing to each mean value plotted. Individual 
values are listed in Appendix V 
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C-(lineC) c-ruq66 
18 27 36 45 M 
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Figure 4.30. Quercetin-3,7-diglucoside absorbance as a percent of the 
340 nm absorbance attributed to six quercetin derivatives 
(Figure 4.20). Means are plotted for five tissue maturities 
(18, 27, 36, 45 DAP and mature (M)) for each of four 
genotypes (| C-(lineC) sh Bz wx, C-I(A69) sh Bz wx, 0 
c-ruq66 sh Bz wx, and « c sh Bz wx) 
119 
(Figure 4.29) and percent absorbance (Figure 4.30) produce similar profiles 
for each genotype. 
4.3.2.4. Quercetin-3-sophoroside expression A fourth flavonol 
glycoside identified in the flavonol screening is quercetin-3-sophoroside 
(Figure 4.31). Quercetin-3-sophoroside is a derivative of quercetin-3-
glucoside. The 3-position glucose undergoes a 1-2 linkage to another glucose 
molecule. The enzyme responsible for the glycosylation of quercetin-3-
glucoside with glucose to form the sophorose side chain is unknown. 
Accumulation of quercetin-3-sophoroside as a function of absorption 
peak area is plotted in Figure 4.32. For the C-(lineC) sh Bz wx genotype 
quercetin-3-sophoroside levels increase between 18 and 36 DAP. The level 
then returns to near 18 DAP levels before climbing at maturity. The 
quercetin-3-sophoroside observed in Mature kernel samples is almost three 
times that observed for 36 DAP tissue. 
A) quercetin-3-sophoroside 
O- Sophorose 
B) sophorose 
CHgOH 
HO 
HOHgC 
OH 0 
Figure 4.31. Structure of quercetin-3-sophoroside. A) Structure of 
quercetin illustrating attachment site of sophorose; B) 
Structure of sophorose which consists of two linked glucose 
molecules [Glucose(l-2)Glucose] 
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Figure 4.32. Quercetin-3-sophoroside accumulated during kernel 
development. Five maturities (18, 27, 36, 45 DAP and 
Mature (M)) were sampled for each of four genotypes: | 
C-(lineC) sh Bz wx, C-I(A69) sh Bz wx, 0 c-ruq66 sh Bz 
wx, and m c sh Bz wx. Mean values are reported in units 
of 340 nmabsorbance peak area x 10^. Figure 4.19 
summarizes the ear sources and number of extracts 
contributing to each mean value plotted. Individual 
values are listed in Appendix V 
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The c-ruq66 sh Bz wx genotype exhibits a similar quercetin-3-
sophoroside accumulation pattern. The first peak in accumulation occurs 
earlier at 27 DAP. 
For the C-I(A69) sh Bz wx and c sh Bz wx genotypes, accumulation of 
quercetin-3-sophoroside remains at low levels in early to mid-kernel 
development. This quercetin derivative increases in amount late in 
development. The C-I(A69) sh Bz wx exhibits maximum levels at maturity. 
The maximum observed for the c sh Bz wx genotype is reached at 45 DAP. 
Quercetin-3-sophoroside as a percent of the total 340 nm absorbance is 
plotted in Figure 4.33. Except for one or two maturities sampled per 
genotype, quercetin-3-sophoroside contributes less than 10% of the 340 nm 
absorbance observed. Peak contribution to total absorbance occurs between 36 
DAP and maturity, depending on the genotype. 
4.3.2.5. Quercetin-3-sophoroside-7-glucoside expression Quercetin-3-
sophoroside-7-glucoside (Figure 4.34) is probably derived from quercetin-3,7-
diglucoside (Section 4.3.2.3.). This is a similar reaction to the one that forms 
quercetin-3-sophoroside from quercetin-3-glucoside (Section 4.3.2.4). The 
exact enzyme and reaction mechanism has not been identified. 
Figure 4.35 plots the absorbance due to quercetin-3-sophoroside-7-
glucoside. Note that the scale is reduced compared to the scales used for the 
other quercetin derivatives. The C-(lineC) sh Bz wx genotype exhibited 
maximum levels of this glycoside derivative in the youngest and oldest 
maturities examined. The other three genotypes exhibit an accumulation 
maxima at 27 DAP. For the C-I(A69) sh Bz wx and c sh Bz wx genotypes, the 
pattern of accumulation is similar to that observed for C-(lineC) sh Bz wx 
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Figure 4.33. Quercetin-3-sophoroside absorbance as a percent of total 340 
nm absorbance attributed to six quercetin derivatives (Figure 
4.20). Means are plotted for five tissue maturities (18, 27, 36, 45 
DAP and Mature (M)) for each of four genotypes (jj C-(lineC) 
sh Bz wx, C-I(A69) sh Bz wx, 0 c-ruq66 sh Bz wx, and m c sh 
Bz wx) "" 
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Figure 4.34. Structure of quercetin-3-sophoroside-7-glucoside. See Figure 
4.31. Part B. for the structure of sophorose which consists of 
two linked glucose molecules 
tissue. In the c-ruq66 sh Bz wx genotype, the quercetin-3-sophoroside-7-
glucoside levels accumulate to a second maxima at 45 DAP. This is earlier 
than the second maxima for the other genotypes. 
The percent contribution of quercetin-3-sophoroside-7-glucoside to the 
total 340 nm absorbance is plotted in Figure 4.36. Except in C-I(A69) sh Bz wx 
27 DAP tissue and c sh Bz wx 27 and 45 DAP tissue this derivative contributes 
less than 8% of the observed 340 nm absorbance. At no time does it exceed a 
16% contribution. 
4.3.2.6. Quercetin-3-(cafFeovlsophoroside)-7-glucQside expression The 
final quercetin derivative detected in this survey is quercetin-3-
(cafFeoylsophoroside)-7-glucoside (Figure 4.37). This derivative is formed by 
the acylation of the 3-0 sugar chain of the quercetin-3-sophoroside-7-
glucoside with caffeic acid. 
The absorbance due to quercetin-3-(caffeoylsophoroside)-7-glucoside is 
plotted against maturity in Figure 4.38. The C-dineC) sh Bz wx, C-I(A69) sh 
Bz wx, and c-ruq66 sh Bz wx genotypes exhibit large absorption 
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Figure 4.35. Quercetin-3-sophoroside-7-glucoside accumulation during 
kernel development. Mean values are reported in units of 340 
nm absorbance peak area x 10^. For each genotype (| 
C-(lineC) sh Bz wx, C-I(A69) sh Bz wx, Q c-ruq66 sh Bz wx, 
and I" c sh Bz wx), five maturities were assayed. These 
include 18, 27, 36, 45 DAP and Mature (M) tissue samples. 
Figure 4.19 summarizes the ear sources and number of 
extracts contributing to each mean value plotted. Individual 
values are listed in Appendix V 
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C-(lineC) c-ruq66 
18 27 36 45 M 
Maturity (DAP) 
Figure 4.36. Quercetin-3-sophoroside-7-glucoside absorbance as a percent of 
total 340 nm absorbance attributed to six quercetin derivatives 
(Figure 4.20). Means are plotted for five tissue maturities (18, 
27, 36, 45 DAP and Mature (M)) for each of four genotypes (jf 
C-(lineC) sh Bz wx, C-I(A69) s/i Bz wx, 0 c-ruq66 sh Bz wx, 
and m c sh Bz wx) 
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A) quercetin-3-(cafFeoylsophoroside)-7-glucoside 
OH 
OH 
Glucoside— 0^7 
0- Sophorose- caffeate 
OH O 
B) caffeic acid 
OH 
HO-C-CH=CH 
Figure 4.37. Structure of quercetin-3-(caffeoylsophoroside)-7-glucoside. A) 
Structure of quercetin illustrating attachment site of sophorose 
[glucose(l-2)glucose], and caffeic acid; B) Structure of caffeic 
acid. Attachment is through the carboxy group 
peaks for this derivative in HPLC profiles of 18 DAP tissue. The observed 
absorption peaks decrease in later maturities (36 and 45 DAP) 10 to 17 fold. 
Only the C-(lineC) sh Bz wx genotype exhibits an increased level of quercetin-
3-(caffeoylsophoroside)-7-glucoside at maturity (M). 
The c sh Bz wx genotype exhibits low levels of quercetin-3-
(caffeoylsophoroside)-7-glucoside in 18 DAP tissue. The maxima in 
accumulation for this genotype occurs at 27 DAP. 
When the quercetin-3-(cafreoylsophoroside)-7-glucoside levels are 
examined as a percent of the 340 nm absorbance by the quercetin derivatives, 
the accumulation profile is nearly alike for all four genotypes (Figure 4.39). 
The low quercetin-3-(caffeoylsophoroside)-7-glucoside content of 18 DAP c sh 
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Figure 4.38. Quercetin-3-(caffeoylsophoroside)-7-glucoside accumulation 
during kernel development. Mean values are reported in units 
of 340 nm absorbance peak area x 10^ . For each genotype (I 
C-(lineC) sh Bz wx, C-I(A69) sh Bz wx, gj c-ruq66 sh Bz wx, 
and ^ c shBz wx), five maturities were assayed. These 
include 18, 27, 36, 45 DAP and Mature (M) tissue samples. 
Figure 4.19 summarizes the ear sources and number of 
extracts contributing to each mean value plotted. Individual 
values are listed in Appendix V 
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Figure 4.39. Quercetin-3-sophoroside-7-glucoside absorbance as a percent of 
total 340 nm absorbance attributed to six quercetin derivatives 
(Figure 4.20). Means are plotted for five tissue maturities (18, 
27, 36, 45 DAP and Mature (M)) for each of four genotypes ( jj 
C-(lineC) sh Bz wx, C-I(A69) sh Bz wx, 0 c-ruq66 sh Bz wx, 
and ^ c sh Bz wx) 
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Bz wx tissue (Figure 4.38) is a reflection of the low total 340 nm absorbance 
extractable from this tissue (Figure 4.18) and consequently the low 
absorbance attributable to quercetin derivatives (Figure 4.20). 
4.3.3. Identification of two substituted cinnamic acids 
The flavonol extracts also contain two substituted cinnamic acids, 
p-coumaric acid (Figure 4.40) and cafïeic acid-glucoside (Figure 4.41). The 
HO^ X H 
H C-OH II 
o 
Figure 4.40. p-Coumaric acid structure. p-Coumaric acid is also called 4-
coumarate or 4-hydroxy-cinnamic acid 
HQ 
HO 
C=C 
C-0-Glucose II 
0 
Figure 4,41. Cafïeic acid-glycoside structure. Cafïeic acid is a cinnamic 
acid derivative which also goes by the name 3,4-dihydroxy-
cinnamic acid. The exact glucose linkage in this study is 
unknown. J. B. Harborne and J. J. Corner (1961) have 
reported that Petunia hybrida contains l-cafTeoyl glucose (the 
1-position of D-glucose attached via a (3-linkage to the carboxyl 
group of cafïeic acid). They also report cafïeic acid 3-P- and 
4-p-glucoside structures present in other species 
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p-coumaric acid (or 4-coumarate) is activated by 4-coumarate:CoA ligase 
(also called hydroxycinnamate:CoA ligase) to form 4-coumaroyl-CoA (see 
Figure 2.1 and Section 2.2.1). This CoA ester is a precursor for chalcone 
formation. Caffeic acid-glucoside is a glycosylated derivative of caffeic acid 
(caffeate). It is not a precursor for anthocyanin formation. A related 
compound, caffeoyl:CoA is the caffeate donor for the acylation of 
anthocyanidin-3-glycosides. 
Figure 4.42 illustrates the accumulation of p-coumaric acid measured 
as absorbance at 340 nm. The C-(lineC) sh Bz wx, C-I(A69) sh Bz wx^ and c 
sh Bz wx genotypes exhibit a gradual increase in p-coumaric acid during 
development. The period between 45 DAP and kernel maturity experiences 
the greatest increase in accumulation. When comparing the genotypes, a 
5.6-, 1.8-, and 2.2-fold increase is observed for the c sh Bz wx, C-(lineC sh Bz 
wx, and C-I(A69) sh Bz wx genotypes respectively. The c-ruq66 sh Bz wx 
genotype is the only genotype to exhibit high levels of p-coumaric acid at 18 
DAP, followed by a precipitous drop and a partial recovery of approximately 
50% of 18 DAP levels at maturity. 
The observed caffeic acid-glucoside levels in each of the four genotypes 
are plotted in Figure 4.43. Caffeic acid-glucoside accumulation fluctuates at 
low levels throughout kernel maturation for all four genotypes. Only the 27 
DAP endosperm tissue from c-ruq66 sh Bz wx kernels accumulates more 
than 25 x 10^ area units of caffeic acid-glucoside. 
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Figure 4.42. Accumulation of p-coumaric acid during kernel development. 
Mean values are reported in units of 340 nm absorbance peak 
area x 10^. For each genotype (| C-(lineC) s/i Bz wx, ^ 
C-I(A69) sh Bz wx, 0 c-ruq66 sh Bz wx, and sh Bz wx), five 
maturities were assayed. These include 18, 27, 36, 45 DAP and 
Mature (M) tissue samples. Figure 4.19 summarizes the ear 
sources and number of extracts contributing to each mean 
value plotted. Individual values are listed in Appendix V 
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Figure 4.43. Caffeic acid-glucoside accumulation during kernel 
development. Mean values are reported in units of 340 nm 
absorbance peak area x 10^. For each genotype (| C-(lineC) sh 
Bz wx, \ C-I(A69) sh Bz wx, 0 c-ruq66 sh Bz wx, and shBz 
wx), five maturities were assayed. These include 18, 27, 36, 45 
DAP and Mature (M) tissue samples. Figure 4.19 summarizes 
the ear sources and number of extracts contributing to each 
mean value plotted. Individual values are listed in Appendix 
V 
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4.4 Analysis of Anthocyanins in Selected Maize 
Kernel Genotypes and Maturities 
To further examine the possible fates of quercetin, kernels from each of 
the 20 genotype/maturity combinations were screened for the presence of 
anthocyanins (see Sections 3.4.4. to 3.4.6.). Comparison of HPLC profiles 
from each extract with a standard profile identifies three anthocyanins. 
Each 540 nm absorbance peak area is corrected for the volume assayed (see 
Section 4.3 Equation 8). The corrected absorbance peak areas can then be 
compared on a "per kernel" basis. The number of single kernel extracts 
assayed and their ear sources are listed in Figure 4.44. 
4.4.1. Total 540 nm absorbance of each kernel extract 
The total absorbance peak area at 540 nm for each anthocyanin extract 
is the sum of the individual volume-correct peak areas. Figure 4.45 plots the 
mean total extractable (1% H CI in methanol) absorbance at 540 nm in units of 
peak area x 10^ for the four genotypes and five maturities tested. The C-I(A69) 
sh Bz wx, c-ruq66 sh Bz wx, and c sh Bz wx genotypes exhibit nearly identical 
540 nm absorbance profiles. This includes low absorbance levels by the 18 to 
36 DAP extracts (total of peak area less than 16 x 10"^). The later maturities 
express absorbance levels between four and nine times greater. The C-
(lineC) sh Bz wx genotype deviates from the expression of the colorless 
genotypes starting with the 36 DAP tissue. The mean 540 nm absorbance 
detected for the 36, 45 DAP and Mature kernel samples are much higher 
(from 3.7 to 5.8 times higher) than the highest mean value observed for the 
colorless genotypes. 
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Genotype 
Maturity C-(lineC) C-I(A69) c-ruq66 c 
18 DAP 6227-lt©, 3 6133-60, 3 6233-80,3 6424-5/-15t, 3 
6228-2t®, 3 6138-80, 3 6440-120, 3 
27 DAP 6228-10,2 6134-10, 3 6230-30, 3 6422-50, 3 
6137-130,3 6233-10, 3 6424-140, 3 
36 DAP 6225-40,3 6135-50, 3 6234y-30, 3 6423-50,3 
6225-70,3 6137-40, 3 6424,-60, 3 
45 DAP 6228-6t0,3 6134-10, 3 6230-10, 3 6422-20,3 
6229-120, 3 6136-60, 3 6422-190, 3 
Mature 6226-40, 3 6132-30, 3 6231-70, 3 6422-190, 3 
6228-50, 3 6136-100, 3 6234y-30, 3 6424-80,3 
Figure 4.44. The ears and number of single kernel extracts sampled for 
anthocyanin content. The genotypes are listed by column. 
Each genotype is the sh Bz wx converted line containing the 
designated C locus allele. Maturities are listed by row. The 
box for each genotype (column)/maturity (row) contains the 
1987 ear numbers followed by a comma and the number of 
kernels from each ear assayed. The means reported in the 
following subsections of Section 4.4. are derived from the 
analysis of these samples 
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*Bh 
18 
c-ruq66 C'GineC) 
:§ o 400 
350 
â 300 
" 200 
27 36 45 M 
Maturity (DAP) 
Figure 4.45. Total 540 nm absorbance of anthocyanin extracts. Absorbances 
are reported as mean values in units of peak ai'ea x 10^. For 
each genotype (| C-(lineC) sh Bz wx, ' C-I(A69) sh Bz wx, 0 
c-ruq66 sh Bz wx, and ^ c sh Bz wx), five maturities were 
assayed. These include 18, 27, 36, 45 DAP and Mature (M) 
tissue samples. Figure 4.44 summarizes the ear sources and 
number of extracts contributing to each mean. Individual 
values are listed in Appendix VI 
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4.4.2. Expression of peonidin derivatives 
Peonidin is an anthocyanin derivative of the flavonol quercetin. The B 
ring is modified by the methylation of the 3' hydroxyl group. With the 
available standard, the anthocyanin extracts were screened for two different 
peonidin derivatives. 
4.4.2.1. Peonidin -3-(caffevlrutinoside)-5-glucoside expression As with 
the total 540 nm absorbance, accumulation of peonidin -3-(cafFeylrutinoside)-
5-glucoside (Figure 4.46 for structure. Figure 4.47 for accumulation) is nearly 
A) peonidin-3-(caffeylrutinoside)-5-glucoside 
OH 
Glucose 
0— rutinose- caffeate 
rutinose C) caffeic acid 
HO 
/^P\ 
OH OH HO 
—O-CH2 h HOH OH HO- C - CH= CH—OH 
Figure 4.46. Structure of peonidin-3-(caffeylrutinoside)-5-glucose Part A) 
shows attachment of substitution groups onto the anthocyanin 
ring structure; Part B) shows rutinose, a sugar dimer made 
from D-glucose and L-rhamnose [6((5-l-L-rhamnosido)-D-
glucose]; Part C) shows cafFeic acid 
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c-ruqBS C-(lineC) 
'o S T) 
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140 i l  
II 
3 m Pico 
120 
CO 
I. 
I I  f t  §  
3 
' Î &  
I  ^  
18 27 36 45 M 
Maturity (DAP) 
Figure 4.47. Peonidin-3-(caffeylrutinoside)-5-glucoside as absorbance peak 
area x IC^. Mean values are reported for the | C-(lineC) sh Bz 
wx, C-I(A69) sh Bz wx, |c-ruq66 sh Bz wx, and shBz 
wx genotypes sampled at five different maturities. These 
include 18, 27, 36,45 DAP and Mature (M) tissues. Figure 4.44 
summarizes the ear sources and number of extracts 
contributing to each mean 
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identical for the three colorless genotypes. The C-I(A69) sh Bz wx, c-ruq66 sh 
Bz wx, and c sh Bz wx tissue exhibit either very low or no detectable levels of 
this anthocyanin. The mean peak areas are all less than 34 x lO'^. 
For the C-(lineC) sh Bz wx genotype, accumulated peonidin-3-
(caffeylrutinoside)-5-glucoside levels increase during development. 
Following the 45 DAP maxima (179 x 10^), levels of this anthocyanin return to 
near 27 DAP levels. 
Absorbance due to petunidin-3-(caffeylrutinoside)-5-glucoside is also 
compared as a percent of the total 540 nm absorbance (Figure 4.48). In 
general, for all four genotypes, this anthocyanin is the predominant or the 
only anthocyanin detected in young tissue. At intermediate maturities this 
anthocyanin contributes very little to the 540 nm absorbance observed. For 
the 45 DAP and Mature kernel samples, the 540 nm absorbance contributed 
by peonidin-3-(cafFeylrutinoside)-5-glucoside varies with the genotype. 
4.4.2.2. Peonidin-3-(p-coumarvlrutinoside)-5-glucoside expression 
When testing for the presence of peomdin-3-(p-coumarylrutinoside)-5-
glucoside (Figure 4.49), almost all tissue extracts produce 540 nm absorbance 
peaks which are less than 3 x 10^. Only the pigmented tissue (i.e., C-(lineC) 
sh Bz wx\ 36, 45 DAP and Mature) expresses higher levels (Figure 4.50). 
When the 540 nm absorbance due to peonidin-3-(p-coumarylrutinoside)-5-
glucoside is examined as a percent of total extract absorbance, each genotype 
is different (Figure 4.51). For C-(lineC) sh Bz wx tissue this anthocyanin 
contributes to the 540 nm absorbance of extracts from older tissues. For 
C-I(A69) sh Bz wx and c-ruq66 sh Bz wx the contribution to 540 nm 
absorbance is only observed in younger tissue. Peonidin-3-(p-coumaryl-
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c-ruq66 C-(lineC) 
18 27 36 45 M 
Maturity (DAP) 
Figure 4.48. Peonidin-3-(cafreylrutinoside)-5-glucoside 540 nm absorbance 
as a percent of the total 540 nm absorbance. Mean values are 
reported for four genotypes and five tissue maturities. These 
are the |C-(lineC) sli Bz wx, ^  C-I(A69) sh Bz wx, 0 c-ruq66 
sh Bz wx, and ^ c shBz wx genotypes and 18, 17, 36, 45 DAP 
and Mature (M) maturities. Figure 4.44 summarizes the ear 
sources and number of extracts contributing to each mean 
140 
A) peonidin-3-(p-coumarylrutinoside)-5-glucoside 
H0^7 
Glucose 
0— rutinose—p-coumarate 
B) rutinoside C) p-coumaric acid 
HO 
a 
-O-CHg 
OH OH HO 
OH \ HOH 
OH 
HO- C - CH=CH—OH 
Figure 4.49. Structure of peonidin-3-(p-coumarylrutinoside)-5-glucoside. 
Part A) shows attachment of substitution groups onto the 
anthocyanin ring structure. Part B) shows rutinoside, a sugar 
dimer made from D-glucose and L-rhamnose [6(P-1-L-
rhamnosido)-D-glucose]; Part C) shows caffeic acid 
rutinoside)-5-glucoside does not contribute significantly to the 540 nm 
absorbance of c sh Bz wx extracts. 
4.4.3. Expression of a malvidin derivative 
The anthocyanidin malvidin is a quercetin derivative which is 
structurally related to peonidin. The only difference between these two 
anthocyanins is their B-ring substitution. The 5' carbon in peonidin is first 
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c-ruq66 C-(HneC) 
z Ub 160 
,o 
Maturity (DAP) 
Figure 4.50 Peonidin-3-(p-coumarylrutinoside)-5-glucoside as absorbance 
peak area x lO^. Mean values are reported for the | C-(lineC) 
sh Bz wx, ^  5 C-I(A69) sh Bz wx, c-ruq66 sh Bz wx, and m c sh 
Bz wx genotypes samples at five different maturities. These 
include 18, 27, 36, 45 DAP and Mature (M) tissues. Figure 4.44 
summarizes the ear sources and number of extracts 
contributing to each mean. Individual values are listed in 
Appendix W 
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c-ruq66 C-(UneC) 
<u cn P-4 Cd 
Maturity (DAP) 
Figure 4.51. Peonidin-3-(p-coumarylrutinoside)-5-glucoside 540 nm 
absorbance as a percent of the total 540 nm absorbance. Mean 
values are reported for four genotypes and five tissue 
C-I(A69) sh maturities. These are the I C-(lineC) sh Bz wx, 
Bz wx, g c-ruq66 sh Bz wx, and m c sh Bz wx genotypes and 18, 
17, 36,45 DAP and Mature (M) matunties. Figure 4.44 
summarizes the ear sources and number of extracts 
contributing to each mean 
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hydroxylated to form petunidin. This hydroxyl group is then methylated 
forming malvidin. 
Malvidin-3-(caffeylrutinoside)-5-gIucoside (Figure 4.52) was detected in 
all four genotypes examined (Figure 4.53). The colorless genotypes iC-I(A69) 
sh Bz wx, c-ruq66 sh Bz wx and c sh Bz wx) only express this anthocyanin 
A) malvidin-3-(cafFeylrutinoside)-5-glucoside 
5 ' O- CHg 
0— rutinose— cafFeate 
Glucose 
jR) rutinose C) caffeic acid 
OH HO 0-CH 
HO-C-CH=CH OH HOH 
OH OH HO 
OH 
Figure 4.52. Structure of malvidin-3-(ca£feylrutinoside)-5-glucose. Fart A) 
shows attachment of substitution groups onto the anthocyanin 
ring structure; Part B) shows rutinose, a sugar dimer made 
from D-glucose and L-rhamnose [6(P-l-L-rhamnosido)-D-
glucose]; Part C) shows cafFeic acid 
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c-ruq66 C-(lineC) 
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i l l  2 2 0  
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18 27 36 45 M 
Maturity (DAP) 
Figure 4.53. Malvidin-3-(cafreylrutinoside)-5-gl,ucoside as absc > bance peak 
area x lO^. Mean values are reported for the I C-(lineC) sh Bz 
wx, • C-I(A69) sh Bz wx, g c-ruq66 sh Bz wx, and ^ c shBz 
wx genotypes samples at five different maturities. These 
include 18, 27, 36, 45 DAP and Mature (M) tissues. Figure 4.44 
summarizes the ear sources and number of extracts 
contributing to each mean. Individual values are listed in 
Appendix VI 
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late in development. The C-(lineC) sh Bz wx genotype expresses much 
higher levels starting earlier in kernel development. When the 540 nm 
absorbance due to malvidin-3-(cafFeylrutinoside)-5-glucoside is examined as a 
percent of total 540 nm absorbance, this anthocyanin becomes the prominent 
or only contributor late in development (Figure 4.54). This is true for all four 
genotypes. 
4.5. Analysis of Variance (ANOVA) for the Detected Flavonol Glycosides, 
Substituted Cinnamic Acids, and Anthocyanins 
Calculations for analysis of variance tables were performed on the 
flavonol glucoside, substituted cinnamic acid, and anthocyanin observations. 
These include the four genotype treatments {.C-(lineC), C-I(A69), c-ruq66, and 
c) and four of the five maturity treatments (18, 27, 36, and 45 DAP) used to 
construct the plots in Sections 4.3. and 4.4. A summary of the ANOVA 
results are listed in Table 4.2 along with the corresponding figure numbers. 
The analysis of variance assigns effects to the treatments through a 
series of contrasts. The effects due to genotype and the three genotype 
contrasts ignores maturity. From the plots of treatment means, many of the 
detected compounds are expressed at similar levels by all genotypes for at 
least two out of the four maturities tested. This contributes to the lack of 
significant genotype differences for many of the compounds examined in this 
analysis. 
The maturity treatment effects were examined ignoring genotype. The 
fit of a straight line and a simple curve to the pooled genotype data was tested. 
By these tests, maturity had a significant effect on the accumulation of seven 
of the eleven compounds detected (see Table 4.2). 
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Figure 4.54. Malvidin-3"(caffeylrutinoside)-5-glucoside 540 nm absorbance 
as a percent of the total 540 nm absorbance. Mean values are 
reported for four genotypes and five tissue maturities. These 
are the 0 C-(lineC) sh Bz wx, C-I(A69) sh Bz wx, 0 c-ruq66 
sh Bz wx, and mm c sh Bz wx genotypes and 18, 17, 36, 45 DAP 
and Mature iM; maturities. Figure 4.44 summarizes the ear 
sources and number of extracts contributing to each mean 
Table 4.2. Summary of the analysis of variance (ANOVA) results from the 
statistical analysis of flavonol glycoside, substituted cinnamic 
acid, and anthocyanin accumulation data. The compounds or 
set of compounds for which data was tested are listed as column 
headings. Figure numbers are given for the plots of the 
treatment means. Treatments tested are listed by row and 
include 1) genotype ignoring maturity, 2) C-(lineC) verses the 
pooled colorless genotypes, 3) C-I(A69) verses the pooled c and 
c-ruq66 genotypes, 4) c verses c-ruq66, 5) maturity ignoring 
genotype, 6) fit of a straight line through the maturities, 7) fit of a 
simple curve through maturities, 8) both genotype and maturity 
considered, 9) C-(lineC) verses the pooled colorless genotypes 
using a linear model for maturity, 10) C-I(A69) verses the pooled 
c and c-ruq66 genotypes using a linear model for maturity, and 
11) c verses c-ruq66 using a linear model for maturity 
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TREATMENTS 
1. Genotype 2.5 
2. L vs si =6 
3. i vs s6 
4. s vs 6 .5 
5. Maturity 5 .5 .5 .5 5 2.5 .5 .5 
6. Linear 1 2.5 .5 .5 .5 .5 
7. Quadratic .5 .5 1 .5 
8. Genotype by 
Maturity 
.5 1 
9. L vs si6*M 
10. i vs s6*M 
11. s vs 6*M 5 

4.29 Quercetiii-3,7-diglucoside 
en en 4.30 % Quercetin-3,7-diglucoside 
en 4.32 Quercetin-3-sophoroside 
en 4.33 % Quercetin-3-sophoroside 
to 4.35 Quercetin-3-sophoroside-7-glucoside 
en 4.36 % Quercetin-3-sophoroside-7-glucoside 
H* en en N> C" en 4.38 Quercetin-3-(caffeoylsophoroside)-7-glucoside 
en en en 4.39 % Quercetin-3-(cafieoylsophoroside)-7-glucoside 
bO 
en en 4.42 p-cotunaric acid 
4.43 cafTeie acid-glucoside 
M en 4.45 Total 540 nm 
bi en M 4.47 Peomdin-3-(cafferylrutinoside)-5-glucoside 
4.48 % Peomdin-3-(cafiferylrutinoside)-5-glucoside 
en en en I-» en en 4.50 Peonidin-3-(p-coumarylrutinoside)-5-glucoside 
en 4.51 % Peonidin-3-(p-coiimarylrutinoside)-5-glucoside 
to en 4.53 Malvidin-3-(cafferylrutinoside) 5-glucoside 
t-» en en en en en en 4.54 % Malvidin-3-(cafFerylmtinoside)-5-glucoside 
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When both the genotype and maturity effects were examined together 
(i.e. sixteen separate treatments), few significant differences among 
treatments were exposed. This suggests that the variation in accumulation 
for many of the compounds within the treatment replications is high enough 
that this analysis does not detect a significant difference among the sixteen 
treatments. 
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5. DISCUSSION 
The main objective in this study was to characterize how different alleles 
of a regulatory gene affect accumulation of a pathway's products. To this 
end, four different alleles of the CI regulatory locus were compared for their 
effects on the accumulation of compounds associated with anthocyanin 
pathway expression during maize endosperm (aleurone) development. To 
accomplish this objective the study identified pathway products present in 
maize endosperm. These were then used to monitor the effects of the 
genotype (C locus alleles) and maturity treatments on pathway expression. 
These products include enzymes, flavonol glycosides, substituted cinnamic 
acids and anthocyanin derivatives. Some of these compounds have not been 
previously reported in maize. Selection of the four CI locus allelic variations 
and five kernel maturities used as treatments in this study followed an 
evaluation of 12 alleles and 14 maturities. 
5.1. Identification of Expressed Anthocyanin Pathway Products 
UDPglucose:flavonoid glucosyltransferase (UFGT) was the only enzyme 
activity specifically targeted in this study. The reaction (Figure 2.9) used to 
identify UFGT activity is the conversion of the flavonol, quercetin, to the 
flavonol-3-glucoside, isoquercetin (also known as quercetin-3-glucoside). The 
disappearance of quercetin in some of the assays occurred without either the 
addition of exogenous UDPglucose or the appearance of isoquercitrin. This 
strongly suggests the presence of another quercetin utilizing enzyme (Section 
2.2,7.2). 
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Three quercetin glucosides were identified in this study which have been 
previously reported in maize. Quercetin-3-glucoside (isoquercitrin) was 
previously identified in both husks and pollen (Sando and Bartlett, 1922; 
Larson and Coe, 1968). More recently quercetin-3,7-diglucoside has been 
identified in pollen (Ceska and Styles, 1984). Quercetin-7-glucoside was 
identified in enzyme extracts of hz embryos when feed labeled quercetin 
(Dooner, 1979). 
The standard used to identify the aforementioned quercetin glucosides 
was a flower petal extract from the petunia variety, Blue Magic. These 
flowers also express three other quercetin derivatives and two substituted 
cinnamic acids. These are quercetin-3-sophoroside, quercetin-3-sophoroside-
7-glucoside, and quercetin-3-(cafreoylsophoroside)-7-glucoside, caffeic acid-
glucoside and p-coumaric acid. All five of these compounds were identified 
in maize endosperm in this study. Three of the compounds contain a 
diglucoside residue identified as sophorose [glucose(l-2)glucose]. In a 
previous study, unspecified quercetin-3-diglycosides were identified in maize 
coleoptiles and pollen (Styles and Ceska, 1987a,b). The attached sugar 
residues were not identified. 
Three anthocyanins were identified in maize endosperm using flower 
petal extracts from the petunia variety, USDA-83 as a standard. These 
compounds are peonidin-3-(caffeyh'utinoside)-5-glucoside, peonidin-3-(p-
coumarylrutinoside)-5-glucoside, and malvidin-3-(caffeylrutinoside)-5-
glucoside. Peonidin-3-glucoside has been repor-ted in purple maize husks 
(Chen, 1973), but not the above listed derivatives. 
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5.2. Evaluation of Cl locus Variability for the 
Selection of Genotype Treatments 
To select the CI locus allelic variability for inclusion in this study,the 
relative dominance of twelve alleles was examined. These included three 
dominant color inhibitors [C-I(Cornell), C-I(K55), and C-I(A69)], four color 
expressing alleles [C-S, C-(hiloss), C-(Cshbz), and C-(lineC)], four transposon 
induced colorless mutants ic-ruq67, c-ruq66, c-ruq65, and c-ruq31), and one 
stable recessive colorless allele (c). 
The homozygous colored [C-S, C-(hiloss), C-(Cshbz), and C-(lineC)} and 
colorless [C-I(Cornell), C-I(K55), C-I(A69), c-ruq67, c-ruq66, c-ruq65, c-ruq31, 
and c] alleles were crossed in a complete diallel design. A comparison of the 
progeny from these intermatings shows that all three C-I alleles noticeably 
reduced or completely eliminated visual pigmentation by the C alleles. As 
expected (Coe, 1962; Peterson and Leleji, 1974), suppression of pigmentation 
was greatest when the C-I alleles were the female parent. As a female 
parent the c-ruq and c alleles minimally reduced pigment expression of some 
of the C alleles. No such effect was observed when the c-ruq and c alleles 
were the male parent. 
Based on the interactions which reduced or eliminated aleurone 
pigmentation, the alleles are ranked in the following descending order of 
dominance: C-I(K55), C-I(Cornell), C-I(A69), C-S, C-(hiloss), C-(lineC), 
C-(Cshbz), c-ruq67 (66 or 65), c-ruq31 and c. 
Four representative alleles were selected for utilization as the CI locus 
treatments in the remainder of this study. These alleles are C-I(A69), 
C-dineC), c-ruq66, and c. They will be discussed further in Sections 5.3 
through 5.9. 
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5.3. Evaluation of Kernel Developmental Variability for the 
Selection of Maturity Treatments 
To select the kernel maturity treatments for inclusion in this study, an 
initial group of 14 maturities were examined. These include 13 maturities 
between 15 and 51 days after pollination (DAP) spaced at three day intervals 
plus fully mature dry kernels (M or Mature). Samples were collected for 
each maturity from the C-I(A69) sh Bz wx, C-(lineC) sh Bz wx, c-ruq66 sh Bz 
wx, and c sh Bz wx lines carrying the previously selected CI locus genotypes. 
Each genotype/maturity treatment was then assayed for UDPglucose: 
flavonoid glucosyltransferase activity. Following analysis of these results, 
four evenly spaced maturities (18, 27, 36, and 45 DAP) plus Mature (M) 
treatments were selected as representative of the endosperm maturation 
process. 
5.4. Expression of UFGT in Response to 01 Locus Genotype 
and Kernel Maturity Treatments 
UFGT activity was low or undetected throughout maturity for all three 
colorless alleles. The results from the C-I(A69) sh Bz wx (Figure 4.9) and 
c-ruq66 sh Bz wx (Figure 4.11) genotypes agree with the previous observations 
of a c allele (Dooner and Nelson, 1979) in which the already low isoquercitrin 
production ability (UFGT activity) stays steady throughout development or 
decreases slightly as the kernel matures. In contrast to C-I(A69) and c-
ruq66, extracts from the c allele tested in this study (c sh Bz wx) did not 
produce detectable isoquercitrin levels until kernel maturity (Figures 4.12 
and 4.13). 
For the colored genotype, C-(lineC) sh Bz wx, expression of UFGT 
activity followed the same pattern reported by H. K. Dooner and O. E. Nelson 
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(1977b, 1979) for immature wild-type CBz samples. These authors did not 
observe reduced UFGT activity with desiccation of physiologically mature 
kernels. In Section 4.2.1.4. mature fully-dry kernels were also compared. 
Extracts from these Mature (M) samples contained only 86% of the activity 
observed for the 45 DAP maturity (Figures 4.10 and 4.13) indicating that the 
C'(lineC) sh Bz wx differs slightly from other C Bz genotypes reported in the 
literature. 
5.5. Consumption of Quercetin in Response to CI Locus Genotype 
and Kernel Maturity Treatments not Associated with UFGT 
While examining the expression of UFGT, quercetin consumption by the 
crude enzyme extracts deviated from isoquercitrin production (Section 
4.2.2.2.). That is, tissues representing genotype/maturity treatments with 
little or no UFGT activity consumed quercetin. Quercetin consumption was 
at a maximum early in kernel development for all genotypes. The maximum 
occurred at 18 DAP for C-QineC) sh Bz wx, and at 27 DAP for the colorless 
genotypes. Therefore, the quercetin consumption must be associated with an 
enzyme activity other than the Bz encoded UFGT. This enzyme activity must 
not be under C locus control based on the similarity of the data when 
comparing all C locus genotypes. 
This study has identified six different glycosylated derivatives of 
quercetin which accumulate in maize endosperm (Section 4.3.2., and 
Subsections 1. to 6.). Among these were four compounds (quercetin-7-
glucoside, quercetin-3,7-diglucoside, quercetin-3-sophoroside-7-glucoside, 
and quercetin-3-(caffeoylsophoroside)-7-glucoside) which require a flavonoid 
7-0-glycosyltransferase for their synthesis. Such an enzyme (see Section 
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2.2.7.2.) has been described in parsley (Sutter et al., 1972; Sutter and 
Griesbach, 1973). 
In 1979, H. K. Dooner observed labeled quercetin converted to quercetin-
7-glucoside and quercetin-3'-glucoside in bz embryo extracts. Together with 
Dr. Dooner's observed enzyme activities, this study's observations suggest 
that the unknown enzyme activity responsible for the observed non-UFGT 
utilization of quercetin (Section 4.2.2.2.) may be the result of a flavonoid 7-0-
glucosyltransferase. The possibility that other enzymes such as a flavonoid-
3'-glucosyltransferase or non-Bz encoded flavonoid-3-glucosyltransferase 
contributed to quercetin disappearance in the UFGT assays cannot be ruled 
out. 
The high consumption rates of quercetin by the young kernel tissues in 
this study suggest that these tissues may be useful in future studies. The 27 
DAP tissue from the three colorless genotypes appear suitable for 
identification of a flavonol 7-glucosyltransferase, flavonol 3 -
glucosyltransferase or other quercetin utilizing enzymes in maize. 
5.6. Accumulation of Quercetin Glycosides in Response 
to CI Locus Genotype and Kernel Maturity Treatments 
A total of six quercetin glycosides were detected in the flavonol glycoside 
extracts. These were quercetin-3-glucoside (Section 4.3.2.1.), quercetin-7-
glucoside (Section 4.3.2.2.), quercetin-3,7-diglucoside (Section 4.3.2.3.), 
quercetin-3-sophoroside (Section 4.3.2.4.), quercetin-3-sophoroside-7-glucoside 
(Section 4.3.2.5.), and quercetin-3-(caffeoylsophoroside)-7-glucoside (Section 
4.3.2.6.). Each of these compounds was reported as absorption units 
extracted from individual kernels. 
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Initially, means for total 340 nm absorbance (Figure 4.18) and total 340 
nm absorbance for six quercetin glycosides (Figure 4.20) were compared. The 
purpose was to examine general genotype trends in flavonol glycoside 
accumulation. For both sets of values the c-ruq66 sh Bz wx and C-(lineC) sh 
Bz wx genotypes showed distinct patterns of flavonol accumulation. The 
values for immature (18 and 27 DAP) c-ruq66 tissue were higher than the 
other genotypes. At these maturities the C-(lineC), C-I(A69), and c genotypes 
exhibited values which clustered together. For Mature (M), C-(lineC) tissue, 
values exceeded all other genotype/maturity treatments examined. Low 
values for all genotypes at 36 and 45 DAP support the idea that individual 
flavonol-glycoside species have a finite life in the cell and are turned over 
during tissue development. 
5.6.1. Evidence for a second flavonoid 3-0-^lvcosvltransferase 
For quercetin-3-glucoside (Figure 4.23), accumulation in C-(lineC) sh Bz 
wx tissue corresponds to the UFGT activity observed in enzyme extract from 
the same ears (Figure 4.13). The quercetin-3-glucoside accumulation in 
tissue of the other genotypes is higher than expected from the observed UFGT 
activity. For many of the genotype/maturity treatments the quercetin-3-
glucoside values are higher than the corresponding C-(lineC)/mat\xrity 
treatments. 
These results indicate that an enzyme not related to the CI locus 
controlled UFGT (Bz product) is producing the accumulated quercetin-3-
glucoside. This enzyme is expected to have a broad tissue specificity based on 
the observation of flavonol-3-glucosides in bz coleoptiles (Styles and Ceska, 
1981b). If this unknown flavonoid-3-O-glycosyltransferase is under the 
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control of the CI locus, then the control differs from that experienced by 
UFGT. 
Alternatively, the CI locus may control flavonoid movement towards 
anthocyanin synthesis (via enzymes such as the Bz encoded UFGT) without 
affecting the expression of flavonoids with non-anthocyanin destinations. 
Then, the non-Bz associated flavonoid 3-0-glucosyltransferase may function 
in the synthesis of flavonoids not destined as precursors for anthocyanins. 
Styles and Ceska (1989) have proposed a model to explain their observation 
that P- and jR-determined products do not compete for precursors in pericarp 
tissue. This model includes the creation of flavanone "pools" which are then 
"earmarked" for either flavon-4-ol synthesis (P controlled) or 3-hydroxylation 
(i? controlled). The 72-controlled 3-hydroxylation of flavanones is required to 
create the substrates for UFGT and the proposed non-Bz encoded flavonoid 
3-0-glucosyltransferase. Further regulation of the anthocyanin pathway 
may destine dihydroflavonols (3-hydroxylated flavanone) to anthocyanin 
synthesis (Ci locus) and flavonol-glycoside synthesis (an unidentified 
regulatory locus?). The presence of enzymes with duplicate functions would 
be consistent with this model. 
5.6.2. Evidence for a flavonoid 7-0-0vcosvltransferase 
For quercetin-7-glucoside accumulation (Figure 4.26), all four genotypes 
show a variation on a common theme. This includes an initial peak in 
accumulation of quercetin-7-glucoside at 27 DAP and another at maturity. 
These similarities suggest that the flavonoid 7-0-glucosyltransferase 
responsible for quercetin-7-glucoside synthesis is not under C locus control. 
Differences between the individual genotypes may indicate substrate 
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availability and quercetin-7-glucoside utilization in other reactions rather 
than differences in regulation. 
Quercetin-3,7-diglucoside accumulation (Figure 4.29) is dependent on 
two classes of enzymes. The first reaction is the formation of quercetin-7-
glucoside (Figfure 4.26). The second is the 3-glucosylation of quercetin-7-
glucoside by the Bz encoded UFGT and/or a second as yet uncharacterized 
3-0-glucosyltransferase. The excessive quercetin-3,7-diglucoside 
accumulation in mature C-(lineC) when compared with mature colorless 
iC-I(A69), c-ruq66, and c] genotypes suggests that two 3-0-glucosyltrans-
ferases (one under C locus control) may be contributing to this accumulation. 
The colorless genotypes would only have the hypothesized flavonoid 3-0-
glycosyltransferase to explain the accumulation of quercetin-3-glucoside 
(Figure 4.29) and quercetin-3,7-diglucoside (Figure 4.29). UFGT activity was 
not detected in these tissues (Figure 4.13). 
The 18 DAP extracts from c-ruqGG tissue contain unexpectedly high 
levels of quercetin-3,7-diglucoside when compared with the other genotypes. 
This high level is consistent when examining the overall accumulation of 
flavonol derivatives (Figures 4.18 and 4.20). The c-ruq66 genotype appears to 
have more resources feeding into flavonol derivative synthesis than the other 
genotypes early in tissue development (18-27 DAP). This may indicate that 
the c-ruq66 line developed for this set of experiments carried an allelic 
variation of another regulatory locus not contained in the other three lines, 
which increases the expression of the flavonol-glycoside branch from the 
anthocyanin pathway. Alternatively the c-ruq66 allele may affect the 
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flavonol-glycoside branch of the anthocyanin pathway differently than the 
other C locus alleles tested. 
5.6.3. Evidence for a flavonoid 3-0-glucoside dvcosvltransferase 
The three remaining flavonol-glycosides identified in this study have 
sophorose attached to the 3-position hydroxyl group of quercetin. Sophorose is 
another name for gIucose(l-2) glucose. Therefore, a possible route of 
synthesis for quercetin-3-sophorose (Figures 4.31 and 4.32) is the coupling of 
glucose to quercetin-3-glucoside. In the same manner quercetin-3-
sophoroside-7-glucoside (Figures 4.34 and 4.36) and quercetin-3-
(caffeoylsophoroside)-7-glucoside (Figures 4.37 and 4.38) could be derived 
from quercetin-3,7-diglucoside. 
The presence of these three sophoroside derivatives in the extracts tested 
suggests that maize expresses a flavonoid 3-0-glucoside glucosyltransferase. 
No such enzyme has been described which is specific for flavonol-3-glucoside 
substrates. However, similar enzymes, anthocyanidin-3-O-glucoside 
glycosyltransferases, have been described which use anthocyanidin-3-0-
glucosides as substrates (see Section 2.2.7.3. for further discussion of this type 
of reaction). 
From the plots of quercetin-3-sophoroside (Figure 4.32), quercetin-3-
sophoroside-7-glucoside (Figure 4.35), and quercetin-3-(caffeoyl-sophoroside)-
7-glucoside (Figure 4.38), synthesis of these compounds does not appear to be 
directly controlled by the C locus. 
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5.7. Accumulation of Substituted Cinnamic Acids in Response to CI Locus 
Genotype and Kernel Maturity Treatments 
Two substituted cinnamic acids were detected in the flavonol glycoside 
extracts. These were p-coumaric acid and caffeic acid-glucoside (Section 
4.3.3.). Accumulation patterns for both of these compounds follow the trend 
set by the quercetin glycosides. This included the young (18 or 27 DAP) 
c-ruq66 sh Bz wx kernels exhibiting the highest levels of these compounds for 
any genotype/maturity treatment. 
5.8. Accumulation of Anthocyanins in Response to CI Locus Genotype 
and Kernel Maturity Treatments 
A total of three anthocyanin derivatives were detected in the anthocyanin 
extracts. These were peonidin-3-(cafFeylrutinoside)-5-glucoside (Section 
4.4.2.1.), peonidin-3-(p-coumarylrutinoside)-5-glucoside (Section 4.4.2.2.), and 
malvidin-3-(cafferylrutinoside)-5-glucoside (Section 4.4.3.). The presence of 
these compounds is consistent with a previous report of trace amounts of a 
partially characterized cyanidin-5-glycoside in maize coleoptiles (Styles and 
Ceska, 1981b). 
In contrast with the quercetin glycosides accumulation, the colorless 
genotypes (C-I(A69) sh Bz wx, c-ruq66 sh Bz wx, and c sh Bz wx) accumulate 
little if any anthocyanins. All genotypes exhibit peak accumulation at 36 
DAP or later in maturity. The C-(lineC) sh Bz wx genotype exhibits 180 to 210 
times more anthocyanin at peak accumulation than the other genotypes. 
As with the flavonol glycosides discussed in Section 5.6, examination of 
the structures for the identified anthocyanins suggests several as of yet 
uncharacterized maize enzymes. All three anthocyanin derivatives 
identified in maize endosperm are 3-0-rutinoside derivatives. These are 
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formed by the attachment of rhamnose to a glucose molecule previously 
attached by UFGT to the 3-OH of the anthocyanidin precursor. The result is a 
dissaccharide chain on the 3-position hydroxyl group. This saccharide 
linkage requires the action of an enzyme such as 3-0-glucoside 
glycosyltransferase (Kamsteeget a/., 1980a; Teuch, 1986). 
A second glycosyltransferase necessary for the production of the 
observed anthocyanins is one which attaches a glucose to the 5-position 
hydroxyl group of anthocyanins. Such an enzyme, anthocyanidin-3-0-
glycoside 5-0-glucosyltransferase has been described in Silene dioica 
(Kamsteeg et al., 1980b). 
Additional enzymes which are required, include: a methyltransferase 
specific for 3' and 5' hydroxyl groups (Section 2.2.7.5) and one or more 
acyltransferases for attaching 4-coumaric or cafFeic acid to rhamnose 
(Section 2.2.7.4). This acyltransferase may also be responsible for the 
acylation of quercetin-3-(cafreoylsophoroside)-7-glucoside which was also 
identified in endosperm extracts (Section 4.3.2.6). 
All three anthocyanins detected in this study exhibit accumulation 
maximas at 36 DAP in C-(lineC) extracts (Malvidin exhibits a second 
maxima in Mature tissue). As such, an investigation of any of the proposed 
enzymes should focus on tissue of this age or slightly younger where these 
enzymes are known to be active. 
5.9. Summary of Accomplishments 
Studying the effects of different CI locus alleles on the expression of the 
anthocyanin pathway during maize endosperm (aleurone) development 
resulted in the following: A) description of the relative dominance of 12 
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alleles of the CI  locus, B) identification of 6 quercetin glycosides, 2 substituted 
cinnamic acids, and 3 anthocyanins, 6 of which are new reports for maize, 
C) description of the genotype and maturity effects on the expression of 
UFGT, 6 quercetin glycosides, 2 substituted cinnamic acids, and 3 
anthocyanins, and D) identification of genotypes and tissue maturities for a 
possible search for a new flavonoid 3-0-glucosyltransferase, flavonoid 7-0-
glucosyltransferase, flavonoid 3-0-glucoside glycosyltransferase, 
anthocyanidin-3-O-glycoside 5-0-glucosyltransferase, methyltransferase, 
and acyltransferase in maize. 
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APPENDIX I. FLAVONOID NOMENCLATURE AND TERMS 
179 
Aglycones see C-glycosylflavonoids. 
Anthocyanidins are rarely, if ever, found in nature. Anthocyanidins 
naturally occur as glycosides (anthocyanins) but can be formed by acid 
hydrolysis of monomeric or polymeric proanthocyanidins (Mathew, 1969) 
and hydroxyflavanones (Jurd, 1969). 
Anthocyanins are water soluble pigments and are glycoside derivatives of 
anthocyanidins. The 3-0-glycosides (glucose is the most common sugar) 
are the first stable products of anthocyanin biosynthesis (Heller and 
Forkmann, 1988). The 3-0-glycoside structure illustrated below is based 
on the flavylium cation structure. 
Aurones are yellow compounds and have an isomeric relationship to the 
flavones (Bate-Smith and Greissman, 1951). 
R 
R 
R 
0-Glucose 
R 
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Bioflavonoids are dimers containing flavones, flavanones, or isoflavones. 
There are several possible interflavonyl linkages (Geiger and Quinn, 
1988). 
Catechins see Flavan-3-ols. 
C-Glycosylflavonoids are glycosylated flavonoids with the sugar attached 
through a carbon-carbon bond. This bond is not susceptible to acid 
hydrolysis. The mono- and di-C-glycosylflavonoids (aglycones) are 
completely unhydrolyzable. Their 0-glycoside and 0-acylated derivatives 
may be hydrolyzed to the corresponding aglycone. 
Chalcones are the first isolatable C15 precursors in flavonoid biosynthesis. 
They are open chain flavonoids. (A and B rings are joined by a three 
carbon a,P-unsaturated carbonyl group.) The parent compound (chalcone) 
does not occur in nature but is hydroxylated. Note: The numbering 
system for the carbons is reversed from most other flavonoids. 
Condensed Proanthocyanidins see proanthocyanidins. 
Dihydrochalcones are derived from chalcones by the reduction of the a,p-
double bond. The ring numbering system is the one used for chalcones. 
2 3 
3" 2' 
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Dihydroflavonols are position-3 hydroxylated derivatives of flavanones. 
Also called S-hydroxyflavanones or flavanonals, they have two asymmetric 
carbons (C-2 and C-3). Dihydroflavonols yield flavonols when 
dehydrogenated. Reduction of the carbonyl function yields flavan-3,4-
diols, while enolization and oxidation produces anthocyanidins. 
Flavan 3,4-diols are monomeric proanthocyanidins and historically 
classified as leucoanthocyanins (Haslam, 1982). 
3' 
Flavan-S-ols (catechins) are related to flavan-3,4-diols. They condense to 
form the condensed proanthocyanidins and tannins. Epimerization of 
catechin at the 2 position forms epicatechin. 
3' 
0 
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Flavanones are isomeric derivatives of chalcones. The optical activity 
observed for many naturally occurring flavanones is due to a center of 
asymmetry at C-2. The simplest naturally occurring plant flavanone is a 
hydroxylated (position-?) derivative of 2-phenylbenzopyran-4-one. 
Dehydrogenation of flavanones produces flavones, while hydroxylation at 
position-3 produces dihydroflavanols. 
3' 
O 
Flavanonols see dihydroflavonols. 
Flavones are formed by the desaturation of their related flavanones 
(formation of double bond). Glycoside derivatives are common. 
Substitution of a hydroxyl group for the hydrogen at the 3 position 
produces flavonols. 
3' 
O 
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Flavonols are simple flavones with a hydroxyl group at the 3 position. 
Glycoside derivatives are common. 
3' 
OH 
Flavyliiim Salt is a cation structure representing the positively charged 
nature of the organic skeleton for anthocyanidins, anthocyanins, and 
)roanthocyanidins. R represents sites for group substitution. 
OH 
3-Hydrozyflavonones see dihydroflavonols. 
Leucoanthocyanidins are monomeric proanthocyanidins such as the 
flavan-3,4-diols (Weinges et al., 1969). Edwin Haslam in his 1982 review 
of proanthocyanidin nomenclature states that the term 
leucoanthocyanidin should no longer be used. 
Isoflavonoids include many classes of naturally occurring compounds which 
are structurally based on the CgCgCg skeleton. 
184 
Neoflavanoids share the 15 carbon, 4-arylchromEin skeleton and are closely 
related to the flavanoids and isoflavanoids. 
Proanthocyanidins are colorless compounds isolated from plants which 
form anthocyanidins when heated with acid (Freudenberg and Weinges, 
1960). This is an organic chemistry definition and does not imply a 
biosynthetic or metabolic pathway relationship. Proanthocyanidins may 
be monomeric such as the flavan-3,4-diols or condensed into flavan-3-ol 
dimers or higher oligomers. Extensive condensation leads to the polymeric 
condensed tannins. 
5 
4' 
185 
APPENDIX IL HPLC PUMP PROGRAMS 
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Name: AN 
Time Flow %A %B C^rv$ N9. 
initial 1 ml/min 100 0 * 
50 min 1 ml/min 80 20 6 
55 min 1 ml/min 100 0 6 
Program used initially when developing anthocyanidin separation and 
quantification method. Replaced by ANTWO. Pump A = 15:1.5:83.5 
acetic acid:phosphoric acid:water. Pump B = acetonitrile. Curve No. 6 = 
linear gradient. Detection at 540 nm. 
Name: ANTWO 
Time Flow %A %B Curve No. 
initial 1 ml/min 99 1 * 
10 min 1 ml/min 99 1 6 
60 min 1 ml/min 80 20 6 
65 min 1 ml/min 99 1 6 
Program used to separate and quantify anthocyanidins. At end of 
gradient returns to initial conditions. Pump A = 15:1.5:83.5 acetic 
acid:phosphoric acid:water. Pump B = acetonitrile. Curve No. 6 = linear 
gradient. Detection at 540 nm. 
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Name: FLABEG 
Time Flow ^^ Curve No. 
initial 0 ml/min 30 70 * 
6 min 1 ml/min 100 0 6 
10 min 1 ml/min 100 0 6 
Program used to establish initial solvent conditions for flavonol analysis. 
Pump A = 1% triethylamine in water, adjusted to pH3 with phosphoric 
acid. Pump B = acetonitrile. Curve No. 6 = linear gradient. 
Name: FLAEND 
Time Flow %k Curve No. 
initial 1 ml/min 100 0 * 
15 min 1 ml/min 100 0 6 
20 min 1 ml/min 30 70 6 
25 min 1 ml/min 30 70 6 
30 min 0 ml/min 30 70 6 
Program used to store column in 30% water, 70% acetonitrile upon 
completion of either flavonol or anthocyanidin analysis (FLAV or 
ANTWO). Initial 15 minutes is used to rinse salts from column. Pump 
A = water. Pump B = acetonitrile. Curve No. 6 = linear gradient. 
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Name: FLAV 
Time Mow M ^ Curve No. 
initial 1 ml/min 100 0 * 
20 min 1 ml/min 80 20 6 
35 min 1 ml/min 80 20 6 
45 min 1 ml/min 100 0 6 
Program used to separate and quantify flavonols. At end of gradient 
returns to initial conditions. Pump A = 1% triethylamine, adjusted to 
pH3 with phosphoric acid. Pump B = acetonitrile. Curve No. 6 = linear 
gradient. Detection at 340 nm. 
Name: QPRIME 
Time Flow %A %B Curve No. 
initial 0 ml/min 50 50 * 
10 min 11 ml/min 50 50 6 
20 min 11 ml/min 50 50 6 
25 min 25 ml/min 50 50 6 
Program used to prime pumps at the beginning of each days work. Used 
for all HPLC procedures (flavonol and anthocyanin detection, and UFGT 
enzyme assay). Column is disconnected before running program. 
Pump A = aqueous eluen. Pump B = organic eluen. Curve No. 6 = 
linear gradient. 
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Name: QUER45 
Time Flow %A %B Çyryg 
initial 3 ml/min 75 25 * 
20 min 3 ml/min 75 25 11 
Program used to quantify isoquercetin production from UFGT assay. 
Pump A = 10:65 acetic acid. Pump B = methanol. Curve No. 11 = 
isocratic conditions. Detection at 254 nm. 
Name: QUERBEG 
Time Flow %A %B Curve No, 
initial 0 ml/min 0 100 * 
20 min 3 ml/min 0 100 6 
40 min 3 ml/min 75 25 6 
50 min 3 ml/min 75 25 6 
Program used to establish initial solvent conditions for program 
QUER45 (quantifying isoquercetin production from UFGT assay). Pump 
A = 10:65 acetic acid:water. Pump B = methanol. Curve No. 6 = linear 
gradient. 
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Name: QUEREND 
Time Flow %k %B Curve No. 
initial 3 ml/min 75 25 * 
I min 3 ml/min 0 100 6 
II min 0 ml/min 0 100 6 
Program used to store column in 100% methanol when turning off 
equipment after running QUER45. Pump A - water. Pump B = 
methanol. Curve No. 6 = linear gradient. 
Note: Conversations with Dr. R. Griesbach (USDA, Beltsville, MD) 
indicate that in the future this procedure should be replaced by FLAEND 
with appropriate changes in the initial conditions. 
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APPENDIX III. ISOQUERCITRIN PRODUCTION DATA FROM UFGT 
ACTIVITY (RAW DATA) 
Table A.3.1. Isoquercitrin data from UFGT assays for C-I (A69) sh Bz wx used to construct Figures 4.4 
and 4.8, Section 4.2.1.3. Assay results are ordered by tissue maturity and ear source. 
Results are presented as isoquercitrin peak area (raw data corrected for endogenov^ 
isoquercitrin), intermediate calculations and ng isoquercitrin produced in 300 seconds 
corrected for UFGT extract volume 
Peak Area Total ng/300 sec 
Maturity Ear Isoquercitrin Incubation Time- ng Extract Volume-
CD AP) (1987) Assay Peak Area Time (sec) Corrected^ Isoquercitrin^ Volume Corrected^ 
15 6132-70 038 ad 0 300 0 0 n.a. 0 
038 bd 0 302 0 0 h.a. 0 
18 6138-80 226 ad 0 300 0 0 420 0 
226 bd 0 300 0 0 420 0 
21 6137-100 208 ad 0 300 0 0 n.a. 0 
208 bd 0 316 0 0 n.a. 0 
24 6133-30 003 ad 0 300 0 0 n.a. 0 
003 bd 0 300 0 0 n.a. 0 
27 6134-10 212 ad 0 300 0 0 550 0 
212 bd 0 300 0 0 550 0 
iPeak area time-corrected values were calculated using Equation 1, Section 4.2.1.2. 
2ng Isoquercitrin calculated using standard curve and Equation 2, Section 4J2.1.2. 
3ng Isoquercitrin/300 sec volume-corrected values were calculated using Equation 3, Section 4.2.1.2. 
Table A.3.1. Continued 
Peak Area Total ng/300 sec 
Maturity Ear Isoquercitrin Incubation Time- ng Extract Volume-
(DAP) (1987) Assay Peak Area Time (sec) Correctedi Isoquercitrin^ Volume Corrected^ 
30 6135-5© 253 ad 0 300 0 0 425 0 
253 bd 0 300 0 0 425 0 
33 6136-2t© 220 ad 0 305 0 0 n.a. 0 
220 bd 0 305 0 0 n.a. 0 
36 6135-50 228 ad 0 301 0 0 350 0 
228 bd 0 305 0 0 350 0 
39 6137-5© 216 bd 0 304 0 0 420 0 
216 cd 0 305 0 0 420 0 
42 6135-3© 102 ad 0 315 0 0 465 0 
102 bd 0 301 0 0 465 0 
45 6136^© 258 ad 0 300 0 0 325 0 
258 bd 32368 300 32368 203 325 1321 
48 n.a. 
51 6132-2© 245 ad 0 307 0 0 240 0 
245 bd 0 300 0 0 240 0 
Mature 6132-3© 929a81 0 300 0 0 290 0 
929b81 0 300 0 0 290 0 
Table A.3.2. Isoquercitrin data from UFGT assays for C-(lineC) sh Bz wx used to construct Figures 4.5 
and 4.8, Section 4.2.1.3. Assay results are ordered by tissue maturity and ear source. 
Results are presented as isoquercitrin peak area (raw data corrected for endogenous 
isoquercitrin), intermediate calculations and ng isoquercitrin produced in 300 seconds 
corrected for UFGT extract volume 
Peak Area Total ng/300 sec 
Maturity Ear Isoquercitrin Incubation Time- ng Extract Volume-
CD AP) (1987) Assay Peak Area Time (sec) Corrected^ Isoquercitrin^ Volume Corrected^ 
15 n.a. 
18 6228-2t0 119 ad 0 300 0 0 460 0 
119 bd 0 300 0 0 460 0 
21 6229-50 123 ad 0 300 0 0 310 0 
123 bd 33818 300 33818 208 310 1292 
24 n.a. 
27 6228-1® 115 ad 47030 300 47030 256 340 1741 
115 cd 39707 300 39707 230 340 1562 
30 6228-10© 088 ad 47037 300 47037 256 400 2049 
088 bd 68154 300 38154 332 400 2658 
ipeak area time-corrected values were calculated using Equation 1, Section 4.2.1.2. 
%g Isoquercitrin calculated using standard curve and Equation 2, Section 4.2.1.2. 
3ng Isoquercitrin/300 sec volume-corrected values were calculated using Equation 3, Section 4.2.1.2. 
Table A.3.2. Continued 
Peak Area Total ng/300 sec 
Maturity Ear Isoquercitrin Incubation Time- ng Extract Volume-
(DAP) (1987) Assay Peak Area Time (sec) Corrected! Isoquercitrin^ Volume Corrected^ 
33 6225-20 010 ad 328119 300 328119 1270 340 8635 
010 bd 300618 300 300618 1171 340 7961 
36 6225-7© 130 ad 162170 300 162170 671 200 2684 
130 bd 160111 300 160111 664 200 2656 
39 6225-6© 126 ad 87922 300 87922 404 275 2220 
126 bd 103122 300 103122 458 275 2521 
6229-110 134 ad 164685 300 164685 680 380 5171 
134 bd 176497 300 176497 723 380 5495 
45 6228-6t0 233 ad 446026 300 446026 1695 390 13222 
233 bd 507092 300 507092 1915 390 14940 
48 6228-20 162 ad 300 380 
162 bd 300 380 
51 62264© 101 bd 494840 300 494840 1871 280 10479 
101 cd 460434 300 460434 1747 280 9784 
Mature 622640 al2867 330176 300 330176 1277 325 8302 
bl2867 307628 300 307628 1196 325 7774 
Table A.8.3. Isoquercitrin data from UFGT assays for c-ruq66 sh Bz wx used to construct Figures 4.6 
and 4.8, Section 4.2.1.3. Assay results are ordered by tissue maturity and ear source. 
Results are presented as isoquercitrin peak area (raw data corrected for endogenous 
isoquercitrin), intermediate calculations and ng isoquercitrin produced in 300 seconds 
corrected for UFGT extract volume 
Peak Area Total ng/300 sec 
Maturity Ear Isoquercitrin Incubation Time- ng Extract Volume-
(DAP) (1987) Assay Peak Area Time (sec) Corrected^ Isoquercitrin^ Volume Corrected^ 
15 
18 
21 
24 
27 
30 
33 
n.a. 
6223-80 328 bd 18201 
328 cd 23649 
n.a. 
n.a. 
6230-30 292 ad 69196 
292 bd 20035 
n.a. 
n.a. 
315 
301 
300 
300 
17334 
23570 
69196 
20035 
149 
171 
336 
159 
345 
345 
465 
465 
1028 
1183 
3125 
1476 
^Peak area time-corrected values were calculated using Equation 1, Section 4.2.1.2. 
%g Isoquercitrin calculated using standard curve and Equation 2, Section 4.2.1.2. 
%g Isoquercitrin/300 sec volume-corrected values were calculated using Equation 3» Section 4.2.1.2. 
Table A.3.3. Continued 
Maturity 
(DAP) 
Ear 
(1987) Assay 
Isoquercitrin 
Peak Area 
Incubation 
Time (sec) 
Peak Area 
Time-
Corrected  ^
Total 
ng Extract 
Isoquercitrin  ^ Volume 
ng/300 sec 
Volume-
Corrected  ^
36 6234y-30 296 ad 0 300 0 0 310 0 
296 bd 0 306 0 0 310 0 
39 n.a. 
42 n.a. 
45 6230-10 300 ad 24283 315 23127 170 205 696 
300 bd 17903 300 17903 151 205 619 
48 n.a. 
51 n.a. 
Mature 6234y-3© 365 ad 0 302 0 0 400 0 
365 bd 10625 300 10625 125 400 998 
Table A.3.4. Isoquercitrin data from UFGT assays for c sh Bz wx used to construct Figures 4.7 and 4.8, 
Section 4.2.1.3. Assay results are ordered by tissue maturity and ear source. Results are 
presented as isoquercitrin peak area (raw data corrected for endogenous isoquercitrin), 
intermediate calculations and ng isoquercitrin produced in 300 seconds corrected for UFGT 
extract volume 
Peak Area Total ng/300 sec 
Maturity Ear Isoquercitrin Incubation Time- ng Extract Volume-
(DAP) (1987) Assay Peak Area Time (sec) Corrected  ^ Isoquercitrin^ Volume Corrected  ^
15 6443-11© 200 ad 0 300 0 0 n.a. 0 
200 bd 0 300 0 0 n.a. 0 
18 6424-5/-15t 186 ad 0 300 0 0 440 0 
186 bd 0 304 0 0 440 0 
21 6423-14© 193 ad 0 300 0 0 n.a. 0 
193 bd 0 300 0 0 n.a. 0 
6441-13© 182 af 0 300 0 0 n.a. 0 
182 bf 0 310 0 0 n.a. 0 
27 6424-14© 174 ag 0 300 0 0 415 0 
174bg 0 300 0 0 415 0 
iPeak area time-corrected values were calculated using Equation 1, Section 4.2.1.2, 
^ng Isoquercitrin calculated using standard curve and Equation 2, Section 4.2.1.2. 
3ng Isoquercitrin/300 sec volume-corrected values were calculated using Equation 3, Section 4.2.1.2. 
Table A.3.4. Continued 
Maturity 
(DAP) 
Ear 
(1987) Assay 
Isoquercitrin 
Peak Area 
Incubation 
Time (sec) 
Peak Area 
Time-
Corrected! 
Total 
ng Extract 
Isoquercitrin  ^ Volume 
ng/300 sec 
Volume-
Corrected  ^
30 6442-9© 204 ad 0 300 0 0 n.a. 0 
204bd 0 300 0 0 n.a. 0 
33 6424-120 196 ad 0 300 0 0 n.a. 0 
196 bd 0 300 0 0 n.a. 0 
36 6423-5© 178 ad 0 301 0 0 335 0 
178 bd 0 300 0 0 335 0 
39 3424-7© 095 ad 0 300 0 0 n.a. 0 
095 bd 0 301 0 0 n.a. 0 
42 6422-2© 242 ad 0 300 0 0 500 0 
242 bd 0 304 0 0 500 0 
45 6422-2® 243 ad 10257 300 10257 123 445 1095 
243 bd 0 300 0 0 445 0 
48 n.a. 
51 n.a. 
Mature 6424-8© 927a71 0 300 0 0 310 0 
927e71 0 300 0 0 310 0 
Table A.3.5. Isoquercitrin data from UFGT assays for C-I(A69) sh Bz wx used to construct Figures 4.9 
and 4.13, Section 4.2.1.4. Assay results are ordered by tissue maturity and ear source. 
Results are presented as isoquercitrin peak area (raw data corrected for endogenous 
isoquercitrin), intermediate calculations and ng isoquercitrin produced in 300 seconds 
corrected for UFGT extract volume 
Peak Area Total ng/300 sec 
Maturity Ear Isoquercitrin Incubation Time- ng Extract Volume-
CD AP) (1987) Assay Peak Area Time (sec) Corrected  ^ Isoquercitrin^ Volume Corrected  ^
18 6138-80 226 ad 0 300 0 0 420 0 
226 bd 0 300 0 0 420 0 
368 ad 36659 300 36659 219 320 1399 
368 bd 52748 330 47953 259 320 1660 
6133-60 332 ad 0 302 0 0 400 0 
332 bd 0 300 0 0 400 0 
334 ad 0 300 0 0 230 0 
334 bd 0 304 0 0 230 6 
27 6134-1© 212 ad 0 300 0 0 550 0 
212 bd 0 300 0 0 550 0 
iPeak area time-corrected values were calculated using Equation 1, Section 4.2.1.2. 
^ng Isoquercitrin calculated using standard curve and Equation 2, Section 4.2.1.2. 
3ng Isoquercitrin/300 sec volume-corrected values were calculated using Equation 3, Section 4.2.1.2. 
Table A.3.5. Continued 
Maturity Ear Isoquercitrin Incubation 
(DAP) (1987) Assay Peak Area Time (sec) 
214 ad 0 340 
214 bd 0 300 
6137-13© 336 ad 0 320 
336 bd 0 305 
337 ad 0 303 
337 bd 11198 301 
6135-5© 228 ad 0 301 
228 bd 0 305 
230 ad 0 300 
230 bd 0 298 
6137-4© 340 af 12979 310 
340 df 14910 304 
341 ad 12846 301 
341 bd 10850 306 
613&6© 258 ad 0 300 
258 bd 32368 300 
Peak Area Total ng/300 sec 
Time- ng Extract Volume-
Corrected  ^ Isoquercitrin  ^ Volume Corrected  ^
0 0 630 0 
0 0 630 0 
0 0 465 0 
0 0 465 0 
0 0 590 0 
11161 127 590 1495 
0 0 350 0 
0 0 350 0 
0 0 500 0 
0 0 500 0 
12560 132 465 1225 
14714 139 465 1297 
12803 133 520 1379 
10637 125 520 1298 
0 0 325 0 
32368 203 325 1321 
Table A.â.5. Continued 
Peak Area Total ng/300 sec 
Maturity Ear Isoquercitrin Incubation Time- ng Extract Volume-
CD AP) (1987) Assay Peak Area Time (sec) Corrected  ^ Isoquercitrin  ^ Volume Corrected  ^
Mature 
259 ad 0 300 0 0 375 0 
259 bd 13866 301 13820 136 375 1022 
6134-1© 344 ad 0 300 0 0 450 0 
344 bd 16863 305 16587 146 450 1316 
346 ad 0 305 0 0 595 0 
346 bd 0 300 0 0 595 0 
6132-3© 929a81 0 300 0 0 290 0 
929b81 0 300 0 0 290 0 
374 ad 19106 300 19106 155 270 839 
374 bd 11766 300 11766 129 270 696 
6136-10® 350 ad 0 300 0 0 300 0 
350 bd 13363 300 13363 135 300 807 
375 ad 19999 300 19999 159 295 936 
375 bd 36223 304 35746 215 295 1271 
Table A.3.6. Isoquercitrin data from UFGT assays for C-QineC) sh Bz wx used to construct Figures 4.10 
and 4.13, Section 4.2.1.4. Assay results are ordered by tissue maturity and ear source. 
Results are presented as isoquercitrin peak area (raw data corrected for endogenous 
isoquercitrin), intermediate calculations and ng isoquercitrin produced in 300 seconds 
corrected for UFGT extract volume 
Peak Area Total ng/300 sec 
Maturity Ear Isoquercitrin Incubation Time- ng Extract Volume-
(DAP) (1987) Assay Peak Area Time (sec) Corrected  ^ Isoquercitrin  ^ Volume Corrected  ^
18 6228-2t0 119 ad 0 300 0 0 460 0 
119 bd 0 300 0 0 460 0 
120 ad 0 300 0 0 470 0 
120 bd 0 305 0 0 470 0 
6227-lt© 147 ad 0 300 0 0 410 0 
147 bd 0 302 0 0 410 0 
146 ad 0 300 0 0 570 0 
146 bd 0 300 0 0 570 0 
27 6228-10 115 ad 47030 300 47030 256 340 1741 
115 cd 39707 300 39707 230 340 1562 
iPeak area time-corrected values were calculated using Equation 1, Section 4.2.1.2. 
%g Isoquercitrin calculated using standard curve and Equation 2, Section 4.2.1.2. 
3ng Isoquercitrin/300 sec volume-corrected values were calculated using Equation 3> Section 4.2.1.2. 
Table A.3.6. Continued 
Maturity Ear Isoquercitrin Incubation 
(DAP) (1987) Assay Peak Area Time (sec) 
117 ad 
117 bd 
27387 
27963 
301 
295 
n.a. 
36 6225-70 
45 6228-6t© 
130 ad 
130 bd 
353 ad 
353 bd 
6229-120 
157 ad 
157 bd 
233 ad 
233 bd 
235 ad 
235 bd 
360 ad 
360 bd 
162170 
160111 
253907 
260605 
62254© 154 ad 142828 
154 bd 156982 
92426 
97501 
446026 
507092 
131057 
174448 
309225 
364837 
300 
300 
300 
305 
300 
304 
308 
300 
300 
300 
301 
304 
300 
310 
Peak Area Total ng/300 sec 
Time- ng Extract Volume-
Correctedl Isoquercitrin  ^ Volume Corrected  ^
27296 185 305 1128 
28437 189 305 1153 
162170 671 200 2685 
160111 664 200 2656 
253907 1002 480 9621 
256333 1011 480 9705 
142828 602 450 5414 
154916 645 450 5807 
90025 411 500 4111 
97501 438 500 4381 
446026 1695 390 13222 
507092 1915 390 14940 
130622 558 520 5799 
172153 707 520 7357 
309225 1202 440 9614 
353068 1360 400 10879 
Table A.3.6. Continued 
Peak Area Total ng/300 sec 
Maturity Ear Isoquercitrin Incubation Time- ng Extract Volume-
CD AP) (1987) Assay Peak Area Time (sec) Corrected  ^ Isoquercitrin  ^ Volume Corrected  ^
361 ad 132105 304 130367 557 225 2505 
361 bd 135576 305 133353 367 225 2553 
Mature 622&4© al2867 330176 300 330176 1277 325 8303 
bl2867 307628 300 307628 1196 325 7774 
348 ad 323720 300 323720 1254 355 8904 
348 bd 331285 300 331285 1281 355 9097 
6228-5© 915a81 309089 330 280990 1100 325 7149 
915b81 289405 300 289405 1130 325 7347 
349 ad 150593 300 150593 630 365 4596 
349 bd 151065 300 151065 631 365 4608 
Table A.3.7. Isoquercitrin data from UFGT assays for c-ruq66 sh Bz wx used to construct Figures 4.11 
and 4.13, Section 4.2.1.4. Assay results are ordered by tissue maturity and ear source. 
Results are presented as isoquercitrin peak area (raw data corrected for endogenous 
isoquercitrin), intermediate calculations and ng isoquerdtrin produced in 300 seconds 
corrected for UFGT extract volume 
Peak Area Total ng/300 sec 
Maturity Ear Isoquercitrin Incubation Time- ng Extract Volume-
(DAP) (1987) Assay Peak Area Time (sec) Corrected  ^ Isoquercitrin  ^ Volume Corrected  ^
18 6233-80 328 bd 18201 315 17334 149 345 1028 
328 cd 23649 301 23570 171 345 1183 
331 ad 8907 300 8907 119 340 806 
331 bd 0 300 0 0 340 0 
n.a. 
27 6230-3© 292 ad 69196 300 69196 336 465 3125 
292 bd 20035 300 20035 159 465 1476 
294 ad 39668 300 ^668 230 470 2157 
294 bd 19624 300 19624 157 470 1478 
iPeak area time-corrected values were calculated using Equation 1, Section 4.2.1.2. 
%g Isoquercitrin calculated using standard curve and Equation 2, Section 4.2.1.2. 
3ng Isoquercitrin/300 sec volume-corrected values were calculated using Equation 3, Section 4.2.1.2. 
Table A.3.7. Continued 
Maturity Ear Isoquercitrin Incubation 
(DAP) (1987) Assay Peak Area Time (sec) 
36 
6233-1© 288 ad 0 
288 bd 17732 
289 ad 0 
289 bd 0 
6234y-30 296 ad 0 
296 bd 0 
297 ad 26960 
297 bd 0 
300 
300 
300 
300 
300 
306 
300 
300 
45 
n.a. 
6230-1© 300 ad 
300 bd 
301 ad 
301 bd 
24283 
17903 
0 
16366 
315 
300 
300 
300 
n.a. 
Mature 6234y-3© 365 ad 0 
365 bd 10625 
302 
300 
Peak Area Total ng/300 sec 
Time- ng Extract Volume-
Correctedl Isoquercitrin  ^ Volume Corrected  ^
0 0 370 0 
17732 150 370 1113 
0 0 325 0 
0 0 325 0 
0 0 310 0 
0 0 310 0 
26960 183 265 973 
0 0 265 0 
23127 170 205 696 
17903 151 205 619 
0 0 360 0 
16366 145 360 1047 
0 0 400 0 
10625 125 400 998 
to 
o 
Table A.3.7. Continued 
Peak Area Total ng/300 sec 
Maturity Ear Isoquercitrin Incubation Time- ng Extract Volume-
CD AP) (1987) Assay Peak Area Time (sec) Corrected  ^ Isoquercitrin^ Volume Corrected  ^
364 ad 0 300 0 0 520 0 
364 bd 0 300 0 0 520 0 
6231-7© 372 ad 16655 310 16118 145 250 723 
372 bd 0 300 0 0 250 0 
367 ad 26172 308 25492 178 300 1070 
367 bd 17326 300 17326 149 300 894 
Table A.3.8. Isoquercitrin data from UFGT assays for c sh Bz wx used to construct Figures 4.12 and 
4.13, Section 4.2.1.4. Assay results are ordered by tissue maturity and ear source. Results 
are presented as isoquercitrin peak area (raw data corrected for endogenous isoquercitrin), 
intermediate calculations and ng isoquercitrin produced in 300 seconds corrected for UFGT 
extract volume 
Peak Area Total ng/300 sec 
Maturity Ear Isoquercitrin Incubation Time- ng Extract Volume-
(DAP) (1987) Assay Peak Area Time (sec) Corrected  ^ Isoquercitrin  ^ Volume Corrected  ^
6424-5/-15t 186 ad 0 300 0 0 440 0 
186 bd 0 304 0 0 440 0 
188 ad 0 300 0 0 540 0 
188 bd 0 305 0 0 540 0 
6440-12© 320 ad 0 315 0 0 300 0 
320 bd 0 301 0 0 300 0 
321 ad 0 295 0 0 300 0 
321 bd 0 299 0 0 300 0 
6424-14© 174 ag 0 300 0 0 415 0 
174 bg 0 300 0 0 415 0 
iPeak area time-corrected values were calculated using Equation 1, Section 4.2.1.2. 
^ng Isoquercitrin calculated using standard curve and Equation 2, Section 4.2.1.2. 
3ng Isoquerdtrin/SOO sec volume-corrected values were calculated using Equation 3, Section 4.2.1.2. 
Table A.3.8. Continued 
Maturity Ear Isoquercitrin Incubation 
(DAP) (1987) Assay Peak Area Time (sec) 
176 ad 0 300 
176 bd 0 300 
6422-5© 312 ad 0 315 
312 bd 0 315 
313 bd 0 300 
313 cd 0 305 
6423-5© 178 ad 0 301 
178 bd 0 300 
180 ad 0 301 
180 bd 0 305 
6424-6© 316 ad 0 300 
316 bd 0 310 
317 ad 0 300 
317 bd 0 300 
6422-2© 243 ad 10257 300 
243 bd 0 300 
Peak Area Total ng/300 sec 
Time- ng Extract Volume-
Corrected  ^ Isoquercitrin  ^ Volume Corrected  ^
0 0 450 0 
0 0 450 0 
0 0 306 0 
0 0 306 0 
0 0 410 0 
0 0 410 0 
0 0 335 0 
0 0 335 0 
0 0 550 0 
0 0 550 0 
0 0 408 0 
0 0 408 0 
0 0 395 0 
0 0 395 0 
10257 123 445 1098 
0 0 445 0 
Table A.3.8. Continued 
Peak Area Total ng/300 sec 
Maturity Ear Isoquercitrin Incubation Time- ng Extract Volume-
(DAP) (1987) Assay Peak Area Time (sec) Correctedl Isoquercitrin  ^ Volume Corrected  ^
324 ad 0 308 0 0 280 0 
324 bd 0 308 0 0 280 0 
6422-190 308 ad 0 300 0 0 320 0 
308 bd 0 300 0 0 320 0 
309 ad 0 320 0 0 330 0 
309 bd 0 300 0 0 330 0 
Mature 6424-8© 927a71 0 300 0 0 310 0 
927e71 0 300 0 0 310 0 
104a73 25674 300 25674 179 250 895 
104673 0 300 0 0 250 0 
6422-19© 378 ad 31515 300 31515 200 285 1141 
378 cd 31515 300 0 0 285 0 
377 ad 19828 300 19828 158 270 853 
377 bd 25569 3(S 25150 177 270 957 
212 
APPENDIX IV. QUERCETIN CONSUMPTION DATA FROM UFGT 
ACTIVITY (RAW DATA) 
Table A.4.1. Quercetin consumption in UFGT assays and blanks for C-I(A69) sh Bz wx used to construct 
Figure 4.14, Section 4.2.2.2. Results are ordered by tissue maturity and ear source and are 
present as quercetin peak area, intermediate calculations, and quercetin peak area 
consumed in 300 seconds corrected for UFGT extract volume 
Peak Area/ 
Peak Area Total 300 Sec 
Maturity Ear Quercetin Incubation Time- Extract Volume-
(DAP) (1987) Assay Blank Consumed 1 Time (sec) Corrected  ^ Volume Corrected  ^
18 6138-8© 226 a 340 300 340 420 2856 
226b 346 300 346 420 2906 
226d 299 300 299 420 2512 
368 a 221 300 221 320 1414 
368b 229 330 208 320 1331 
368d 221 303 219 320 1402 
6133-60 332 a 321 302 319 400 2552 
332b 314 300 314 400 2512 
332 d 249 300 249 400 1992 
334a 252 300 252 230 1159 
334b 201 304 198 230 911 
334 d 222 300 222 230 1021 
IQuercetin consumed is the mean initial peak area (modified blank) minus observed peak area 
Equation 5, Section 4.2.2.1. 
^Peak area time-corrected values were calculated using Equation 6, Section 4.2.2.1. 
^Quercetin consumed/300 sec volume-corrected values were calculated using Equation 7, Section 
4.2.2.1. 
Table A.4.1. Continued 
Maturity Ear Quercetin 
(DAP) (1987) Assay Blank Consumed  ^
27 6134-10 212 a 348 
212b 353 
292 d 353 
214 a 334 
214b 312 
214 d 327 
6137-13© 336 a 231 
336b 122 
336d 156 
337 a 0 
337 b 0 
337 d 0 
36 6135-50 228 a 345 
228 b 325 
228 d 347 
230a 286 
230b 282 
230 d 266 
Peak Area 
Incubation Time-
Time (sec) Corrected  ^
300 348 
300 353 
303 349 
340 293 
300 312 
300 327 
320 216 
305 120 
305 153 
303 0 
301 0 
300 0 
301 344 
305 320 
300 347 
300 286 
298 234 
300 266 
Peak Area/ 
Total 300 Sec 
Extract Volume-
Volume Corrected  ^
550 3828 
550 3883 
550 3839 
630 3692 
630 3931 
630 4120 
465 2009 
465 1116 
465 1423 
590 0 
590 0 
590 0 
350 2408 
350 2240 
350 2429 
500 2860 
500 2340 
500 2660 
Table A.4.1. Continued 
Maturity Ear Quercetin 
(DAP) (1987) Assay Blank Consumed ^  
6137-40 340 a 183 
340d 189 
340 f 200 
341a 0 
341b 171 
341 d 0 
45 613&60 258 a 202 
258 b 170 
258 d 145 
259 a 245 
259b 314 
259 d 188 
6134-1© 344 a 229 
344b 125 
344 d 20 
346 a 9 
346b 0 
346 d 0 
Peak Area 
Incubation Time-
Time (sec) Corrected  ^
310 177 
304 186 
304 197 
301 0 
306 168 
299 0 
300 202 
300 170 
300 145 
300 245 
301 313 
301 187 
300 229 
305 123 
297 20 
305 9 
300 0 
300 0 
Peak Area/ 
Total 300 Sec 
Extract Volume-
Volume Corrected  ^
465 1647 
465 1734 
465 1835 
520 0 
520 1743 
520 0 
325 1313 
325 1105 
325 942 
375 1837 
375 2347 
375 1405 
450 2061 
450 1106 
450 182 
595 105 
595 0 
595 0 
Table A.4.1. Continued 
Peak Area/ 
Peak Area Total 300 Sec 
Maturity Ear Quercetin Incubation Time- Extract Volume-
(DAP) (1987) Assay Blank Consumed  ^ Time (sec) Corrected  ^ Volume Corrected  ^
Mature 6132-30 
6136-10© 
92981a 109 300 109 290 632 
92981b 230 300 230 290 1334 
92981d 34 300 m 290 197 
374 a 0 300 0 270 0 
374b 0 300 0 270 0 
374 d 33 300 33 270 178 
350 a 0 300 0 300 0 
350b 0 300 0 300 0 
350 d 0 300 0 300 0 
375 a 0 300 0 295 0 
375b 30 304 30 295 177 
375 d 23 315 22 295 129 
Table A.4.2. Quercetin data from UFGT assays and blanks for C-(line C) sh Bz wx used to construct 
Figure 4.15, Section 4.2.2.2. Results are ordered by tissue maturity and ear source and are 
present as quercetin peak area, intermediate calculations, and quercetin peak area 
consumed in 300 seconds corrected for UFGT extract volume 
Maturity 
(DAP) 
18 
Ear 
(1987) Assay Blank 
Quercetin 
Consumed! 
Incubation 
Time (sec) 
Peak Area 
Time-
Corrected  ^
Total 
Extract 
Volume 
Peak Area/ 
300 Sec 
Volume-
Corrected  ^
6228-250 119 a 309 300 309 460 2843 
119 b 320 300 320 460 2944 
119 d 318 300 318 460 2926 
120 a 332 300 332 470 3121 
120b 333 305 327 470 3079 
120 d 329 300 329 470 3093 
6227-lt0 147 a 276 300 276 410 2263 
147b 276 302 274 410 2248 
147 d 285 300 285 410 2337 
146 a 321 300 321 570 3659 
146b 327 300 327 570 3728 
146 d ^1 304 317 570 3611 
iQuercetin consumed is the mean initial peak area (modified blank) minus observed peak area 
Equation 5, Section 4.2.2.1. 
^Peak area time-corrected values were calculated using Equation 6, Section 4.2.2.1. 
^Quercetin consumed/300 sec volume-corrected values were calculated using Equation 7, Section 
4.2.2.1. 
Table A.4.2. Continued 
Peak Area/ 
Peak Area Total 300 Sec 
Maturity Ear Quercetin Incubation Time- Extract Volume-
(DAP) (1987) Assay Blank Consumed  ^ Time (sec) Corrected  ^ Volume Corrected  ^
27 6228-10 115 a 
115 c 
117 a 
117b 
115 d 
117 d 
353 
346 
332 
252 
333 
293 
300 
300 
303 
301 
295 
300 
353 
346 
330 
251 
339 
293 
340 
340 
340 
305 
305 
305 
2400 
2353 
2243 
1532 
2066 
1787 
36 
n.a. 
6225-7© 
6225-4© 
130 a 
130b 
353a 
353b 
154 a 
154b 
157 a 
157 b 
130 d 
353 d 
154 d 
157 d 
342 
337 
341 
209 
201 
129 
256 
230 
148 
133 
0 
21 
300 
300 
300 
300 
305 
301 
300 
304 
300 
308 
300 
300 
342 
337 
341 
209 
198 
128 
256 
227 
148 
129 
0 
21 
200 
200 
200 
480 
480 
480 
450 
450 
450 
500 
500 
500 
1368 
1348 
1364 
2006 
1898 
1234 
2304 
2043 
1332 
1295 
0 
210 
Table A.4.2. Continued 
Maturity Ear Quercetin 
(DAP) (1987) Assay Blank Consumed  ^
45 6228-6tô 233 a 330 
233b 350 
233 d 206 
235 a 299 
235b 297 
235 d 299 
6229-12© 360 a 277 
360 b 269 
360 d 153 
361a 363 
361b 320 
361d 279 
Mature 62264© 12867 a 259 
12867b 241 
12867d 217 
348 a 291 
348 b 281 
348 d 99 
Peak Area/ 
Peak Area Total 300 Sec 
Incubation Time- Extract Volume-
Time (sec) Corrected  ^ Volume Corrected  ^
300 330 390 2574 
300 350 390 2730 
300 206 390 1607 
301 298 520 3099 
304 293 520 3048 
300 299 520 3110 
300 277 400 2216 
310 260 400 2082 
299 153 400 1228 
304 358 225 1612 
305 315 225 1416 
300 279 225 1256 
300 259 325 1683 
300 241 325 1566 
304 214 325 13  ^
300 291 355 2066 
300 281 355 1995 
300 99 355 702 
Table A.4.2. Continued 
Peak Area/ 
Peak Area Total 300 Sec 
Maturity Ear Quercetin Incubation Time- Extract Volume-
(DAP) (1987) Assay Blank Consumed 1 Time (sec) Corrected  ^ Volume Corrected  ^
6228-50 91581a 146 330 133 325 863 
91581b 143 300 143 325 929 
91581c 61 300 61 325 396 
349 a 59 300 59 365 431 
349b 19 300 19 365 139 
349 d 37 300 37 365 270 
Table A.4.3. Quercetin data from UFGT assays and blanks for c-ruqSG sh Bz wx used to construct Figure 
4.16, Section 4.2.2.2. Results are ordered by tissue maturity and ear source and are present 
as quercetin peak area, intermediate calculations, and quercetin peak area consumed in 
300 seconds corrected for UFGT extract volume 
Peak Area/ 
Peak Area Total 300 Sec 
Maturity Ear Quercetin Incubation Time- Extract Volume-
(DAP) (1987) Assay Blank Consumed 1 Time (sec) Corrected  ^ Volume Corrected  ^
18 6233-80 328 b 254 315 242 345 1669 
328 c 255 301 254 345 1754 
328 d 249 300 249 345 1718 
331a 268 300 268 340 1822 
331b 239 300 239 340 1625 
331 d 271 300 271 340 1843 
27 
n.a. 
6230-30 292 a 248 300 248 465 2306 
292b 248 300 248 465 2306 
292 d 297 300 297 465 2762 
^Quercetin consumed is the mean initial peak area (modified blank) minus observed peak area 
Equation 5, Section 4.2.2.1. 
^Peak area time-corrected values were calculated using Equation 6, Section 4.2.2.1. 
^Quercetin consumed/300 sec volume-corrected values were calculated using Equation 7, Section 
4.2.2.1, 
Table A.4.3. Continued 
Maturity Ear 
(DAP) (1987) Assay Blank 
Quercetin 
Consumed  ^
294 a 
294b 
294 d 
315 
284 
275 
6233-1® 288 a 
288b 
288 d 
315 
299 
305 
36 
289 a 
289b 
6234y-30 296 a 
296b 
289 d 
296 d 
314 
278 
291 
329 
313 
321 
297 a 
297b 
297 d 
180 
180 
270 
45 
n.a. 
6230-1© 300 a 
300b 
300 d 
309 
300 
257 
Peak Area/ 
Peak Area Total 300 Sec 
Incubation Time- Extract Volume-
Time (sec) Corrected  ^ Volume Corrected  ^
300 
300 
300 
315 
284 
275 
470 
470 
470 
2961 
2670 
2585 
300 
300 
301 
315 
299 
304 
370 
370 
370 
2331 
2213 
2250 
300 
300 
300 
314 
278 
291 
325 
325 
325 
2041 
1807 
1891 
300 
306 
300 
329 
307 
321 
310 
310 
310 
2140 
1902 
1990 
300 
300 
300 
180 
180 
270 
265 
265 
265 
954 
954 
1431 
315 
300 
300 
294 
300 
257 
205 
205 
205 
1206 
1230 
1054 
Table A.4.3. Continued 
Peak Area/ 
Peak Area Total 300 Sec 
Maturity Ear Quercetin Incubation Time- Extract Volume-
(DAP) (1987) Assay Blank Consumed  ^ Time (sec) Corrected  ^ Volume Corrected  ^
301a 
301b 
301 d 
194 
285 
248 
300 
300 
320 
194 
285 
232 
360 
360 
360 
1397 
2052 
1674 
n.a. 
Mature 6234y-3® 365 a 
365b 
365 d 
73 
0 
199 
302 
300 
300 
72 
0 
199 
400 
400 
400 
580 
0 
1592 
6231-7© 
364 a 
364b 
372 a 
372b 
364 d 
372 d 
0 
0 
0 
98 
98 
33 
300 
300 
300 
310 
300 
305 
0 
0 
0 
90 
93 
32 
520 
520 
520 
250 
250 
250 
0 
0 
0 
450 
465 
162 
367 a 
367b 
367 d 
96 
84 
84 
308 
300 
302 
93 
84 
83 
300 
300 
300 
561 
504 
501 
Table A.4.4. Quercetin data from UFGT assays and blanks for c sh Bz wx used to construct Figure 4.17, 
Section 4.2.2.2. Results are ordered by tissue maturity and ear source and are present as 
quercetin peak area, intermediate calculations, and quercetin peak area consumed in 300 
seconds corrected for UFGT extract volume 
Peak Area/ 
Peak Area Total 300 Sec 
Maturity Ear Quercetin Incubation Time- Extract Volume-
(DAP) (1987) Assay Blank Consumed  ^ Time (sec) Corrected  ^ Volume Corrected  ^
18 6424-5/-15t 186 a 348 300 348 440 3062 
186 b 348 304 343 440 3022 
186 d 354 305 348 440 3064 
188 a 165 300 165 540 1782 
188b 174 305 171 540 1843 
180 d 189 300 189 540 2041 
6440-12© 320 a 212 315 202 300 1211 
320b 210 301 209 300 1256 
320 d 196 305 193 300 1157 
321a 224 295 228 300 1367 
321b 169 299 169 300 1017 
321 d 222 300 222 300 1332 
^Quercetin consumed is the mean initial peak area (modified blank) minus observed peak area 
Equation 5, Section 4.2.2.1. 
2Peak area time-corrected values were calculated using Equation 6, Section 4.2.2.1. 
^Quercetin consumed/300 sec volume-corrected values were calculated using Equation 7, Section 
4.2.2.1. 
Table A.4.4 Continued 
Maturity Ear Quercetin 
(DAP) (1987) Assay Blank Consumed  ^
27 6424-14® 174 a 336 
174 b 340 
174 g 356 
176 a 336 
176 b 340 
176 d 338 
6422-5© 312 a 223 
312b 204 
312 d 262 
313b 261 
313 c 225 
313 d 219 
36 6423-50 178 a 151 
178 b 150 
178 d 206 
180 a 159 
180b 142 
180 d 208 
Peak Area 
Incubation Time-
Time (sec) Corrected  ^
300 336 
300 340 
300 356 
300 336 
300 340 
300 338 
315 212 
315 194 
300 262 
300 261 
305 221 
310 212 
301 150 
300 150 
300 206 
301 158 
305 140 
300 208 
Peak Area/ 
Total 300 Sec 
Extract Volume-
Volume Corrected  ^
415 2789 
415 2822 
415 2955 
450 3024 
450 3060 
450 3042 
306 1300 
306 1189 
306 1603 
410 2140 
410 1815 
410 1738 
335 1008 
335 1005 
335 1380 
550 1743 
550 1536 
550 2288 
Table A.4.4. Continued 
Maturity Ear Quercetin 
(DAP) (1987) Assay Blank Consumed  ^
6424r60 316 a 193 
316 b 177 
316d 272 
317 a 179 
317 b 209 
317d 130 
45 6422-2© 243 a 341 
243b 341 
243 d 320 
324 a 222 
324b 141 
324d 227 
6422-190 308 a 117 
308 b 76 
308 d 125 
309 a 161 
309b 137 
309d 81 
Peak Area 
Incubation Time-
Time (sec) Corrected^ 
300 193 
310 171 
300 272 
300 179 
300 209 
300 130 
300 341 
300 341 
301 319 
308 216 
308 137 
300 227 
300 117 
300 76 
300 125 
320 151 
300 137 
302 80 
Peak Area/ 
Total 300 Sec 
Extract Volume-
Volume Corrected^ 
408 1575 
408 1398 
408 2219 
395 1414 
395 1651 
395 1027 
445 3035 
445 3035 
445 2838 
280 1211 
280 769 
280 1271 
320 749 
320 486 
320 800 
330 996 
330 904 
330 531 
Table AAA. Continued 
Peak Area/ 
Peak Area Total 300 Sec 
Maturity Ear Quercetin Incubation Time- Extract Volume-
(DAP) (1987) Assay Blank Consumed  ^ Time (sec) Corrected  ^ Volume Corrected  ^
Mature 6424-80 92771a 199 300 199 310 1234 
92771e 320 300 320 310 1984 
92771d 114 300 114 310 707 
10473 a 0 300 0 250 0 
10473b 0 300 0 250 0 
10473 d 0 300 0 250 0 
6422-19© 378 a 78 300 78 285 445 
378 c 90 300 90 285 513 
378 d 69 300 69 285 393 
377 a 0 305 0 270 0 
377b 37 305 36 270 196 
377 d 81 300 81 270 437 
228 
APPENDIX V. PEAK AREA RAW DATA FROM HPLC ANALYSIS OF 
QUERCETIN GLYCOSIDE AND SUBSTITUTED 
CINNAMIC ACID ACCUMULATION 
Table A.5.1. Data from flavonol extracts of C-I(A69) sh Bz wx kernels. Includes total 340 nm absorbance 
(Figure 4.18) and quercetin glycosides. Results are ordered by tissue maturity and ear 
source. Results are corrected for total extract volume and volume assayed. The following 
abbreviations are used for the quercetin glycosides: QU3G, quercetin-3-glucoside (Figures 
4.22 to 4.24); QU7G, quercetin-7-glucoside (Figures 4.25 to 4.27); and QU37D, quercetin-3,7-
diglucoside (Figures 4.28 to 4.30) 
Total 340 nm 
Maturity Ear Absorbance 
(DAP) (1987) Extract x 10  ^ QU3G QU7G QU37D 
18 6138-80 FlllOa 
Flllla . 
n.a. 
3649.52 
2122.97 
0 
298425 
960778 
39710 
1336340 
63438 
6133^0 FI013a 
FI056a 
FI08a 
2973.90 
3955.67 
8511.71 
422105 
199953 
762510 
57068 
124930 
45043 
11428 
48530 
8698 
27 6134-1© FI029a 
FI057a 
FI058a 
4399.06 
13595.72 
10124.64 
0 
513548 
593558 
2857475 
269698 
0 
157223 
189403 
56985 
6137-13® FI014a 
FI059a 
FI060a 
12176.63 
8127.45 
4345.96 
8258090 
430865 
358195 
362315 
383695 
6963 
176000 
737290 
31628 
36 6135-5© FI028a 
FI061a 
FI107a 
9768.27 
15476.00 
19457.51 
59208 
1023370 
348745 
207248 
121993 
568248 
36125 
423578 
31090 
Table A.5.1. Continued 
Total 340 nm 
Maturity Ear Absorbance 
(DAP) (1987) Extract x 103 QU3G QU7G QU37D 
45 
Mature 
6137-4© FI027a 7469.73 118825 563035 311165 
FI062a 5591.39 260220 673540 20420 
FI112a 11814.35 8527678 6558 1386988 
6136-6© FI104a 11471.91 400530 229380 131888 
FllOSa 6106.51 4860705 120368 136688 
FI106a 6193.41 4367453 229208 242460 
6134-1© FllOla 16077.48 12567215 301218 561503 
FI102a 17046.00 285893 190535 160508 
FI103a 17273.77 10558600 582810 564963 
6132-3© FI026a 17975.76 120725 1091970 2257665 
FI055a 7847.91 213575 193740 186270 
FI064b 14141.63 907928 995213 1482900 
6136-10© FI025a 15886.37 209460 1222823 3145658 
FI053a 19649.97 7667633 2643068 1832595 
FI054b 52.61 531248 788670 116250 
Table A.5.2. Data from flavonol extracts of C-GineC) sh Bz wx kernels. Includes total 340 nm absorbance 
(Figure 4,18) and quercetin glycosides. Results are ordered by tissue maturity and ear 
source. Results are corrected for total extract volume and volume assayed. The following 
abbreviations are used for the quercetin glycosides: QU3G, quercetin-3-glucoside (Figures 
4.22 to 4.24); QU7G, quercetin-7-glucoside (Figures 4.25 to 4.27); and QU37D, quercetin-3,7-
diglucoside (Figures 4.28 to 4.30) 
Total 340 nm 
Maturity Ear Absorbance 
(DAP) (1987) Extract x 10  ^ QU3G QU7G QU37D 
18 
27 
6228-2t0 
6227.1t0 
6228-1© 
FL031a 
FL066a 
FL067a 
FL068a 
FL069a 
FLC03a 
FL097a 
FL098a 
FLlOOa 
1155.57 
2212.09 
11092.67 
10231.33 
4808.57 
47422.14 
8798.13 
13539.15 
20249.29 
46265 
145570 
0 
0 
8370 
3317865 
0 
513548 
1187115 
176883 
569428 
0 
0 
142655 
292525 
5714950 
269698 
0 
220863 
302875 
276718 
254145 
45510 
241450 
314445 
189403 
113970 
36 
n.a. 
6225-7® FLOlOa 
FL070a 
FL099a 
17642.02 
8782.65 
15572.24 
2958830 
660375 
383845 
821700 
2764688 
353875 
4115130 
35078 
914155 
Table A.5.2. Continued 
Maturity 
(DAP) 
Ear 
(1987) Extract 
Total 340 nm 
Absorbance 
X10  ^ QU3G QU7G QU37D 
6225AQ FLi092a 
FLi093a 
FL094a 
10874.65 
12671.06 
8193.41 
208815 
538790 
12730 
76535 
98265 
55475 
135675 
784160 
61440 
45 6228-6tô FLOSOa 
FL072a 
FL073a 
24552.90 
5018.40 
9015.56 
14962628 
0 
1439530 
1522050 
382235 
1841720 
849075 
100940 
132750 
6229-120 FI063a 
FL091a 
n.a. 
10312.40 
8256.68 
2206925 
176648 
6043155 
137430 
112605 
50190 
Mature 622&4© FL065a 
FL071a 
FL117a 
58597.75 
102351.25 
71844.41 
3181320 
1195133 
1251270 
8798670 
2092740 
3222600 
27260590 
70754190 
36250965 
6228-5© FL032a 
FL095a 
FL096a 
11183.21 
30967.82 
18179.76 
870350 
2176140 
1512720 
290108 
1472850 
2149740 
4184633 
16013115 
7003733 
Table A.5.3. Data from flavonol extracts of c-ruq66 sh Bz wx kernels. Includes total 340 nm absorbance 
(Figure 4.18) and quercetin glycosides. Results are ordered by tissue maturity and ear 
source. Results are corrected for total extract volume and volume assayed. The following 
abbreviations are used for the quercetin glycosides: QU3G, quercetin-3-glucoside (Figures 
4.22 to 4.24); QU7G, quercetin-7-glucoside (Figures 4.25 to 4.27); and QU37D, quercetin-3,7-
diglucoside (Figures 4.28 to 4.30) 
Total 340 nm 
Maturity Ear Absorbance 
(DAP) (1987) Extract x 103 QU3G QU7G QU37D 
18 
27 
36 
6233-80 
n.a. 
6230-3® 
6233.1® 
6234y-3© 
F6074a 
F6075a 
F6076a 
F6033a 
F6079a 
F6080a 
F6017a 
F6077a 
F6078a 
F6018a 
F6081a 
F6086a 
12060.76 
15161.14 
16117.71 
13784.67 
35411.52 
22517.80 
26294.81 
15599.29 
40340.31 
7253.90 
10199.35 
10410.23 
924037 
43847 
43220 
5117390 
5420495 
165000 
11417090 
9842330 
596650 
79265 
4752743 
2022538 
549238 
296553 
1326890 
1646553 
433458 
245850 
2031885 
0 
22578850 
864000 
215^243 
315683 
37285 
11724848 
141998 
511463 
1666560 
979193 
1264580 
275460 
1431293 
232055 
288145 
483735 
n.a. 
Table A.5.3. Continued 
Total 340 nm 
Maturity Ear Absorbance 
(DAP) (1987) Extract x 103 QU3G QU7G QU37D 
45 6230-1© F6019a 
F6084a 
F6085a 
13321.48 
4331.53 
5083.25 
3025570 
1312275 
1500443 
267350 
453570 
615315 
3375210 
1150350 
25358 
Mature 
n.a. 
6234y-3® 
6231-7© 
F6035a 
F6087a 
F6088a 
F6034a 
F6089a 
F6090a 
15122.54 
19187.19 
38009.99 
4173.62 
30451.53 
14657.30 
146312 
3160508 
5854305 
0 
2407455 
1219118 
1909179 
1853430 
2872635 
108195 
2675340 
2247555 
474179 
308895 
9492645 
1482415 
71468 
592478 
Table A.5.4. Data from flavonol extracts of c sh Bz wx kernels. Includes total 340 nm absorbance (Figure 
4.18) and quercetin glycosides. Results are ordered by tissue maturity and ear source. 
Results are corrected for total extract volume and volume assayed. The following 
abbreviations are used for the quercetin glycosides: QU3G, quercetin-3-glucoside (Figures 
4.22 to 4.24); QU7G, quercetin-7-glucoside (Figures 4.25 to 4.27); and QU37D, quercetin-3,7-
diglucoside (Figures 4.28 to 4.30) 
Total 340 nm 
Maturity Ear Absorbance 
(DAP) (1987) Extract x 103 QU3G QU7G QU37D 
18 6424-5/-15t FC020a 
FC036a 
FC037a 
2605.89 
195.86 
3020.46 
11940 
9845 
500848 
146378 
36265 
120265 
27618 
9010 
439583 
6440-120 FC012a 
FC038a 
FC039a 
1999.81 
117.21 
95.88 
176980 
4865 
8030 
103938 
29163 
21293 
4708 
18588 
0 
27 6424-140 FCOlla 
FC041a 
FC042a 
8093.02 
6814.69 
4982.04 
2187070 
1535308 
0 
452905 
172553 
0 
670895 
44680 
879353 
6422-5© FC114a 
FC115a 
FC116a 
8389.91 
3966.53 
10446.68 
5436040 
68895 
131375 
150008 
970685 
4030753 
285225 
512760 
447733 
36 6423-50 FC021a 
FC043b 
FC044a 
8293.11 
4243.49 
7561.75 
6285520 
2995 
65658 
372660 
282998 
363118 
92230 
160890 
309920 
Table A.5.4. Continued 
Total 340 mn 
Maturity Ear Absorbance 
(DAP) (1987) Extract x 103 QU3G QU7G QU37D 
36 6424-6© FC045a 
FC046a 
FCCOSa 
7599.61 
8531.38 
9826.86 
502003 
628798 
6812560 
192023 
135923 
425420 
423700 
558925 
58220 
45 6422-2© FC015a 
FC047a 
FCllSa 
11286.68 
8838.60 
6548.65 
92505 
589950 
344700 
368970 
84850 
3047145 
1891925 
1792245 
291770 
6422-19© FC022a 
FC048b 
FC049b 
12562.62 
7681.47 
8150.44 
96520 
556050 
459507 
697940 
59132 
40420 
439465 
261355 
9450 
Mature 6424-8© FC024a 
FCOSla 
FC052a 
16082.92 
22901.37 
56082.40 
2477090 
587370 
3542910 
314455 
841755 
15692500 
5166430 
5848800 
18860180 
6422-19© FC023a 
FC040a 
FC050a 
22333.69 
10119.60 
23029.50 
489120 
193850 
2870330 
2966893 
1095790 
4052890 
548993 
469653 
909880 
Table A.5.5. Data from flavonol extracts of C'I(A69) sh Bz wx kernels. Includes quercetin glycosides 
and substituted cinnamic acids. Results are ordered by tissue maturity and ear source. 
Results are corrected for total extract volume and volume assayed. The following 
abbreviations are used for the quercetin glycosides and substituted cinnamic acids: QU3S, 
quercetin-S-sophoroside (Figures 4.31 to 4.33); QU3S7G, quercetin-3-sophoroside-7-glucoside 
(Figures 4.34 and 4.35); QU3C7G, quercetin-3-(caffeoylsophoroside)-7-glucoside (Figures 
4.37 to 4.39); CAFAG, cafifeic acid-glucoside (Figures 4.41 and 4.43); and pCOUMA, 
p-coumaric acid (Figures 4.40 and 4.42) 
Maturity Ear 
(DAP) (1987) Extract QU3S QU3S7G QU3C7G CAFAG p-COUMA 
IB 6138-8© FlllOa 
Flllla 
n.a. 
137215 
107743 
0 
0 
122510 
1298940 
62488 
22153 
35993 
18950 
6133-60 FI013a 
FI056a 
FI08a 
47228 
71808 
88238 
218725 
205025 
167488 
1991925 
2827418 
6871975 
46135 
133080 
0 
11553 
42313 
106853 
27 6134-10 FI029a 
FI057a 
FI058a 
751288 
296675 
60553 
93035 
42893 
263453 
97058 
132525 
57190 
0 
43625 
19168 
37475 
448208 
181945 
6137-130 FI014a 
FI059a 
FI060a 
75840 
83065 
82978 
901875 
753920 
47860 
119530 
0 
125553 
28470 
14290 
20848 
173250 
106970 
41303 
36 6135-50 FI028a 
FI061a 
FI107a 
30653 
175938 
88815 
60063 
589518 
12720 
645188 
160068 
78808 
84225 
91823 
107313 
152010 
176328 
81883 
Table A.5.5. Continued 
Maturity Ear 
(DAP) (1987) Extract QU3S QU3S7G QU3C7G CAFAG p-COUMA 
45 
Mature 
6137-40 FI027a 
FI062a 
FI112a 
115263 
46785 
238603 
65070 
19455 
71823 
329923 
33695 
47530 
46593 
18960 
92740 
296608 
100850 
331610 
6136^0 FI104a 
FI105a 
FI106a 
93390 
91185 
225878 
293175 
21915 
51585 
56033 
25695 
16005 
803738 
41693 
120705 
26820 
90960 
13313 
6134-10 FllOla 
FI102a 
FllOSa 
54608 
285755 
2298 
569153 
483355 
1169527 
143240 
194613 
310948 
125800 
147465 
106153 
450090 
426368 
32320 
6132-30 FI026a 
FI055a 
FI064b 
1875430 
24005 
50580 
216695 
165385 
146078 
686725 
101015 
109575 
203270 
30320 
85710 
429500 
174425 
512055 
6136-100 FI025a 
FI053a 
FI054b 
4638765 
254895 
52260 
122925 
275633 
49290 
356993 
225480 
25058 
139680 
107258 
16523 
399143 
338490 
54158 
Table A.5.6. Data from flavonol extracts of C-GineC) sh Bz wx kernels. Includes quercetin glycosides 
and substituted cinnamic acids. Results are ordered by tissue maturity and ear source. 
Results are corrected for total extract volume and volume assayed. The following 
abbreviations are used for the quercetin glycosides and substituted cinnamic acids: QU3S, 
quercetin-3-sophoroside (Figures 4.31 to 4.33); QU3S7G, quercetin-3-sophoroside-7-glucoside 
(Figures 4.34 to 4.36); QU3C7G, quercetin-3-(cafifeoylsophoroside)-7-glucoside (Figures 4.37 
to 4.39); CAFAG, cafiFeic acid-glucoside (Figures 4.41 and 4.43); and pCOUMA, p-coumaric 
acid (Figures 4.40 and 4.42) 
Maturity Ear 
(DAP) (1987) Extract QU3S QU3S7G QU3C7G CAFAG p-COUMA 
18 6228-2t© FL031a 
FL066a 
FL067a 
61193 
63075 
313005 
103685 
10020 
309280 
431888 
649783 
6266485 
0 
70528 
122653 
11610 
51075 
257203 
6227-lt® FL068a 
FL069a 
FLC03a 
229118 
80365 
164380 
378663 
437250 
751315 
7532075 
2370333 
1053910 
29113 
143658 
181245 
8563 
619088 
0 
27 6228-1© 
n.a. 
6225-7© 
FL097a 
FL098a 
FLlOOa 
1502575 
296675 
121105 
186070 
42893 
526905 
194115 
132525 
114380 
0 
43625 
38335 
74950 
448208 
363890 
36 FLOlOa 
FL070a 
FL099a 
2511030 
2034713 
406045 
53540 
8918 
52105 
233850 
77633 
176660 
34380 
52928 
1022995 
180940 
353610 
24260 
Table A.5.6. Continued 
Maturity Ear 
(DAP) (1987) Extract QU3S QU3S7G QU3C7G CAFAG p-COUMA 
622&4® FL092a 
FL093a 
FL094a 
71150 
92980 
117780 
0 
303660 
31900 
161885 
905645 
72175 
174875 
79075 
68715 
250150 
197940 
176920 
45 6228-6t0 FLOSOa 
FL02a 
FL073a 
146220 
121790 
654445 
124290 
311205 
134980 
493568 
542190 
267090 
365858 
342920 
190260 
274980 
259680 
53200 
6229-12© FL063a 
FL091a 
n.a. 
0 
20220 
58560 
0 
0 
130418 
0 
0 
636690 
250343 
Mature 62264© FL065a 
FL071a 
FL117a 
1111800 
4454258 
3902040 
162140 
921330 
287618 
358430 
8341590 
3707363 
114940 
535320 
173895 
1211360 
1515818 
842925 
6228-5© FL032a 
FL095a 
FL096a 
1933175 
3623655 
404963 
213800 
263648 
476408 
456150 
1878608 
972615 
0 
37943 
197460 
91258 
166043 
0 
Table A.5.7. Data from flavonol extracts of c-ruq66 sh Bz wx kernels. Includes quercetin glycosides and 
substituted cinnamie acids. Results are ordered by tissue maturity and ear source. Results 
are corrected for total extract volume and volume assayed. The fofiowing abbreviations are 
used for the quercetin glycosides and substituted dnnamic acids: QU3S, quercetin-3-
sophoroside (Figures 4.31 to 4.33); QU3S7G, quercetin-3-sophoroside-7-glucoside (Figures 
4.34 to 4.36); QtJ3C7G, quercetin-3-(ca£Feoylsophoroside)-7-glucoside (Figures 4.37 to 4.39); 
CAFAG, caffeic acid-glucoside (Figures 4.41 Eind 4.43); and pCOUMA, p-coumaric acid 
(Figures 4.40 and 4.42) 
Maturity Ear 
(DAP) (1987) Extract QU3S QU3S7G QU3C7G CAFAG p-COUMA 
18 6233-80 
i
l
l
 
61640 
125588 
282230 
812688 
35368 
732370 
8428435 
1212353 
11821063 
22780 
34043 
14948 
760398 
922905 
1102803 
27 
u. â.. 
62303-0 F6033a 
F6079a 
F6080a 
7433 
970610 
441375 
1411075 
152075 
37298 
3431798 
2550548 
2280278 
34380 
118215 
117845 
488968 
1753315 
816968 
6233-1® 
I
I
I
 
364270 
2020780 
3299665 
0 
32305 
2600650 
3982200 
49515 
2477345 
3819125 
19500 
41213 
237910 
0 
538233 
36 6234y-30 
I
I
I
 
37445 
133215 
226933 
647365 
119653 
0 
653880 
25450 
378155 
120420 
48230 
76093 
28365 
225210 
317455 
n.a. 
Table A.5.7. Continued 
Maturity Ear 
(DAP) (1987) Extract QU3S QU3S7G QU3C7G CAFAG p-COUMA 
45 6230-1® 
n.a. 
6234y-30 
F6019a 
F6084a 
F6085a 
1488500 
687113 
1634385 
1124830 
189803 
68993 
876920 
120503 
0 
32880 
58838 
38985 
0 
33968 
55755 
Mature F6035a 
F6087a 
F6088a 
138596 
80925 
9047265 
220150 
99143 
461385 
311092 
254040 
707085 
74283 
62265 
966803 
675596 
604088 
138675 
6231-7® F6034a 
F6089a 
F6090a 
1044305 
220748 
137520 
97480 
625913 
0 
298215 
888435 
59955 
0 
131160 
42983 
139345 
1220595 
68970 
Table A.5.8. Data from flavonol extracts of c sh Bz wx kernels. Includes quercetin glycosides and 
substituted cinnamic acids. Results are ordered by tissue maturity and ear source. Results 
are corrected for total extract volume and volume assayed. The foUowing abbreviations are 
used for the quercetin glycosides and substituted cinnamic acids: QU3S, quercetin-3-
sophoroside (Figures 4.31 to 4.33); QU3S7G, quercetin-3-sophoroside-7-glucoside (Figures 
4.34 to 4.36); QU3C7G, quercetin-3-(c£iffeoylsophoroside)-7-glucoside (Figures 4.37 to 4.39); 
CAFAG, caffeic acid-glucoside (Figures 4.41 and 4.43); and pCOUMA, p-coumaric acid 
(Figures 4.40 and 4.42) 
Maturity Ear 
(DAP) (1987) Extract QU3S QU3S7G QU3C7G CAFAG p-COUMA 
18 6424-5/-15t FC020a 
FC036a 
FC037a 
294443 
13658 
115725 
191878 
62773 
58540 
145653 
25945 
1514188 
63495 
14003 
0 
101723 
0 
14463 
6440-120 FC012a 
FC038a 
FC039a 
80103 
10715 
11573 
8260 
30980 
43603 
1429250 
0 
0 
12945 
0 
0 
118783 
0 
0 
27 6424-14© FCOlla 
FC041a 
FC042a 
63580 
0 
261338 
1119615 
462965 
447590 
3185765 
4295603 
1492468 
28020 
30125 
7325 
19180 
265460 
55970 
6422-5© FC114a 
FCllSa 
FC116a 
59625 
164958 
478685 
354520 
0 
3298178 
967665 
1512898 
0 
50220 
447455 
676355 
45280 
7360 
187615 
36 6423-53 FC021a 
FC043b 
FC044a 
69695 
33813 
8813 
506970 
139463 
51250 
576515 
20163 
16540 
0 
29675 
22653 
63835 
45690 
68798 
Table A.5.8. Continued 
Maturity 
(DAP) 
Ear 
(1987) Extract QU3S QU3S7G QU3C7G CAPAG p-COUMA 
36 6424-6® FC045a 
FC046a 
FCCOSa 
224013 
9963 
185975 
0 
55770 
23475 
90900 
23760 
81580 
14428 
27218 
30760 
272265 
111668 
193030 
45 6422-20 FCOlSa 
FC047a 
FCllSa 
2678370 
3916470 
197540 
84305 
39325 
19765 
154660 
262520 
120515 
95975 
42505 
115385 
78880 
18575 
305880 
6422-190 FC022a 
FC048b 
FC049b 
198225 
9386 
6367 
0 
76827 
71317 
945340 
45009 
58703 
6725 
0 
33683 
524375 
211086 
8310 
Mature 6424-8® FC024a 
FCOSla 
FC052a 
1968485 
361223 
505670 
737665 
108968 
144010 
1030500 
184493 
388720 
57205 
97035 
242480 
141610 
1090808 
2639700 
6422-19® F0023a 
F0040a 
FOOSOa 
296780 
179695 
262090 
769813 
258913 
438210 
116693 
67783 
771000 
124693 
54773 
297520 
1315187 
456245 
806140 
245 
APPENDIX VI. PEAK AREA RAW DATA PROM HPLC ANALYSIS OF 
ANTHOCYANIN ACCUMULATION 
Table Â.6.1. Data from anthocyanin extracts of C-I(A69) sh Bz wx kernels. Includes total 540 nm 
absorbance (Figure 4.45) and anthocyanin derivatives. Results are ordered by tissue 
maturity and ear source. Results are corrected for total extract volume and volume 
assayed. The following abbreviations are used for the anthocyanin derivatives: 
PN3CAF5G, peonidin-3-(caffeylrutinoside)-5-glucoside (Figure 4.47); PN3COU5G, peonidin-
3-(p-coimiaryl rutinoside)-5-glucoside (Figure 4.50); and MV3CAF5G, malvidin-3-
(caffeylrutinoside)-5-glucoside (Figure 4.53) 
Maturity Ear Total 540 nm 
(DAP) (1987) Extract Absorbance PN3CAF5G PN3COU5G MV3CAF5G 
18 6138-8© UAI564 0 0 0 0 
UAI615 0 0 0 0 
UAI614 0 0 0 0 
6133-60 UAI563 0 0 0 0 
UAI612 0 0 0 0 
UAI613 459540 386235 73305 0 
27 6134-1© UAI652 0 0 0 0 
UAI611 97765 0 0 97765 
UAI610 129200 0 129200 0 
6137-13© UAI561 346760 346760 0 0 
UAI609 43045 0 43045 0 
UAI608 317795 317795 0 0 
36 6135-5® UAI560 0 0 0 0 
UAI603 0 0 0 0 
UAI602 0 0 0 0 
Table A.6.1. Continued 
Maturity Ear Total 540 nm 
(DAP) (1987) Extract Absorbance PN3CAF5G PN3COU5G MV3CAF5G 
36 6137-40 UAI554 94825 0 0 0 
UAI673 0 0 0 0 
UAI674 0 0 0 0 
45 613&G0 UAI550 0 0 0 0 
UAI600 0 0 0 0 
UAI601 0 0 0 0 
6134-1© UAI544 0 0 0 0 
UAI699 274235 200760 0 73475 
UAI700 0 0 0 0 
Mature 6132-30 UAI535 2942100 0 0 2942100 
UAL662 778980 778980 0 0 
UAI663 144890 144890 0 0 
6136-100 UAI651 0 0 0 0 
UAI652 0 0 0 0 
UAI653 92730 0 0 0 
Table A.6.2. Data from anthocyamn extracts of C-GineC) sh Bz wx kernels. Includes total 540 nm 
absorbance (Figure 4.45) and anthocyanin derivatives. Results are ordered by tissue 
maturity and ear source. Results are corrected for total extract volume and volume 
assayed. The following abbreviations are used for the anthocyanin derivatives: 
PN3CAF5G, peonidin-3-(caffeylrutinoside)-5-glucoside (Figure 4.47); PN3COU5G, peonidin-
3-(p-coumaryl rutinoside)-5-glucoside (Figure 4.50); and MV3CAF5G, malvidin-3-
(caffeylrutinoside)-5-glucoside (Figure 4.53) 
Maturity Ear Total 540 nm 
(DAP) (1987) Extract Absorbance PN3CAF5G PN3COU5G MV3CAF5G 
18 6228-2t0 UAL569 0 
UAL630 142135 
UAL631 0 
6227-lt0 UAL658 558895 
UAL628 0 
UAL629 0 
27 6228-10 UAL567 0 
UAL627 600540 
n.a. 
n.a. 
36 6225-7® UAL566 11505520 
UAL625 8608820 
UAL675 13942945 
0 0 0 
142135 0 0 
0 0 0 
558895 0 0 
0 0 0 
0 0 0 
0 0 0 
600540 0 0 
1144620 7323690 512960 
1700070 6392625 516125 
3999405 49860 8739080 
Table A.6.2. Continued 
Maturity Ear Total 540 nm 
(DAP) (1987) Extract Absorbance PN3CAF5G PN3COU5G MV3CAF5G 
36 622540 UAL565 0 0 0 0 
UAL598 0 0 0 0 
UAL656 775210 721940 53270 0 
45 6228-6t0 UAL551 4187575 3347040 187800 473055 
UAL582 5274945 4328435 617325 0 
UAL596 2568640 2113780 218045 0 
6229-12® UAL545 3585820 494675 2593080 252195 
UAL581 911030 96735 322890 491405 
UAL655 6000965 375450 4660930 964585 
Mature 62264© UAL604 4916755 718965 82160 2364175 
UAL658 5281560 135590 430905 2791285 
UAL659 3532025 0 941705 1491535 
6228-5© UAL529 5627888 0 129225 3688748 
UAL660 3305775 0 1066490 2239285 
UAL661 4153385 832380 1149160 2171845 
Table A.6.3. Data from anthocyanin extracts of c-ruq66 sh Bz wx kernels. Includes total 540 nm 
absorbance (Figure 4.45) and anthocyanin derivatives. Results are ordered by tissue 
maturity and ear source. Results are corrected for total extract volume and volume 
assayed. The following abbreviations are used for the anthocyanin derivatives: 
PN3CAF5G, peonidin-3-(caffeylrutinoside)-5-glucoside (Figure 4.47); PN3COU5G, peonidin-
3-(p-coumaTyl rutinoside)-5-glucoside (Figure 4.50); and MV3CAF5G, malvidin-3-
(caffeylrutinoside)-5-glucoside (Figure 4.53) 
Maturity Ear Total 540 nm 
(DAP) (1987) Extract Absorbance PN3CAF5G PN3COU5G MV3CAF5G 
18 6233-8 UA6572 0 
UA6624 63290 
UA6623 53625 
n.a. 
27 6230-30 UA6570 0 
UA6571 0 
UA6622 0 
6233-1® UA6618 82715 
UA6619 0 
UA6620 0 
36 6234y-3® UA6552 0 
UA6616 240935 
UA6617 0 
n.a. 
0 0 0 
0 63290 0 
53625 0 0 
0 0 0 
0 0 0 
0 0 0 
82715 0 0 
0 0 0 
0 0 0 
0 0 0 
0 92540 148395 
0 0 0 
Table A.6.3. Continued 
Maturity Ear Total 540 mn 
(DAP) (1987) Extract Absorbance PN3CAF5G PN3COU5G MV3CAF5G 
45 6230-1® UA6546 
UA6599 
UA6654 
836260 
2468000 
514295 
0 
0 
0 
0 
0 
0 
836260 
2468000 
514295 
Mature 
n.a. 
6234y-30 
6231-7® 
UA6534 
UA6636 
UA6657 
UA6648 
UA6649 
UA6650 
170840 
320915 
579025 
482890 
1015510 
987985 
0 
0 
579025 
0 
0 
0 
0 
78325 
0 
0 
0 
0 
170840 
242590 
0 
482890 
1015510 
987985 
Table A.6.4. Data &om anthocyanin extracts of c sh Bz wx kernels. Includes total 540 nm absorbance 
(Figure 4.45) and anthocyanin derivatives. Results are ordered by tissue maturity and ear 
source. Results are corrected for total extract volume and volume assayed. The following 
abbreviations are used for the anthocyanin derivatives: PN3CAF5G, peonidin-3-
(cafFeylrutinoside)-5-glucoside (Figure 4.47); PN3COU5G, peonidin-3-(p-coumaryl 
rutinoside)-5-glucoside (Figure 4.50); and MV3CAF5G, m^vidin-3-(cafFeylrutinoside)-5-
glucoside (ÎFigure 4.53) 
Maturity Ear Total 540 nm 
(DAP) (1987) Extract Absorbance PN3CAF5G PN3COU5G MV3CAF5G 
18 6424-5/-15t UAC559 0 0 0 0 
UAC594 0 0 0 0 
UAC595 0 0 0 0 
6440-120 UAC558 308380 308380 0 0 
UAC592 0 0 0 0 
UAC593 0 0 0 0 
27 6424-14© UAC557 0 0 0 0 
UAC591 0 0 0 0 
UAC590 0 0 0 0 
6422-5© UAC556 0 0 0 0 
UAC589 0 0 0 0 
UAC588 0 0 0 0 
38 6423-5© UAC555a 0 0 0 0 
UAC586 0 0 0 0 
UAC587 0 0 0 0 
Table A.6.4. Continued 
Maturity Ear Total 540 nm 
(DAP) (1987) Extract Absorbance PN3CAF5G PN3COU5G MV3CAF5G 
36 6424-6© UAC553 0 0 0 0 
UAC585 0 0 0 0 
UAC670 0 0 0 0 
45 6422-20 UAC583 1793435 0 124480 1668955 
6228-6t0 UAC584 948415 0 0 958415 
6228-6t0 UAC671 321320 0 0 321320 
6422-190 UAC543 0 0 0 0 
UAC580 2926290 0 0 2926290 
UAC672 0 0 0 0 
Mature 6424-80 UAC606 1419835 1419835 0 0 
UAC665 1992185 119120 0 1873065 
UAC666 827815 508500 0 319315 
6422-190 UAC531 0 0 0 0 
UAC607 0 0 0 0 
UAC664 0 0 0 0 
